Excitotoxicity is a process where nerve cells are damaged and killed by excessive stimulation from neurotransmitters, particularly glutamate, leading to an influx of calcium ions into the cells. This triggers a cascade of events that ultimately result in cell death.

Excitotoxicity is harmful to the brain due to various reasons:

– Neuronal damage and death, contributing to neurodegenerative diseases like Alzheimer’s Disease and epilepsy.

– Oxidative stress, disrupting cellular processes and leading to cell death.

– Mitochondrial dysfunction, impairing energy metabolism and producing free radicals.

– Calcium dysregulation, leading to mitochondrial and synaptic dysfunction.

– Astrocytic dysfunction, disrupting glutamate homeostasis and increasing neuronal excitability.

– Inflammatory responses, exacerbating neuronal damage.

– Disruption of normal cellular processes, mitochondrial dysfunction, oxidative stress, and ultimately cell death.

– Contribution to neurodegenerative diseases like ALS.

– Involvement in various neurological disorders such as Parkinson’s disease, stroke, and ALS.

– Disruption of neurotransmitter and ion balance mechanisms.

– Impaired synaptic function and cognitive processes.

The role of glutamate excitotoxicity and neuroinflammation in depression and suicidal behavior are as follows:

1. **Glutamate Excitotoxicity**: – Abnormalities in glutamatergic neurotransmission are common in depressed individuals. – Overactivation of N-methyl-D-aspartate receptors (NMDAR) plays a critical role in major depressive disorder (MDD). – NMDA antagonists have been investigated for their potential antidepressant effects and improvement of suicidal ideation beyond the traditional monoamine hypothesis. – Elevated levels of kynurenic acid, a metabolite of the kynurenine pathway, can reduce glutamate release in certain brain regions and inhibit specific receptors. – Increased levels of kynurenic acid may lead to altered connectivity between cortical structures and the limbic system.

2. **Neuroinflammation**: – Inflammatory processes in depressed patients suggest the immunological origin of major depression. – Inflammatory mediators and oxidative stress can lead to glutamate excitotoxicity, playing a significant role in the pathogenesis of MDD. – Microglial cells, as immunologic sentinel cells of the brain, are associated with abnormal immune responses in MDD and suicidal behavior. – Microglial cells are proposed as potential targets for both glutamatergic- and inflammatory-mediated alterations underlying MDD and suicidal behavior. – Aberrant levels of quinolinic acid, produced by abnormal pathways inside microglia cells, are considered intracellular mediators of pathologically inflammatory- and glutamatergic-related changes.

Therefore, glutamate excitotoxicity and neuroinflammation play crucial roles in the development and progression of depression and suicidal behavior, with a specific focus on the involvement of microglial cells in these processes.

1. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration
2. excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator
3. Inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α impart neuroprotection to an excitotoxin through distinct pathways
4. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure
5. … dissociations of the effects of amygdala and insular cortex lesions on conditioned taste aversion, passive avoidance, and neophobia in the rat using the excitotoxin …
6. L-cysteine, a bicarbonate-sensitive endogenous excitotoxin
7. excitotoxin lesions in primates as a model for Huntington’s disease: histopathologic and neurochemical characterization
8. A possible central mechanism in autism spectrum disorders, part 3: the role of excitotoxin food additives and the synergistic effects of other environmental toxins.
9. The excitotoxin quinolinic acid induces tau phosphorylation in human neurons
10. Nerve growth factor (NGF) regulates adult rat cultured dorsal root ganglion neuron responses to the excitotoxin capsaicin
11. Activated human microglia produce the excitotoxin quinolinic acid
12. The excitotoxin hypothesis in relation to cerebral ischemia.
13. Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo
14. … , a cAMP-Specific Phosphodiesterase-4 Inhibitor, Reduces Oxidative Stress and Improves Synapse Functions in Human Cortical Neurons Exposed to the excitotoxin …
15. excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area
16. Glutamate‐mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised
17. Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures
18. Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons
19. Reactive microglia and IL1β/IL-1R1-signaling mediate neuroprotection in excitotoxin-damaged mouse retina
20. Nuclear factor-κB contributes to excitotoxin-induced apoptosis in rat striatum
21. Differential sparing of somatostatin‐neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions
22. Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys
23. Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin
24. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans
25. Enhanced cellular glutathione peroxidase immunoreactivity in activated astrocytes and in microglia during excitotoxin induced neurodegeneration
26. Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK 1/2–CREB–ATF3 signaling pathway
27. Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene
28. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral …
29. A caspase‐3‐dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell …
30. Chronic excitotoxin-induced axon degeneration in a compartmented neuronal culture model
31. Short-and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes
32. Contribution of ventral tegmental area dopamine neurons to expression of conditional fear: effects of electrical stimulation, excitotoxin lesions, and quinpirole infusion …
33. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington’s disease
34. Induction of β-amyloid-containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin
35. Evidence for activation of caspase‐3‐like protease in excitotoxin‐and hypoxia/hypoglycemia‐injured neurons
36. Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration
37. Neurochemical characterization of excitotoxin lesions in the cerebral cortex
38. The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process
39. Proteomic identification of hippocampal proteins vulnerable to oxidative stress in excitotoxin-induced acute neuronal injury
40. The HDAC6 inhibitor trichostatin A acetylates microtubules and protects axons from excitotoxin-induced degeneration in a compartmented culture model
41. Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism
42. PARP cleavage, DNA fragmentation, and pyknosis during excitotoxin-induced neuronal death
43. The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain
44. excitotoxin-mediated neuron death in youth and old age
45. excitotoxin paraventricular nucleus lesions: stress and endocrine reactivity and oxytocin mRNA levels
46. Quercetin attenuates oxygen–glucose deprivation-and excitotoxin-induced neurotoxicity in primary cortical cell cultures
47. Rod bipolar cells dysfunction occurs before ganglion cells loss in excitotoxin-damaged mouse retina
48. excitotoxin-induced caspase-3 activation and microtubule disintegration in axons is inhibited by taxol
49. What excitotoxin kills striatal neurons in Huntington’s disease? Clues from neurochemical studies
50. Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1α in a cell-type-specific manner
51. Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain
52. Nerve growth factor selectively prevents excitotoxin induced degeneration of striatal cholinergic neurones
53. Sources of reactive oxygen species production in excitotoxin-stimulated cerebellar granule cells
54. Age-related changes in tolerance to the marine algal excitotoxin domoic acid
55. Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration
56. The Lathyrus excitotoxin β-N-oxalyl-l-α, β-diaminopropionic acid is a substrate of the l-cystine/l-glutamate exchanger system xc−
57. Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment
58. Brain and retinal damage from lathyrus excitotoxin, β-N-oxalyl-L-α, β-diaminopropionic acid
59. Movement disorder following excitotoxin lesions in primates.
60. Neuronal and nonneuronal COX‐2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challenge
61. Cyclophilin-A is involved in excitotoxin-induced caspase activation in rat neuronal B50 cells
62. Moderately delayed post-insult treatment with normobaric hyperoxia reduces excitotoxin-induced neuronal degeneration but increases ischemia-induced …
63. Behavioral disinhibition following basal forebrain excitotoxin lesions: alcohol consumption, defensive aggression, impulsivity and serotonin levels
64. Iron‐mediated oxidation of 3, 4‐dihydroxyphenylalanine to an excitotoxin
65. Potential mechanism of cellular uptake of the excitotoxin quinolinic acid in primary human neurons
66. Strain differences in convulsive response to the excitotoxin kainic acid.
67. Safranal attenuates excitotoxin-induced oxidative OLN-93 cells injury
68. Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury
69. Hypoxia-ischemia or excitotoxin-induced tissue plasminogen activator-dependent gelatinase activation in mice neonate brain microvessels
70. Calcium influx accompanies but does not cause excitotoxin-induced neuronal necrosis in retina
71. Hippocalcin protects hippocampal neurons against excitotoxin damage by enhancing calcium extrusion
72. Pregnenolone sulfate, a naturally occurring excitotoxin involved in delayed retinal cell death
73. The effects of excitotoxin lesions of the lateral hypothalamus on self-stimulation reward
74. Co-stimulation of cyclic-AMP-linked metabotropic glutamate receptors in rat striatum attenuates excitotoxin-induced nuclear factor-κB activation and apoptosis
75. excitotoxin lesions do not mimic the alteration of somatostatin in Huntington’s disease
76. Protection by MK-801 against hypoxia-, excitotoxin-, and depolarization-induced neuronal damage in vitro
77. excitotoxin lesions of the zona incerta/lateral tegmentum continuum: effects on male sexual behavior in rats
78. 3-Nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons
79. Variation in Galr1 expression determines susceptibility to excitotoxin‐induced cell death in mice
80. excitotoxin‐Induced Neuronal Death Is Associated with Response of a Unique Intracellular Aspartic Proteinase, Cathepsin E
81. Differences in ionotropic glutamate receptor subunit expression are not responsible for strain-dependent susceptibility to excitotoxin-induced injury
82. Induction of Ornithine Decarboxylase in Cerebral Cortex by excitotoxin Lesion of Nucleus Basalis: Association with Postsynaptic Responsiveness and N‐Methyl‐d …
83. The direction of apomorphine-induced rotation behavior is dependent on the location of excitotoxin in the rat basal ganglia
84. Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18 F] PBR102 and [18 F] PBR111 in a model of excitotoxin-induced …
85. Microtubule‐dependent processes precede pathological calcium influx in excitotoxin‐induced axon degeneration
86. Lathyrus excitotoxin: mechanism of neuronal excitation by L-2-oxalylamino-3-amino-and L-3-oxalylamino-2-amino-propionic acid
87. … of glia‐derived nexin/protease nexin 1 depends on mode of lesion‐induction or terminal degeneration: Observations after excitotoxin or 6‐hydroxydopamine lesions …
88. GM1 ganglioside protects nucleus basalis from excitotoxin damage: reduced cortical cholinergic losses and animal mortality
89. Effects of excitotoxin exposure on metabolic rate of primary hippocampal cultures: application of silicon microphysiometry to neurobiology
90. Patterns of excitotoxin-induced brain lesions in the newborn rabbit: a neuropathological and MRI correlation
91. Alterations in behavioral responses to stressors following excitotoxin lesions of dorsomedial hypothalamic regions
92. Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum
93. NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain
94. Effect of excitotoxin lesions in the medial prefrontal cortex on cortical and subcortical catecholamine turnover in the rat
95. Magnetic resonance imaging to monitor pathology of caudate-putamen after excitotoxin-induced neuronal loss in the nonhuman primate brain
96. excitotoxin-induced myocardial necrosis
97. TOPA quinone, a kainate-like agonist and excitotoxin is generated by a catecholaminergic cell line
98. Effects of antenatal uteroplacental hypoperfusion on neonatal microvascularisation and excitotoxin sensitivity in mice
99. Alterations in Extracellular Amino Acids and Ca2+ Following excitotoxin Administration and During Status Epilepticus
100. Induction of c-fos mRNA in cerebral cortex by excitotoxin stimulation of cortical inputs: involvement ofN-methyl-d-aspartate receptors
101. Distribution of neuropeptide Y immunoreactivity in the rat basal ganglia: effects of excitotoxin lesions to caudate-putamen
102. Fetal striatal tissue grafts into excitotoxin-lesioned striatum: pharmacological and behavioral aspects
103. In vitro culture duration does not impact the ability of encapsulated choroid plexus transplants to prevent neurological deficits in an excitotoxin-lesioned rat model of …
104. excitotoxin-induced lesions of the central but not basolateral nucleus of the amygdala modulate the baroreceptor heart rate reflex in conscious rats
105. Recombinant human ciliary neurotrophic factor alters the threshold of hippocampal pyramidal neuron sensitivity to excitotoxin damage: synergistic effects of …
106. T1 and T2 weighted magnetic resonance imaging of excitotoxin lesions and neural transplants in rat brain in vivo
107. L-trans-2, 3-pyrrolidine dicarboxylate: characterization of a novel excitotoxin
108. 6-Hydroxydopamine and excitotoxin lesions of medial prefrontal cortex fail to affect schedule-induced drinking in the rat
109. Is quinolinic acid an endogenous excitotoxin in alcohol withdrawal?
110. The calcium response to the excitotoxin kainate is amplified by subsequent reduction of extracellular sodium
111. Quantitative morphometric analysis of the neurotoxic effects of the excitotoxin, ibotenic acid, on the basal forebrain.
112. Receptor interactions of β-N-oxalyl-L-α, β-diaminopropionic acid, the Lathyrus sativus putative excitotoxin, with synaptic membranes
113. The NMDA receptor agonist DL-(tetrazol-5-yl) glycine is a highly potent excitotoxin
114. Crude and Partition Extracts of Newbouldia laevis Leaves Attenuate excitotoxin-induced Stereotypy in Mice
115. Effect of fetal striatal and astrocyte transplants into unilateral excitotoxin-lesioned striatum
116. Low dose quetiapine reverses deficits in contextual and cued fear conditioning in rats with excitotoxin-induced hippocampal neuropathy
117. excitotoxin-induced cerebral hyperemia in newborn piglets: regional cerebral blood flow mapping with contrast-enhanced power Doppler US.
118. Effects of nigral dopaminergic lesions and striatal excitotoxin lesions on brain converting enzyme
119. excitotoxin-induced degeneration of rat vagal afferent neurons
120. Differential temporal patterns of expression of immediate early genes in cerebral cortex induced by intracerebral excitotoxin injection: sensitivity to dexamethasone …
121. Ultrastructural and immunocytochemical studies of macrophages in an excitotoxin induced lesion in the rat brain.
122. … and anatomical analysis of cholinergic, noradrenergic and serotonergic innervation of fetal neocortical transplants placed in excitotoxin-induced neocortical lesions of …
123. excitotoxin-induced changes in transglutaminase during differentiation of cerebellar granule cells
124. Synthesis and pharmacology of N-alkylated derivatives of the excitotoxin ibotenic acid
125. Local and remote microvascular changes in excitotoxin-induced focal brain lesions
126. 6-Hydroxydopa, a catecholamine neurotoxin and endogenous excitotoxin at non-NMDA receptors
127. ATP as a marker of excitotoxin-induced nerve cell death in vivo
128. Immuno-electron microscopy reveals that the excitotoxin quinolinate is associated with the plasma membrane in human peripheral blood monocytes/macrophages
129. Central administration of the excitotoxin N-methyl-D-aspartate increases nerve growth factor mRNA in vivo.
130. Role of Group III Metabotropic Glutamate Receptors in excitotoxin‐Induced Cerebellar Granule Cell Death
131. Expression of c-fos mRNA and c-fos protein in neocortical transplants placed into excitotoxin-induced lesions in adult rats
132. excitotoxin lesion of nucleus basalis causes a specific decrease in Go mRNA in cerebral cortex: sensitivity to MK-801
133. excitotoxin induction of ornithine decarboxylase in cerebral cortex is reduced by phospholipase A2 inhibition
134. excitotoxin mediated neuronal loss and the regulation of excitatory amino acid release in the aging brain
135. Depletion of cortical cholecystokinin levels after excitotoxin injection into the nucleus basalis: sensitivity to MK-801
136. Neuronal damage in the albino rat: excitotoxin, microtubule inhibitor synergism
137. Differential effects of dexamethasone on the induction of c-fos, zif-268 and ornithine decarboxylase by excitotoxin
138. Neuroprotective Effects of a Variety of Pomegranate Juice Extracts (PJE) Against the excitotoxin Quinolinic Acid in Human Primary Neurons.
139. excitotoxin-lesioned rat striatum
140. Macrophage-microglia responses to excitotoxin-induced degeneration in the central nervous system
141. Effect of selective excitatory amino acid antagonists on excitotoxin-induced changes in APP mRNA expression
142. Mechanisms of Zn2+-and excitotoxin-induced oligodendrocyte progenitor cell injury.
143. The role of metabotropic receptors in excitotoxin-induced rat cerebellar granule cell death
144. Evidence for the endogenous formation of the excitotoxin TOPA quinone.
145. 47. Noradrenaline re-uptake inhibition influences neuroinflammatory and degenerative changes associated with the excitotoxin kainic acid
146. MECHANISMS OF KAINIC ACID INDUCED HIPPOCAMPAL EPILEPSY (GLUTAMIC ACID DECARBOXYLASE, excitotoxin, NEUROTOXICOLOGY).
147. The excitotoxin Elimination Diet: A Novel Dietary Intervention for those with Fibromyalgia and Irritable Bowel Syndrome
148. Upregulation of hippocampal Senescence marker protein 30 in response to excitotoxin is involved in the ERK-mediated activation of astrocytes
149. MSG (Monosodium Glutamate): The Flavor Enhancing excitotoxin Linked to Obesity, Brain Damage and other Diseases
150. Pretreatment of curcumin protects hippocampal neurons against excitotoxin-induced cell death
151. Variation in Galr1 expression determines the susceptibility to excitotoxin-induced neuronal death in mice
152. EVALUATION OF excitotoxin RECEPTORS
153. excitotoxic and excitoprotective mechanisms
154. excitotoxic cell death
155. Alternative excitotoxic hypotheses
156. II. excitotoxic models for neurodegenerative disorders
157. Calcium and excitotoxic neuronal injury
158. Inciting excitotoxic cytocide among central neurons
159. excitotoxic mechanisms of epileptic brain damage.
160. Progression of ischaemic stroke and excitotoxic aminoacids
161. excitotoxic amino acids and neuropsychiatric disorders.
162. Requirement for superoxide in excitotoxic cell death
163. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches
164. excitotoxic injury of the neostriatum: a model for Huntington’s disease
165. NBQX attenuates excitotoxic injury in developing white matter
166. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
167. Glutamate receptors and the induction of excitotoxic neuronal death
168. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death
169. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions
170. A revised excitotoxic hypothesis of schizophrenia: therapeutic implications
171. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
172. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
173. excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model
174. Glioma cells release excitotoxic concentrations of glutamate
175. Zinc and excitotoxic brain injury: a new model
176. The link between excitotoxic oligodendroglial death and demyelinating diseases
177. Molecular mechanisms underlying specificity of excitotoxic signaling in neurons
178. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons
179. Diffusion-weighted imaging of acute excitotoxic brain injury
180. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture
181. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
182. Conditioned taste aversion in rats with excitotoxic brain lesions
183. excitotoxic neuronal death in the immature brain is an apoptosis‐necrosis morphological continuum
184. Mutant huntingtin enhances excitotoxic cell death
185. excitotoxic neurodegeneration in Alzheimer disease: new hypothesis and new therapeutic strategies
186. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
187. excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis.
188. Models of white matter injury: comparison of infectious, hypoxic‐ischemic, and excitotoxic insults
189. excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury
190. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults
191. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
192. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?
193. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain
194. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
195. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of …
196. Object recognition and location memory in monkeys with excitotoxic lesions of the amygdala and hippocampus
197. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions
198. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice
199. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
200. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism
201. Akt1 regulates a JNK scaffold during excitotoxic apoptosis
202. Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway.
203. excitotoxic index—a biochemical marker of selective vulnerability
204. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor
205. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection
206. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage
207. Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset.
208. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge
209. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration
210. Retrograde abolition of conditional fear after excitotoxic lesions in the basolateral amygdala of rats: absence of a temporal gradient.
211. Age‐dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate
212. Rethinking the excitotoxic ionic milieu: the emerging role of Zn 2+ in ischemic neuronal injury
213. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death
214. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter
215. excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement
216. Transforming Growth Factor-β1-Mediated Neuroprotection against excitotoxic Injury in Vivo
217. Intracellular calcium concentrations during” chemical hypoxia” and excitotoxic neuronal injury
218. Comparing deficits following excitotoxic and contusion injuries in the thoracic and lumbar spinal cord of the adult rat
219. excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis
220. Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death
221. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo
222. Increased brain damage after stroke or excitotoxic seizures in melatonin‐deficient rats
223. Effect of excitotoxic lesions of rat medial prefrontal cortex on spatial memory
224. Dissociating context and space within the hippocampus: effects of complete, dorsal, and ventral excitotoxic hippocampal lesions on conditioned freezing and spatial …
225. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar …
226. Lack of the p50 subunit of nuclear factor-κB increases the vulnerability of hippocampal neurons to excitotoxic injury
227. Inhibition of succinate dehydrogenase by malonic acid produces an “excitotoxic” lesion in rat striatum
228. Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment
229. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β‐peptide
230. Synaptic regeneration and functional recovery after excitotoxic injury in the guinea pig cochlea.
231. Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production
232. Both pre-and posttraining excitotoxic lesions of the basolateral amygdala abolish the expression of olfactory and contextual fear conditioning.
233. Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain
234. Distinct roles for sodium, chloride, and calcium in excitotoxic dendritic injury and recovery
235. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function
236. Aggravation of acute ischemic stroke by hyperthermia is related to an excitotoxic mechanism
237. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus
238. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
239. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat
240. CREB and NF-κB transcription factors regulate sensitivity to excitotoxic and oxidative stress induced neuronal cell death
241. Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro
242. Poly (ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death
243. excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention
244. Behavioral effects of excitotoxic lesions of ventral medial prefrontal cortex in the rat are hemisphere-dependent
245. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats
246. excitotoxic lesions of the amygdala fail to produce impairment in visual learning for auditory secondary reinforcement but interfere with reinforcer devaluation effects in …
247. excitotoxic lesions of the prelimbic‐infralimbic areas of the rodent prefrontal cortex disrupt motor preparatory processes
248. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells
249. β‐Amyloid neurotoxicity is mediated by a glutamate‐triggered excitotoxic cascade in rat nucleus basalis
250. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults
251. Non‐NMDA and NMDA receptor‐mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis‐necrosis …
252. Role of P2X7 Receptors in Ischemic and excitotoxic Brain Injury In Vivo
253. The PSD95–nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death
254. Carnosine protects against excitotoxic cell death independently of effects on reactive oxygen species
255. A transforming growth factor-β antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury
256. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine
257. Thalamic retrograde degeneration following cortical injury: an excitotoxic process?
258. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the α2A-adrenoceptor subtype
259. Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism?
260. Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury
261. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve
262. Effects of selective excitotoxic lesions of the nucleus accumbens core, anterior cingulate cortex, and central nucleus of the amygdala on autoshaping performance in …
263. Cell-permeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo
264. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat
265. excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey
266. Protective effect of parvalbumin on excitotoxic motor neuron death
267. Post‐training excitotoxic lesions of the dorsal hippocampus attenuate forward trace, backward trace, and delay fear conditioning in a temporally specific manner
268. Cellular defenses against excitotoxic insults
269. Eugenol protects neuronal cells from excitotoxic and oxidative injury in primary cortical cultures
270. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation
271. Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test
272. Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurones
273. On the excitotoxic properties of quinolinic acid, 2, 3-piperidine dicarboxylic acids and structurally related compounds
274. A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture
275. Glial changes following an excitotoxic lesion in the CNS—I. Microglia/macrophages
276. Effects of α2-Adrenoceptor Agonists on Perinatal excitotoxic Brain Injury: Comparison of Clonidine and Dexmedetomidine
277. L-homocysteic acid: an endogenous excitotoxic ligand of the NMDA receptor
278. Apolipoprotein E expression by neurons surviving excitotoxic stress
279. Glial changes following an excitotoxic lesion in the CNS—II. Astrocytes
280. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury
281. Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice
282. Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats
283. Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching‐and matching‐to‐place in the T‐maze in the rat: Differential involvement of the …
284. excitotoxic brain damage in the rat induces interleukin‐1β protein in microglia and astrocytes: Correlation with the progression of cell death
285. Group I metabotropic glutamate receptors reduce excitotoxic injury and may facilitate neurogenesis
286. Specific antagonism of excitotoxic action of ‘uncommon’amino acids assayed in organotypic mouse cortical cultures
287. Hemoglobin potentiates excitotoxic injury in cortical cell culture
288. Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury
289. Selective excitotoxic pathology in the rat hippocampus
290. excitotoxic septal lesions result in spatial memory deficits and altered flexibility of hippocampal single-unit representations
291. excitotoxic calcium overload in a subpopulation of mitochondria triggers delayed death in hippocampal neurons
292. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge
293. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington’s disease
294. Topiramate prevents excitotoxic damage in the newborn rodent brain
295. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and …
296. Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions
297. Release of TNF alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage.
298. Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration
299. δ-, but not μ-and κ-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury
300. Dual-gene, dual-cell type therapy against an excitotoxic insult by bolstering neuroenergetics
301. Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion
302. excitotoxic and post-ischemic neurodegeneration: Involvement of transglutaminases
303. Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death
304. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral …
305. Ionized intracellular calcium concentration predicts excitotoxic neuronal death: observations with low-affinity fluorescent calcium indicators
306. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system
307. excitotoxic lesions of the medial prefrontal cortex attenuate fear responses in the elevated-plus maze, social interaction and shock probe burying tests
308. Perseveration and strategy in a novel spatial self-ordered sequencing task for nonhuman primates: effects of excitotoxic lesions and dopamine depletions of the …
309. Vinpocetin protects against excitotoxic cell death in primary cultures of rat cerebral cortex
310. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington’s disease, as demonstrated by adenoviral gene …
311. Quantitative analysis of the generation of different striatal neuronal subtypes in the adult brain following excitotoxic injury
312. Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats
313. excitotoxic neuronal damage and neuropsychiatric disorders
314. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β‐peptide toxicity
315. excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition
316. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats
317. The effect of excitotoxic lesions centered on the hippocampus or perirhinal cortex in object recognition and spatial memory tasks.
318. Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice
319. excitotoxic lesions of the hippocampus disrupt runway but not consummatory contrast
320. excitotoxic mechanisms in the pathogenesis of dementia
321. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate
322. Specific neuronal protein: a new tool for histological evaluation of excitotoxic lesions
323. Altered sexual partner preference in male ferrets given excitotoxic lesions of the preoptic area/anterior hypothalamus
324. A primate model of Huntington’s disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon
325. Mitochondrial uncoupling protein‐2 protects the immature brain from excitotoxic neuronal death
326. Proton magnetic resonance spectroscopy in Huntington’s disease: Evidence in favour of the glutamate excitotoxic theory?
327. Hypoxic and excitotoxic damage to cultured rat retinal ganglion cells
328. excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs
329. Differential oxidative stress in oligodendrocytes and neurons after excitotoxic insults and protection by natural polyphenols
330. Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis
331. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures
332. A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in marmosets
333. Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease
334. Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain …
335. excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions
336. excitotoxic mitochondrial depolarisation requires both calcium and nitric oxide in rat hippocampal neurons
337. excitotoxic degeneration is initiated at non-random sites in cultured rat cerebellar neurons
338. excitotoxic cell death dependent on inhibitory receptor activation
339. … a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic …
340. Domoic acid: a dementia-inducing excitotoxic food poison with kainic acid receptor specificity
341. Apoptosis in substantia nigra following developmental striatal excitotoxic injury
342. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice
343. Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells
344. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage
345. Effects of excitotoxic lesions of the basolateral amygdala on cocaine-seeking behavior and cocaine conditioned place preference in rats
346. Müller cell swelling, glutamate uptake, and excitotoxic neurodegeneration in the isolated rat retina
347. Reactive astrocytosis from excitotoxic injury in hippocampal organ culture parallels that seen in vivo
348. Changes in the diffusion of water and intracellular metabolites after excitotoxic injury and global ischemia in neonatal rat brain
349. Enhanced drinking after excitotoxic lesions of the parabrachial nucleus in the rat
350. Glucocorticoids, stress and exacerbation of excitotoxic neuron death
351. excitotoxic versus apoptotic mechanisms of neuronal cell death in perinatal hypoxia/ischemia
352. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage
353. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration
354. Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective
355. excitotoxic amino acid injections into the medial amygdala facilitate maternal behavior in virgin female rats
356. excitotoxic lesions of the rat medial prefrontal cortex: effects on abnormal behaviors associated with neonatal hippocampal damage
357. Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation
358. Rolipram reduces excitotoxic neuronal damage
359. Evidence for glutamate-mediated excitotoxic mechanisms during photoreceptor degeneration in the rd1 mouse retina
360. Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference
361. Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia
362. Time course of glial proliferation and glial apoptosis following excitotoxic CNS injury
363. The hippocampus and appetitive Pavlovian conditioning: effects of excitotoxic hippocampal lesions on conditioned locomotor activity and autoshaping
364. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage
365. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury
366. Calpain activation contributes to dendritic remodeling after brief excitotoxic injury in vitro
367. Effects of excitotoxic lesions in the ventral striatopallidal–thalamocortical pathway on odor reversal learning: inability to extinguish an incorrect response
368. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis
369. Nitric oxide and S‐nitrosylation: excitotoxic and cell signaling mechanism
370. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors
371. excitotoxic injury to mitochondria isolated from cultured neurons
372. Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate
373. Proinflammatory cytokines and interleukin‐9 exacerbate excitotoxic lesions of the newborn murine neopallium
374. Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor
375. Testosterone amplifies excitotoxic damage of cultured oligodendrocytes
376. Differential blood–brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats
377. Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington’s disease
378. Neuronal death and blood–brain barrier breakdown after excitotoxic injury are independent processes
379. Comparative behavioral changes between male and female postpubertal rats following neonatal excitotoxic lesions of the ventral hippocampus
380. Endogenous methylarginines regulate neuronal nitric-oxide synthase and prevent excitotoxic injury
381. Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex
382. 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures
383. Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 in vivo
384. excitotoxic lesions of the core and shell subregions of the nucleus accumbens differentially disrupt body weight regulation and motor activity in rat
385. The nature and timing of excitotoxic neuronal necrosis in the cerebral cortex, hippocampus and thalamus due to flurothyl-induced status epilepticus
386. Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries
387. Inhibition of free radical production or free radical scavenging protects from the excitotoxic cell death mediated by glutamate in cultures of cerebellar granule neurons
388. excitotoxic food additives: functional teratological aspects
389. N‐methyl‐D‐aspartate receptor‐mediated mitochondrial Ca2+ overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after …
390. Transcription of the NR1 subunit of the N-methyl-D-aspartate receptor is down-regulated by excitotoxic stimulation and cerebral ischemia
391. Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions.
392. Antioxidant treatment protects striatal neurons against excitotoxic insults
393. Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death
394. excitotoxic destruction facilitates brain tumor growth
395. Nervous system-specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury
396. Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis.
397. Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I
398. Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures
399. excitotoxic lesions of the parabrachial nuclei prevent conditioned taste aversions and sodium appetite in rats.
400. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal …
401. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington’s …
402. excitotoxic cell death
403. Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain
404. The effects of excitotoxic lesions of the nucleus accumbens core or shell regions on intravenous heroin self-administration in rats
405. BDNF heightens the sensitivity of motor neurons to excitotoxic insults through activation of TrkB
406. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death
407. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and …
408. excitotoxic mechanism of cell swelling in rat cerebral cortical slices treated acutely with ammonia
409. excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors
410. Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo
411. High-affinity calcium indicators underestimate increases in intracellular calcium concentrations associated with excitotoxic glutamate stimulations
412. Dimethyl sulfoxide suppresses NMDA-and AMPA-induced ion currents and calcium influx and protects against excitotoxic death in hippocampal neurons
413. S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: clinical implications for the role of S100B in excitotoxic brain injury
414. Learning disturbances following excitotoxic lesion of cholinergic pedunculo-pontine nucleus in the rat
415. Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells
416. The critical role of calpain versus caspase activation in excitotoxic injury induced by nitric oxide
417. Mitochondrial peroxiredoxin‐3 protects hippocampal neurons from excitotoxic injury in vivo
418. Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo
419. Dissociation of function within the hippocampus: effects of dorsal, ventral and complete excitotoxic hippocampal lesions on spatial navigation
420. excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington’s disease in rats: protective role of iron porphyrinate 5, 10, 15, 20-tetrakis (4 …
421. excitotoxic mechanisms may be involved in the pathophysiology of tardive dyskinesia.
422. Tf-lipoplex-mediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury
423. Endocannabinoids potently protect the newborn brain against AMPA‐kainate receptor‐mediated excitotoxic damage
424. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice
425. Oral treatment with rofecoxib reduces hippocampal excitotoxic neurodegeneration
426. excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding
427. … minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of …
428. Interleukin‐1β and the interleukin‐1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat
429. Barbiturates induce mitochondrial depolarization and potentiate excitotoxic neuronal death
430. Neural cell adhesion molecule L1-transfected embryonic stem cells promote functional recovery after excitotoxic lesion of the mouse striatum
431. The effect of excitotoxic hippocampal lesions on simple and conditional discrimination learning in the rat
432. Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury
433. Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro
434. excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice
435. Selected peptides targeted to the NMDA receptor channel protect neurons from excitotoxic death
436. The effects of excitotoxic lesions of the basal forebrain on the acquisition, retention and serial reversal of visual discriminations in marmosets
437. Nitric oxide mediates excitotoxic and anoxic damage in rat retinal ganglion cells cocultured with astroglia
438. Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina
439. The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex
440. Impaired delayed spatial win-shift behaviour on the eight arm radial maze following excitotoxic lesions of the medial prefrontal cortex in the rat
441. … factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 …
442. Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA-and ibotenic acid-induced excitotoxic lesions of the basal …
443. Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo
444. Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus
445. excitotoxic amino acids
446. excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase II activity in cultured hippocampal neurons
447. Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat
448. The identification and characterization of excitotoxic nerve-endings in Alzheimer disease
449. Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex
450. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons
451. The effects of excitotoxic lesions of the nucleus accumbens on a matching to position task
452. Effects of excitotoxic lesions of the basal forebrain on MFB self-stimulation
453. The excitotoxic concept
454. excitotoxic death of a subset of embryonic rat motor neurons in vitro
455. Cu/Zn superoxide dismutase expression in the postnatal rat brain following an excitotoxic injury
456. Apoptosis and necrosis occurring in excitotoxic cell death in isolated chick embryo retina
457. Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain
458. Implication of NMDA type glutamate receptors in neural regeneration and neoformation of synapses after excitotoxic injury in the guinea pig cochlea
459. Lentiviral‐mediated gene transfer of brain‐derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge
460. The anti-excitotoxic effects of certain anesthetics, analgesics and sedative-hypnotics
461. p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults
462. The CNS acute inflammatory response to excitotoxic neuronal cell death
463. Effects of excitotoxic lesions of the rat ventral striatum on the perception of reward cost
464. Ultrastructure of excitotoxic neuronal death in murine cortical culture
465. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins
466. Inhibition by anion channel blockers of ischemia-evoked release of excitotoxic and other amino acids from rat cerebral cortex
467. Selective excitotoxic lesions of the hippocampus and basolateral amygdala have dissociable effects on appetitive cue and place conditioning based on path …
468. Astrocytic factors protect neuronal integrity and reduce microglial activation in an in vitro model of N‐methyl‐d‐aspartate‐induced excitotoxic injury in organotypic …
469. Inhibition of excitotoxic neuronal death by methanol extract of Acori graminei rhizoma in cultured rat cortical neurons
470. Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging
471. excitotoxic lesions of the pre‐and parasubiculum disrupt the place fields of hippocampal pyramidal cells
472. Neuronal protein kinase signaling cascades and excitotoxic cell death
473. Selective vulnerability of the CA1 region of hippocampus to the indirect excitotoxic effects of malonic acid
474. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse
475. Activated microglial cells migrate towards sites of excitotoxic neuronal injury inside organotypic hippocampal slice cultures
476. AMPA receptors are the major mediators of excitotoxic death in mature oligodendrocytes
477. Topiramate reduces excitotoxic and ischemic injury in the rat retina
478. Effects of excitotoxic lesions of the central amygdaloid nucleus on the potentiation of reward-related stimuli by intra-accumbens amphetamine
479. Thalamic amnesia reconsidered: excitotoxic lesions of the intralaminar nuclei, but not the mediodorsal nucleus, disrupt place delayed matching-to-sample …
480. Extragonadal synthesis of estradiol is protective against kainic acid excitotoxic damage to the hippocampus
481. Platelet-derived growth factor-BB pretreatment attenuates excitotoxic death in cultured hippocampal neurons
482. Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes
483. Gas1 is induced during and participates in excitotoxic neuronal death
484. Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing …
485. excitotoxic death induced by released glutamate in depolarized primary cultures of mouse cerebellar granule cells is dependent on GABAA receptors and niflumic …
486. The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo
487. Effects of excitotoxic lesions of the basolateral amygdala on conditional discrimination learning with primary and conditioned reinforcement
488. NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord
489. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures
490. Calcium buffering and protection from excitotoxic cell death by exogenous calbindin-D28k in HEK 293 cells
491. Comparative effects of excitotoxic lesions of the hippocampus and septum/diagonal band on conditional visual discrimination and spatial learning
492. Disruption of Pavlovian contextual conditioning by excitotoxic lesions of the nucleus accumbens core.
493. Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum
494. Aminooxyacetic acid produces excitotoxic lesions in the rat striatum
495. The influence of excitotoxic basal ganglia lesions on motor performance in the common marmoset
496. excitotoxic lesions centered on perirhinal cortex produce delay-dependent deficits in a test of spatial memory.
497. Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice
498. Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death
499. excitotoxic cell death and delayed rescue in human neurons derived from NT2 cells
500. Contribution of endogenous glycine site NMDA agonists to excitotoxic retinal damage in vivo
501. The role of excitotoxic injury in post-traumatic syringomyelia
502. Diffusion-weighted MR imaging in a rat model of syringomyelia after excitotoxic spinal cord injury
503. Changes in sleep–waking cycle after striatal excitotoxic lesions
504. Iodoacetate produces striatal excitotoxic lesions
505. Protection provided by cyclosporin A against excitotoxic neuronal death is genotype dependent
506. Up-regulation of Eph tyrosine kinase receptors after excitotoxic injury in adult hippocampus
507. excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests
508. GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults
509. Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum
510. … and dysfunctions of the nucleus basalis as Alzheimer’s disease models: general and critical overview and analysis of the long-term changes in several excitotoxic …
511. Selective excitotoxic lesions of the nucleus accumbens core and shell differentially affect aversive Pavlovian conditioning to discrete and contextual cues
512. Protective effects of PACAP in excitotoxic striatal lesion
513. Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action
514. Platelet‐activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and …
515. Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration
516. Chronic, selective forebrain responses to excitotoxic dorsal horn injury
517. excitotoxic neuronal injury in acute homocysteine neurotoxicity: role of calcium and mitochondrial alterations
518. excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats
519. The effect of excitotoxic lesions centered on the perirhinal cortex in two versions of the radial arm maze task.
520. Contingent versus incidental context processing during conditioning: dissociation after excitotoxic hippocampal plus dentate gyrus lesions
521. Tumor necrosis factor α increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA–glutamate receptor subunit GluR1 via an acid …
522. GABA accelerates excitotoxic cell death in cortical cultures: protection by blockers of GABA-gated chloride channels
523. excitotoxic damage in traumatic brain injury
524. Multiple pathways of neuroprotection against oxidative stress and excitotoxic injury in immature primary hippocampal neurons
525. Naproxen reduces excitotoxic neurodegeneration in vivo with an extended therapeutic window
526. Effects of laterodorsal tegmentum excitotoxic lesions on behavioral and dopamine responses evoked by morphine and d-amphetamine
527. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre‐ and postsynaptic sites in the rat striatum
528. Comparative behavioral changes in postpubertal rats after neonatal excitotoxic lesions of the ventral hippocampus and the prefrontal cortex
529. Interpretation of intrinsic optical signals and calcein fluorescence during acute excitotoxic insult in the hippocampal slice
530. excitotoxic lesions of the pre-and parasubiculum disrupt object recognition and spatial memory processes.
531. excitotoxic neurodegeneration induced by deprivation of oxygen and glucose in isolated retina.
532. Calpain I activation in rat hippocampal neurons in culture is NMDA receptor selective and not essential for excitotoxic cell death
533. Ca2+-independent excitotoxic neurodegeneration in isolated retina, an intact neural net: a role for Cl− and inhibitory transmitters
534. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol
535. Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats
536. Striatal modulation of cAMP‐response‐element‐binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington’s disease
537. Monocyte chemoattractant protein-1 is a mediator of acute excitotoxic injury in neonatal rat brain
538. Brain‐derived neurotrophic factor induces excitotoxic sensitivity in cultured embryonic rat spinal motor neurons through activation of the phosphatidylinositol 3‐kinase …
539. Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primates
540. Differential effects of excitotoxic basolateral and corticomedial lesions of the amygdala on the behavioural and endocrine responses to either sexual or aggression …
541. excitotoxic lesions of the hippocampus leave sensory preconditioning intact: Implications for models of hippocampal functioning.
542. Opposite effects of TGF-β1 on rapidly-and slowly-triggered excitotoxic injury
543. Primary CA1 and conditionally immortal MHP36 cell grafts restore conditional discrimination learning and recall in marmosets after excitotoxic lesions of the …
544. Developmental spectrum of the excitotoxic cascade induced by ibotenate: a model of hypoxic insults in fetuses and neonates
545. Increase in ferric and ferrous iron in the rat hippocampus with time after kainate-induced excitotoxic injury
546. Intrinsic neurons of fastigial nucleus mediate neurogenic neuroprotection against excitotoxic and ischemic neuronal injury in rat
547. Discriminable excitotoxic effects of ibotenic acid, AMPA, NMDA and quinolinic acid in the rat laterodorsal tegmental nucleus
548. Transplanted human embryonic germ cell‐derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain …
549. Effects of excitotoxic brain lesions on taste-mediated odor learning in the rat
550. excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. II. Examination of eating and drinking, rotation, and reaching and grasping following …
551. Changes in secondary glutamate release underlie the developmental regulation of excitotoxic neuronal cell death
552. Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system—II. Cholinergic drugs …
553. Mechanistic distinctions between excitotoxic and acidotic hippocampal damage in an in vitro model of ischemia
554. Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons
555. excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas …
556. BDNF, and full length and truncated TrkB expression in the hippocampus of the rat following kainic acid excitotoxic damage. Evidence of complex time-dependent and …
557. Gustatory functions, sodium appetite, and conditioned taste aversion survive excitotoxic lesions of the thalamic taste area.
558. Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury
559. Hypoxia induces an excitotoxic-type of dark cell degeneration in cerebellar Purkinje neurons
560. Evaluation of the pathologic characteristics of excitotoxic spinal cord injury with MR imaging
561. 2‐deoxy‐d‐glucose protects hippocampal neurons against excitotoxic and oxidative injury: Evidence for the involvement of stress proteins
562. excitotoxic mechanisms in hypoglycaemic hippocampal injury
563. The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury
564. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage
565. excitotoxic lesions of the pedunculopontine tegmental nucleus in rats impair performance on a test of sustained attention
566. The effects of excitotoxic lesions of the basolateral amygdala on the acquisition of heroin-seeking behaviour in rats
567. The effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on the acquisition and retention of a conditional visual discrimination …
568. Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra
569. excitotoxic food additives–relevance of animal studies to human safety.
570. Interleukin‐1β exacerbates and interleukin‐1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic …
571. Chronic multichannel recordings from organotypic hippocampal slice cultures: protection from excitotoxic effects of NMDA by non-competitive NMDA antagonists
572. Fenamates protect neurons against ischemic and excitotoxic injury in chick embryo retina
573. Rapid appearance of β-amyloid precursor protein immunoreactivity in glial cells follwing excitotoxic brain injury
574. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions
575. Are human neurodegenerative disorders linked to environmental chemicals with excitotoxic properties?
576. Glutamate-mediated excitotoxic death of cultured striatal neurons is mediated by non-NMDA receptors
577. Adrenocorticosteroid receptor blockade and excitotoxic challenge regulate adrenocorticosteroid receptor mRNA levels in hippocampus
578. excitotoxic and metabolic damage to the rodent striatum: role of the P75 neurotrophin receptor and glial progenitors
579. Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate
580. excitotoxic preconditioning elicited by both glutamate and hypoxia and abolished by lactate transport inhibition in rat hippocampal slices
581. Late N‐methyl‐d‐aspartate receptor blockade rescues hippocampal neurons from excitotoxic stress and death after 4‐aminopyridine‐induced epilepsy
582. SIN‐1‐induced cytotoxicity in mixed cortical cell culture: peroxynitrite‐dependent and‐independent induction of excitotoxic cell death
583. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
584. … that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury
585. excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice
586. Intrinsic optical signaling denoting neuronal damage in response to acute excitotoxic insult by domoic acid in the hippocampal slice
587. Bright light suppresses hyperactivity induced by excitotoxic dorsal hippocampus lesions in the rat.
588. Vulnerability to excitotoxic stimuli of cultured rat hippocampal neurons containing the calcium-binding proteins calretinin and calbindin D28K
589. Comparative effects of levobupivacaine and racemic bupivacaine on excitotoxic neuronal death in culture and N-methyl-D-aspartate-induced seizures in mice
590. excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo
591. Methylmalonic acid induces excitotoxic neuronal damage in vitro
592. Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by …
593. excitotoxic hippocampal lesions disrupt allocentric spatial learning in mice: effects of strain and task demands
594. Nitric oxide participates in excitotoxic mechanisms induced by chemical hypoxia
595. Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage
596. Triflusal posttreatment inhibits glial nuclear factor-κB, downregulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain
597. Amelioration of behavioral deficits in a rat model of Huntington’s disease by an excitotoxic lesion to the globus pallidus
598. Neuronal expression of AP-1 proteins in excitotoxic-neurodegenerative disorders and following nerve fiber lesions
599. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice
600. Inhibition of cell cycle pathway by flavopiridol promotes survival of cerebellar granule cells after an excitotoxic treatment
601. excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies.
602. Effects of agmatine, interleukin-10, and cyclosporin on spontaneous pain behavior after excitotoxic spinal cord injury in rats
603. excitotoxic lesions of the gustatory thalamus eliminate consummatory but not instrumental successive negative contrast in rats
604. excitotoxic degeneration of hypothalamic orexin neurons in slice culture
605. Prevention of post-traumatic excitotoxic brain damage with NMDA antagonist drugs: a new strategy for the nineties
606. Prostaglandin A1 protects striatal neurons against excitotoxic injury in rat striatum
607. Contrasting effects of excitotoxic lesions of the prefrontal cortex on the behavioural response to D-amphetamine and presynaptic and postsynaptic measures of striatal …
608. Spatial discrimination deficits by excitotoxic lesions in the Morris water escape task
609. Prostate apoptosis response‐4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction …
610. Quantitative analysis of microglial reaction to a cortical excitotoxic lesion in the early postnatal brain
611. Glial expression of small heat shock proteins following an excitotoxic lesion in the immature rat brain
612. Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector
613. Distinct roles for striatal subregions in mediating response processing revealed by focal excitotoxic lesions.
614. Neurons derived from embryonic stem (ES) cells resemble normal neurons in their vulnerability to excitotoxic death
615. Differential brain area vulnerability to long-term subcortical excitotoxic lesions
616. Cortical neurons containing somatostatin‐or parvalbumin‐like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro
617. excitotoxic insults to the optic nerve alter visual evoked potentials
618. The immunosuppressant mycophenolate mofetil attenuates neuronal damage after excitotoxic injury in hippocampal slice cultures
619. Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death
620. Effects of excitotoxic amino acids on pituitary hormone secretion in the rat
621. Susceptibilities to and mechanisms of excitotoxic cell death of adult mouse inner retinal neurons in dissociated culture
622. Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury
623. Apoptotic neuron death in rat substantia nigra induced by striatal excitotoxic injury is developmentally dependent
624. (-)-Nicotine protects against systemic kainic acid-induced excitotoxic effects
625. excitotoxic insult due to ibogaine leads to delayed induction of neuronal NOS in Purkinje cells.
626. The severity of excitotoxic brain injury is dependent on brain temperature in immature rat
627. Long-term evolution of excitotoxic cortical dysgenesis induced in the developing rat brain
628. Rapid subcellular redistribution of Bax precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain
629. Chronic excitotoxic lesion of the dorsal raphe nucleus induces sodium appetite
630. excitotoxic damage in neurotrauma: fact or fiction
631. 17β-Estradiol enhances cortical cholinergic innervation and preserves synaptic density following excitotoxic lesions to the rat nucleus basalis magnocellularis
632. Inhibition of TNF-α can attenuate or exacerbate excitotoxic injury in neonatal rat brain
633. Early appearance of functional deficits after neonatal excitotoxic and hypoxic-ischemic injury: fragile recovery after development and role of the NMDA receptor
634. Aminoglutethimide prevents excitotoxic and ischemic injuries in cortical neurons
635. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury
636. excitotoxic lesions of the rat entorhinal cortex. Effects of selective neuronal damage on acquisition and retention of a non-spatial reference memory task
637. excitotoxic effect of kainic acid on chicken otoacoustic emissions and cochlear potentials
638. excitotoxic lesions of the tegmental pedunculopontine nucleus impair copulation in naive male rats and block the rewarding effects of copulation in experienced male …
639. excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures
640. Calpain inhibitors prevent nitric oxide-triggered excitotoxic apoptosis
641. VIP neuroprotection against excitotoxic lesions of the developing mouse brain
642. Diltiazem protects against neurotoxicity induced by excitotoxic amino acids on cochlear afferent fibers
643. N-methyl-D-aspartate receptor subunit expression and phosphorylation following excitotoxic spinal cord injury in rats
644. excitotoxic lesions of the medial amygdala differentially disrupt prolactin secretory responses in cycling and mated female rats
645. Role of zinc in blockade of excitotoxic action of quinolinic acid by picolinic acid
646. excitotoxic swelling occurs in oxygen and glucose deprived human cortical slices
647. Mitochondrial transmembrane potential and free radical production in excitotoxic neurodegeneration
648. Effects of excitotoxic thalamic intralaminar nuclei lesions on attention and working memory
649. The effects of excitotoxic lesions of the pedunculopontine tegmental nucleus on conditioned place preference to 4%, 12% and 20% sucrose solutions
650. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism
651. Potentiation of excitotoxic injury by high concentrations of extracellular reduced glutathione
652. NOS Expression in Nigral Cells after excitotoxic and Non‐excitotoxic Lesion of the Pedunculopontine Tegmental Nucleus
653. Is the cuneiform nucleus a critical component of the mesencephalic locomotor region? An examination of the effects of excitotoxic lesions of the cuneiform nucleus on …
654. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats
655. Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in …
656. excitotoxic lateral pallidotomy does not relieve L-DOPA-induced dyskinesia in MPTP parkinsonian monkeys
657. Opioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injury
658. The vulnerability of spinal cord neurons to excitotoxic injury: comparison with cortical neurons
659. Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum
660. Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance, and histology
661. Role of the excitotoxic mechanism in the development of neuronal damage following repeated brief cerebral ischemia in the gerbil: protective effects of MK-801 and …
662. Immediate early gene activation during the initial phases of the excitotoxic cascade
663. Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution and morphology of cell death
664. Thioltransferase (glutaredoxin) mediates recovery of motor neurons from excitotoxic mitochondrial injury
665. excitotoxic hippocampal membrane breakdown and its inhibition by bilobalide: role of chloride fluxes
666. excitotoxic lesions of the pedunculopontine differentially mediate morphine-and d-amphetamine-evoked striatal dopamine efflux and behaviors
667. Seizures and selective CA-1 hippocampal lesions induced by an excitotoxic cyanide metabolite, 2-iminothiazolidine-4-carboxylic acid.
668. Cerebral organic acid disorders induce neuronal damage via excitotoxic organic acids in vitro
669. The cardiac glycoside ouabain potentiates excitotoxic injury of adult neurons in rat hippocampus
670. Lack of excitotoxic cell death in serum-free cultures of rat cerebral cortex
671. An examination of the effects of bilateral excitotoxic lesions of the pedunculopontine tegmental nucleus on responding to sucrose reward
672. excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. I. Comparison of the effects of various excitotoxins, with particular reference to the loss of …
673. Hippocampal neurons exhibit both persistent Ca2+ influx and impairment of Ca2+ sequestration/extrusion mechanisms following excitotoxic glutamate exposure
674. 1‐Methyl‐4‐phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism
675. Ectopic parvalbumin expression in mouse forebrain neurons increases excitotoxic injury provoked by ibotenic acid injection into the striatum
676. Effects of neonatal excitotoxic lesions of the entorhinal cortex on cognitive functions in the adult rat
677. The neuroprotective effects of the recombinant interleukin–1 receptor antagonist rhIL–1ra after excitotoxic stimulation with kainic acid and its relationship to the …
678. Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice
679. excitotoxic lesions of the parafascicular nucleus produce deficits in a socially transmitted food preference
680. Protective action of idebenone against excitotoxic degeneration in cultured cortical neurons
681. Interactive effects of excitotoxic injury and dietary restriction on microgliosis and neurogenesis in the hippocampus of adult mice
682. excitotoxic lesions of the mediodorsal thalamic nucleus attenuate intravenous cocaine self-administration
683. excitotoxic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain
684. Deficits in response initiation, but not attention, following excitotoxic lesions of posterior parietal cortex in the rat
685. Biphasic NF-κB activation in the excitotoxic hippocampus
686. Timing the excitotoxic induction of heat shock protein 70 transcription.
687. Gene therapies that enhance hippocampal neuron survival after an excitotoxic insult are not equivalent in their ability to maintain synaptic transmission
688. Ischemia does not induce the release of excitotoxic amino acids from the hippocampus of newborn rats
689. Glutamate receptor transmission and ischemic nerve cell damage: evidence for involvement of excitotoxic mechanisms
690. Two temporal stages of oligodendroglial response to excitotoxic lesion in the gray matter of the adult rat brain
691. Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity
692. A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N‐methyl‐d‐aspartate or quisqualate, and the effects on toxicity of 2 …
693. excitotoxic basolateral amygdala lesions potentiate the memory impairment effect of muscimol injected into the medial septal area
694. excitotoxic lesions of rat basal forebrain: differential effects on choline acetyltransferase in the cortex and amygdala
695. Opposing effects of excitatory amino acids on chick embryo spinal cord motoneurons: excitotoxic degeneration or prevention of programmed cell death
696. Are aminoglycoside antibiotics excitotoxic?
697. Tat, a human immunodeficiency virus-1 derived protein, augments excitotoxic hippocampal injury in neonatal rats
698. Proteasome inhibitors prevent cytochrome c release during apoptosis but not in excitotoxic death of cerebellar granule neurons
699. Caspase-3-associated apoptotic cell death in excitotoxic necrosis of the entorhinal cortex following intraperitoneal injection of kainic acid in the rat
700. In vivo role of caspases in excitotoxic neuronal death: generation and analysis of transgenic mice expressing baculoviral caspase inhibitor, p35, in postnatal neurons
701. Inhibition of apoptosis‐inducing factor translocation is involved in protective effects of hepatocyte growth factor against excitotoxic cell death in cultured hippocampal …
702. Cells over-expressing EAAT2 protect motoneurons from excitotoxic death in vitro
703. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical …
704. … and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury
705. Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation‐induced cellular defects in …
706. Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat
707. Expression of inducible nitric oxide synthase and cyclooxygenase‐2 after excitotoxic damage to the immature rat brain
708. β‐cyano‐L‐alanine toxicity: Evidence for the involvement of an excitotoxic mechanism
709. Delayed death of septal cholinergic neurons after excitotoxic ablation of hippocampal neurons during early postnatal development in the rat
710. Expression of growth inhibitory factor (metallothionein-III) mRNA and protein following excitotoxic immature brain injury
711. Ciliary neurotrophic factor protects hippocampal neurons from excitotoxic damage
712. Reversed actrocytic GLT-1 during ischemia is crucial to excitotoxic death of neurons, but contributes to the survival of astrocytes themselves
713. Stat3 and NFκB glial expression after excitotoxic damage to the postnatal brain
714. iNOS contribution to the NMDA-induced excitotoxic lesion in the rat striatum
715. Intracellular glutathione levels determine cerebellar granule neuron sensitivity to excitotoxic injury by kainic acid
716. Stability of septohippocampal neurons following excitotoxic lesions of the rat hippocampus
717. Effects of excitotoxic lesions of the septum and vertical limb nucleus of the diagonal band of Broca on conditional visual discrimination: relationship between …
718. Quisqualate‐induced excitotoxic death of glial cells: Transient vulnerability of cultured astrocytes
719. Choline release and inhibition of phosphatidylcholine synthesis precede excitotoxic neuronal death but not neurotoxicity induced by serum deprivation
720. Kainic acid-induced excitotoxic hippocampal neurodegeneration in C57BL/6 mice: B cell and T cell subsets may contribute differently to the pathogenesis
721. Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury
722. Effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on visual discrimination acquisition, performance and reversal in the rat
723. Effects of excitotoxic lesions of the rat prefrontal cortex on CREB regulation and presynaptic markers of dopamine and amino acid function in the nucleus accumbens
724. Astroglial nitration after postnatal excitotoxic damage: correlation with nitric oxide sources, cytoskeletal, apoptotic and antioxidant proteins
725. The neurotrophin receptors trkA, trkB and trkC are differentially regulated after excitotoxic lesion in rat striatum
726. Recovery of song preferences after excitotoxic HVC lesion in female canaries
727. Development of cholinergic amacrine cell stratification in the ferret retina and the effects of early excitotoxic ablation
728. Association between inflammation and nigral neuronal damage following striatal excitotoxic lesion
729. Behavioural sensitisation to repeated d-amphetamine: effects of excitotoxic lesions of the pedunculopontine tegmental nucleus
730. Schedule-induced polydipsia and the nucleus accumbens: electrochemical measurements of dopamine efflux and effects of excitotoxic lesions in the core
731. Selenium reduces the proapoptotic signaling associated to NF‐κB pathway and stimulates glutathione peroxidase activity during excitotoxic damage produced by …
732. Cortical grafts prevent atrophy of cholinergic basal nucleus neurons induced by excitotoxic cortical damage
733. NGF reduces striatal excitotoxic neuronal loss without affecting concurrent neuronal stress.
734. excitotoxic lesions of the ventral anteroventral third ventricle and pressor responses to central sodium, ouabain and angiotensin II
735. Short‐and long‐term survival of large neurons in the excitotoxic lesioned rat caudate nucleus: A light and electron microscopic study
736. Cyclic GMP modulators and excitotoxic injury in cerebral cortical cultures
737. Iodoacetate protects hippocampal neurons against excitotoxic and oxidative injury: involvement of heat‐shock proteins and Bcl‐2
738. Status of the neonatal rat brain after NMDA‐induced excitotoxic injury as measured by MRI, MRS and metabolic imaging
739. Heme oxygenase‐1 activity after excitotoxic injury: Immunohistochemical localization of bilirubin in neurons and astrocytes and deleterious effects of heme oxygenase …
740. excitotoxic lesions of the gustatory thalamus spare simultaneous contrast effects but eliminate anticipatory negative contrast: evidence against a memory deficit.
741. Release of the excitotoxic amino acids, glutamate and aspartate, from the isolated ischemic/anoxic rat heart
742. excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis
743. Local and downstream effects of excitotoxic lesions in the rat medial prefrontal cortex on in vivo 1H-MRS signals
744. Susceptibility to excitotoxic and metabolic striatal neurodegeneration in the mouse is genotype dependent
745. No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo
746. On the probabilistic nature of excitotoxic neuronal death in hippocampal neurons
747. Ontogeny of excitotoxic injury to nicotinamide adenine dinucleotide phosphate diaphorase reactive neurons in the neonatal rat striatum
748. Enprofylline protects motor neurons from in vitro excitotoxic challenge
749. Degeneration of neurons in the thalamic reticular nucleus following transient ischemia due to raised intracranial pressure: excitotoxic degeneration mediated via non …
750. Varied actions of proinflammatory cytokines on excitotoxic cell death in the rat central nervous system
751. Neuropeptide changes following excitotoxic lesion of the insular cortex in rats
752. The effect of excitotoxic lesions of the pedunculopontine tegmental nucleus on performance of a progressive ratio schedule of reinforcement
753. Neurotrophin and GDNF family ligands promote survival and alter excitotoxic vulnerability of neurons derived from murine embryonic stem cells
754. Differential fos expression following aspiration, electrolytic, or excitotoxic lesions of the perirhinal cortex in rats.
755. … MPEP and the Na+ channel blocker riluzole show different neuroprotective profiles in reversing behavioral deficits induced by excitotoxic prefrontal cortex lesions
756. Grafting of fetal CA3 neurons to excitotoxic, axon-sparing lesions of the hippocampal CA3 area in adult rats
757. Inorganic Pi Increases Neuronal Survival in the Acute Early Phase Following excitotoxic/Oxidative Insults
758. Adenovirus-mediated over-expression of interleukin-1 receptor antagonist reduces susceptibility to excitotoxic brain injury in perinatal rats
759. Effects of chronic lithium treatment on ornithine decarboxylase induction and excitotoxic neuropathology in the rat
760. excitotoxic lesions of the paraventricular hypothalamus: metabolic and cardiac effects
761. Conditioning heat stress reduces excitotoxic and apoptotic components of oxygen‐glucose deprivation‐induced neuronal death in vitro
762. excitotoxic hippocampal neuron loss following sustained electrical stimulation of the perforant pathway in the mouse
763. Nitric oxide applications prior and simultaneous to potentially excitotoxic NMDA-evoked calcium transients: Cell death or survival
764. Two phases of behavioral plasticity in rats following unilateral excitotoxic lesion of the hippocampus
765. Protection of excitotoxic neuronal death by gluconate through blockade of N-methyl-D-aspartate receptors
766. The effects of excitotoxic hippocampal lesions in rats on risperidone-and olanzapine-induced locomotor suppression
767. Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease
768. Postnatal development of functional properties of visual cortical cells in rats with excitotoxic lesions of basal forebrain cholinergic neurons
769. Evaluation of quinolinic acid induced excitotoxic neurodegeneration in rat striatum by quantitative magnetic resonance imaging in vivo
770. Age dependent sensitivity of the rat retina to the excitotoxic action ofN-methyl-D-aspartate
771. excitotoxic injury stimulates glial fibrillary acidic protein mRNA expression in perinatal rat brain
772. Transcription of the Huntington disease gene during the quinolinic acid excitotoxic cascade
773. The impact of excitotoxic blockade on the evolution of injury following combined mechanical and hypoxic insults in primary rat neuronal culture
774. … -elicited immediate early gene expression in neurons and glia of the hippocampus: novel patterns of FOS, JUN, and KROX expression following excitotoxic injury
775. Aminooxyacetic acid produces excitotoxic brain injury in neonatal rats
776. A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury.
777. Ischemia as an excitotoxic lesion: protection against hippocampal nerve cell loss by denervation
778. Behavioral evaluation of the anti-excitotoxic properties of MK-801: comparison with neurochemical measurements
779. Mitogen and stress response kinase‐1 (MSK1) mediates excitotoxic induced death of hippocampal neurones
780. … properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy
781. Non-spatial acquisition and retention deficits following small excitotoxic lesions within the hippocampus in monkeys
782. Peptidyl α‐keto amide inhibitor of calpain blocks excitotoxic damage without affecting signal transduction events
783. Differential DNA damage in response to the neonatal and adult excitotoxic hippocampal lesion in rats
784. Effects of excitotoxic lesions of the nucleus basalis magnocellularis on conditioned taste aversion and inhibitory avoidance in the rat
785. Effects of excitotoxic lesions of the gustatory thalamus on latent inhibition and blocking of conditioned taste aversion in rats
786. Topical Insulin and Accumulation of excitotoxic and Other Amino Acids in Ischemic Rat Cerebral Cortex (44510)
787. excitotoxic lesions of the lateral hypothalamus made by N-methyl-d-aspartate in the rat: behavioural, histological and biochemical analyses
788. Fructose-1, 6-biphosphate prevents excitotoxic neuronal cell death in the neonatal mouse brain
789. Glycine antagonist and NO synthase inhibitor protect the developing mouse brain against neonatal excitotoxic lesions
790. excitotoxic damage of retinal glial cells depends upon normal neuron‐glial interactions
791. Glucocorticoid treatment in an ischaemic-like excitotoxic model of periventricular leucomalacia in mice
792. Retrograde degenerative changes in the substantia nigra pars compacta following an excitotoxic lesion of the striatum
793. The effect of intravenous insulin on accumulation of excitotoxic and other amino acids in the ischemic rat cerebral cortex
794. Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington’s disease
795. 3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum
796. Behavioral effects of neonatal and adult excitotoxic lesions of the mediodorsal thalamus in the adult rat
797. excitotoxic lesions of the entorhinal cortex leave gustatory within-event learning intact.
798. Metabotropic glutamate receptor activation selectively limits excitotoxic damage in the intact neostriatum
799. Enhanced locomotor activity in rats with excitotoxic lesions of the entorhinal cortex, a neurodevelopmental animal model of schizophrenia: behavioral and in vivo …
800. Nitric oxide mediates the sustained opening of NMDA receptor-gated ionic channels which follows transient excitotoxic exposure in hippocampal slices
801. Anti-porin antibodies prevent excitotoxic and ischemic damage to brain tissue
802. Neurotrophic factor protection against excitotoxic neuronal death
803. Thiokynurenates prevent excitotoxic neuronal death in vitro and in vivo by acting as glycine antagonists and as inhibitors of lipid peroxidation
804. Apomorphine-induced dyskinesias after excitotoxic caudate-putamen lesions and the effects of neural transplantation in non-human primates
805. Neonatal excitotoxic brain injury
806. excitotoxic lesioning of the rat basal forebrain with S-AMPA: consequent mineralization and associated glial response
807. GABA does not protect cerebro-cortical cultures against excitotoxic cell death
808. Modulation of stress-induced dopamine release by excitotoxic damage of the entorhinal cortex in the rat
809. Effect of nootropic Solcoseryl® on kainic acid-induced excitotoxic brain injury
810. Bone marrow transplantation reveals roles for brain macrophage/microglia TNF signaling and nitric oxide production in excitotoxic neuronal death
811. Increased proportion of high-affinity dopamine D2 receptors in rats with excitotoxic damage of the entorhinal cortex, an animal model of schizophrenia
812. The calretinin‐containing mossy cells survive excitotoxic insult in the gerbil dentate gyrus. Comparison of excitotoxicity‐induced neuropathological changes in the …
813. Changes in extracellular glutamate concentration after acute subdural haematoma in the rat—evidence for an “excitotoxic” mechanism?
814. excitotoxic effect of kainic acid on chicken cochlear afferent neurons
815. Long-lasting aberrant tubulovesicular membrane inclusions accumulate in developing motoneurons after a sublethal excitotoxic insult: a possible model for neuronal …
816. A novel inhibitor of glutamate release reduces excitotoxic injury in vitro
817. Role of tissue-derived plasminogen activator (t-PA) in an excitotoxic mouse model of neonatal white matter lesions
818. Mineralization of the globus pallidus following excitotoxic lesions of the basal forebrain
819. Protective effects of neurotrophin-4/5 and transforming growth factor-α on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid
820. In vivo microdialysis studies on the effects of decortication and excitotoxic lesions on kainic acid‐induced calcium fluxes, and endogenous amino acid release, in the …
821. excitotoxic lesions of the pedunculopontine tegmental nucleus disinhibit orofacial behaviours stimulated by microinjections of d-amphetamine into rat ventrolateral …
822. Competing approaches to excitotoxic neuroprotection by inert and catalytic antioxidant porphyrins
823. excitotoxic lesions of the rhinal cortex in the baboon differentially affect visual recognition memory, habit memory and spatial executive functions
824. excitotoxic Amino Acids Cause Appearance of Magnetic Resonance Spectroscopy‐Observable Zinc in Supervised Cortical Slices
825. Adenoviral expression of CREB protects neurons from apoptotic and excitotoxic stress
826. Cerebral metabolic consequences in the adult brain after neonatal excitotoxic lesions of the amygdala in rats
827. Impairment of energy metabolism and excitotoxic cell death in Huntington disease.
828. Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine
829. Sustained, long-lasting inhibition of nitric oxide synthase aggravates the neural damage in some models of excitotoxic brain injury
830. Topical glucose and accumulation of excitotoxic and other amino acids in ischemic cerebral cortex
831. Dissociation between the excitatory and” excitotoxic” effects of quinolinic acid analogs on the striatal cholinergic interneuron.
832. Learning impairments in monkeys with combined but not separate excitotoxic lesions of the anterior and mediodorsal thalamic nuclei
833. excitotoxic neuronal death: mechanisms and clinical relevance
834. Differential postreceptor signaling events triggered by excitotoxic stimulation of different ionotropic glutamate receptors in retinal neurons
835. Evidence for synaptic proliferation, reorganization, and growth in the excitotoxic lesioned adult rat caudate nucleus
836. Cortical changes in cholecystokinin mRNA are related to spontaneous pain behaviors following excitotoxic spinal cord injury in the rat
837. Effect of perinatal alcohol exposure on ibotenic acid-induced excitotoxic cortical lesions in newborn hamsters
838. 17β-Estradiol treatment retards excitotoxic delayed degeneration in substantia nigra reticulata neurons
839. excitotoxic injury induces production of monocyte chemoattractant protein-1 in rat cortico-striatal slice cultures
840. Comparison of the effects of the 5-HT 3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the …
841. excitotoxic increase of xanthine dehydrogenase and xanthine oxidase in the rat olfactory cortex
842. Parallel development of excitotoxic vulnerability to N-methyl-l-aspartate and kainate in dispersed cultures of the rat cerebral cortex
843. Anti-excitotoxic activity of trimetazidine in the retina
844. MK-801 is cytotoxic to microglia in vitro and its cytotoxicity is attenuated by glutamate, other excitotoxic agents and atropine: Possible presence of glutamate receptor …
845. Effect of excitotoxic lesions of the neonatal ventral hippocampus on the immobility response in rats
846. excitotoxic lesions of the rostral thalamic reticular nucleus do not affect the performance of spatial learning and memory tasks in the rat
847. Glial expression of the 90‐kDa heat shock protein (HSP90) and the 94‐kDa glucose‐regulated protein (GRP94) following an excitotoxic lesion in the mouse …
848. Effect of acamprosate on neonatal excitotoxic cortical lesions in in utero alcohol-exposed hamsters
849. Disparity of cell swelling and rapid neuronal death by excitotoxic insults in rat hippocampal slice cultures
850. Dissociation of effects of glutamate receptor antagonists on excitotoxic and hypoxic neuronal cell death in a novel rat cortical culture system
851. Expression of c-fos mRNA is increased and related to dynorphin mRNA expression following excitotoxic spinal cord injury in the rat
852. excitotoxic injury profiles of low-affinity kainate receptor agonists in cortical neuronal cultures
853. Myosin Va is proteolysed in rat cerebellar granule neurons after excitotoxic injury
854. Bursting properties of units in cat globus pallidus and entopeduncular nucleus: the effect of excitotoxic striatal lesions
855. excitotoxic lesions of the rat striatum: different responses of kynurenine pathway enzymes during ontogeny
856. Synergistic effects of tetrahydroaminoacridine and lithium on cholinergic function after excitotoxic basal forebrain lesions in rat
857. Extrasynaptic NMDA receptors: mediators of excitotoxic cell death
858. PET studies of domoic acid poisoning in humans: excitotoxic destruction of brain glutamatergic pathways, revealed in measurements of glucose metabolism by …
859. Effects of excitotoxic striatal lesions on single unit activity in globus pallidus and entopeduncular nucleus of the cat
860. excitotoxic and anti-excitotoxic mechanisms in neurological disease
861. Bioenergetics and excitotoxicity: the weak excitotoxic hypothesis
862. Distribution of the messenger RNA for the extracellularly regulated kinases 1, 2 and 3 in rat brain: effects of excitotoxic hippocampal lesions
863. Strychnine protection against excitotoxic cell death in primary cultures of rat cerebral cortex
864. Cerebral cortical neuron apoptosis after mild excitotoxic injury in vitro: different roles of mesencephalic and cortical astrocytes
865. excitotoxic amino acid receptors in human complex partial epilepsy
866. excitotoxic lesions of the medial striatum delay extinction of a reinforcement color discrimination operant task in domestic chicks; a functional role of reward …
867. Differential excitatory effects of kainic acid on CA3 and CA1 hippocampal pyramidal neurons: further evidence for the excitotoxic hypothesis and for a receptor …
868. … of damage to the basal forebrain on brain glucose utilization: a reevaluation using positron emission tomography in baboons with extensive unilateral excitotoxic …
869. Concomitant distribution shift of glial GABA transporter and S100 calcium-binding proteins in the rat retina after kainate-induced excitotoxic injury
870. excitotoxic brain injury suppresses striatal high‐affinity glutamate uptake in perinatal rats
871. Polymicrogyria: role of the excitotoxic damage
872. Degeneration of hippocampal CA1 neurons following transient ischemia due to raised intracranial pressure: evidence for a temperature-dependent excitotoxic …
873. Impaired volume regulation is the mechanism of excitotoxic sensitization to complement
874. Mechanical and excitotoxic lesion of motoneurons: effects of neurotrophins and ciliary neurotrophic factor on survival and regeneration
875. Is Purkinje cell loss in Leigh’s disease an excitotoxic event secondary to damage to inferior olivary nuclei?
876. Attenuation of excitotoxic cell swelling and GABA release by the GABA transport inhibitor SKF 89976A
877. Selectivity of excitotoxic mechanisms in Alzheimer’s disease
878. excitotoxic striatal lesions protect against subsequent methamphetamine-induced dopamine depletions.
879. excitotoxic profiles of novel, low-affinity kainate receptor agonists in primary cultures of murine cerebellar granule cells
880. Effects of a new excitotoxic amino acid, dysiherbaine, on cultured Müller cells
881. … alpha-methyl-p-tyrosine abolishes the enhancement of methamphetamine-induced extracellular dopamine levels in the amygdala of rats with excitotoxic lesions of the …
882. The fatty acid composition of maternal diet affects the response to excitotoxic neural injury in neonatal rat pups
883. excitotoxic lesions of the subthalamic nucleus ameliorate asymmetry induced by striatal dopamine depletion in the rat
884. Quantitative histochemical measurement of GABA-transminase: Method for evaluation of intracerebral lesions produced by excitotoxic agents
885. Differentially expressed genes in hippocampal cell cultures in response to an excitotoxic insult by quinolinic acid
886. [24] excitotoxic amino acids as neuroendocrine research tools
887. Site-specific actions of interleukin-1 on excitotoxic cell death in the rat striatum
888. Electron spin resonance studies of the effects of naturally-occurring excitotoxic amino acid analogues on the physical state of membrane proteins in human …
889. 3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum
890. Inhibition of excitotoxic neuronal cell death by total extracts from oriental medicines used for stroke treatment
891. Mitochondrial impairment induces excitotoxic death in cerebellar granule cells
892. Dissociation between the effects of interleukin-1 on excitotoxic brain damage and body temperature in the rat
893. Impact of a preceding striatal excitotoxic lesion and treatment with ciliary neurotrophic factor on striatal graft survival
894. Dextromethorphan analogs are neuroprotective in vitro and block glutamate-induced excitotoxic calcium signals in neurons
895. Age-related vulnerability of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus
896. A 24 h corticosterone exposure exacerbates excitotoxic insult in rat hippocampal slice cultures independently of glucocorticoid receptor activation or protein synthesis
897. excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation
898. Fos protein induction, neuropathology, and pharmacological protection after excitotoxic brain insult
899. Ischemic and excitotoxic damage to brain slices from normal and microencephalic rats
900. … ‐gated channels mediates the delayed, elevated increases in steady‐state c‐fos mRNA levels in cerebellar granule cells exposed to excitotoxic levels of glutamate
901. Alteration of neuronal calcium homeostasis and excitotoxic vulnerability by chronic depolarization
902. Preservation of cholinergic activity and prevention of neuron death by CEP-1347/KT-7515 following excitotoxic injury of the nucleus basalis magnocellularis
903. Determination of acetylcholine and dopamine content in thalamus and striatum after excitotoxic lesions of the pedunculopontine tegmental nucleus in rats
904. Distributed neurodegenerative changes 2–28 days after ventral hippocampal excitotoxic lesions in rats
905. excitotoxic lesions of the prefrontal cortex reduce dopamine D1-like receptors in the ventral tegmental area
906. Diltiazem protects human NT-2 neurons against excitotoxic damage in a model of simulated ischemia
907. excitotoxic Brain Lesion Modifies Binding to a USF Binding Site Acting as a Negative Regulatory Element in theProtease Nexin-1Promoter
908. Caffeine does not affect excitotoxic brain lesions in newborn mice
909. excitotoxic effect of glutamate on the afferent neurons in guinea pigs
910. Magnetic resonance spectroscopy studies on changes in cerebral calcium and zinc and the energy state caused by excitotoxic amino acids
911. excitotoxic and apoptotic neuronal death induce different patterns of glial activation in vitro
912. Expression of heat shock protein 70 induced by 4-aminopyridine through glutamate-mediated excitotoxic stress in rat hippocampus in vivo
913. An analysis of bioelectrical phenomena evoked by microiontophoretically applied excitotoxic amino-acids in the feline spinal cord
914. Activation of the ornithine decarboxylase-polyamine system and induction of c-fos and p53 expression in relation to excitotoxic neuronal apoptosis in normal and …
915. Extracellular putrescine content after acute excitotoxic brain damage in the rat
916. excitotoxic amino acid neurotransmitters are increased in human cerebrospinal fluid after subarachnoid haemorrhage.
917. Ontogenic study of the influence of tissue plasminogen activator (t-PA) in neonatal excitotoxic brain insult and the subsequent microglia/macrophage activation
918. Ventricular dilatation over several weeks following induction of excitotoxic (systemic lithium/pilocarpine) lesions: potential role of damage to the substantia nigra …
919. Expression of N‐methyl‐D‐aspartate receptors using vaccinia virus causes excitotoxic death in human kidney cells
920. excitotoxic mechanisms of apoptosis in the mammalian visual system following monocular visual deprivation
921. Effect of carnosine and its natural derivatives on apoptosis of neurons induced by excitotoxic compounds
922. c-JUN, KROX-24, and c-FOS expression in hippocampal grafts placed in excitotoxic hippocampal lesions of the rat
923. Taste Functions and Na+-Appetite After excitotoxic Lesions of the Parabrachial Nuclei in Rats
924. Recombinant core protein fragment of phosphacan, a brain specific chondroitin sulfate proteoglycan, promote excitotoxic cell death of cultured rat hippocampal …
925. Involvement of excitatory amino acid receptors in the mechanisms underlying excitotoxic phenomena
926. excitotoxic cascade and neuroprotection in various stages of cerebral development
927. Glial response to excitotoxic injury in the immature rat brain
928. C-fos expression in the rat nucleus basalis upon excitotoxic lesion with quisqualic acid: a study in adult and aged animals
929. Effects of excitotoxic median raphe lesion on working memory deficits produced by the dorsal hippocampal muscarinic receptor blockade in the inhibitory avoidance in …
930. The pyrimidine derivative BW 1003C87 protects against excitotoxic lesions induced by kainate in the rat striatum
931. excitotoxic mechanisms and neurological disease
932. Nerve growth factor response to excitotoxic lesion of the cholinergic basal forebrain is slightly impaired in aged rats
933. Crosstalk between calpain and calcineurin in excitotoxic neurodegeneration; Therapeutic targets for the treatment of excitotoxic neurodegeneration
934. excitotoxic profile of LY339434, a GluR5 agonist, in cultured murine cortical neurons
935. Morphological study on the excitotoxic effect of glutamate on rat hippocampus
936. Impaired learning correlates with size of excitotoxic hippocampal CA3 lesions in adult rats, but shows no amelioration by CA3 transplants
937. Decreased dendrite growth from cultured mouse cortical neurons surviving excitotoxic activation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate/kainate …
938. Morphological study on excitotoxic neurodegeneration of exogenous glutamate in newborn rat brain
939. Inhibition of phosphatidylcholine synthesis is associated with excitotoxic cell death in cerebellar granule cell cultures
940. Electrolytic lesions of the locus coeruleus or 6-hydroxydopamine lesions of the medial forebrain bundle protect against excitotoxic damage in rat hippocampus
941. Heat-shock protein 72 expression in excitotoxic versus penetrating injuries of the rodent cerebral cortex
942. excitotoxic neurodegeneration in Alzheimer disease
943. Glutamate receptors and excitotoxic mechanisms in Alzheimer’s disease
944. Ginkgolides protects the cultured rat cortical cells against metabolic, excitotoxic and oxidative insults
945. Changes in the mitochondrial enzyme activity in striatal projection areas after unilateral excitotoxic striatal lesions: partial restoration by embryonic striatal transplants
946. Decreased excitotoxic sensitivity in the olfactory cortex of adult rats after neonatal NMDA blockade.
947. Olfactory bulbectomy protects hippocampal pyramidal neurons against excitotoxic death
948. Fetal striatal transplants reinstate the electrophysiological response of pallidal neurons to systemic apomorphine challenge in rats with excitotoxic striatal lesions.
949. excitotoxic lesions of histaminergic neurons by excitatory amino acid agonists in the rat brain
950. … within primary cultures of mouse cerebellar granule cells stimulated with the excitatory amino acid L-glutamate: Correlation with excitotoxic outcome and derivation of …
951. Absence of excitotoxic neuropathology in microencephalic rats after systemic kainic acid administration
952. Glutamate-receptor elicited acetylcholinesterase release in mouse spinal cord slice: a model of early excitotoxic injury
953. Transient potassium conductances protect nucleus tractus solitarius neurons from NMDA induced excitotoxic plateau depolarizations
954. … neonatal blockade of NMDA receptor does not affect developmental polyamine metabolism but results in altered response to the excitotoxic induction of ornithine …
955. Long-term cortical atrophy after excitotoxic striatal lesion: Effects of intrastriatal fetal-striatum grafts and implications for Huntington disease
956. Effects of excitotoxic median raphe lesions on scopolamine-induced working memory deficits in inhibitory avoidance
957. Constitutive nitric oxide synthase and ischemic/excitotoxic brain injury
958. TH mRNA over-expression in rats with chronic excitotoxic striatal lesions.
959. NGF treatment potentiates c-fos expression in the rat nucleus basalis upon excitotoxic lesion with quisqualic acid
960. excitotoxic lesions of the neostriatum as an animal model of Huntington’s disease
961. Changes in gene expression after transient ischemia as potential markers for excitotoxic pathology
962. c-fos and tyrosine hydroxylase expression after an excitotoxic lesion on the nigrostriatal system: a study on the effects of hypoxia used as a preconditioning stimulus
963. Chemokines and neonatal excitotoxic brain injury
964. Knockout of p75 NTR does not alter the viability of striatal neurons following a metabolic or excitotoxic injury
965. Facilitated extinction of appetitive instrumental conditioning following excitotoxic lesions of the core or the medial shell subregion of the nucleus accumbens in rats
966. Blood-brain barrier permeability and stress; a study on excitotoxic stress and vasogenic edema
967. … α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionate and N‐methyl‐d‐aspartate but not kainate receptors inhibits phosphatidylcholine synthesis before excitotoxic …
968. Use of MRI to study excitotoxic spinal cord injury
969. Effects and mechanisms of ginsenoside Rb3 on glutamate excitotoxic injury in cultured neurons of rat hippocampus
970. Studies on excitotoxic damage in hippocampal neurons
971. An excitotoxic Model of Alzheimer’s Disease: NMDA Lesions and Initial Neural Grafting Results
972. Activation of NOS Interneurones in Striatum after excitotoxic Lesions of Rat Globus Pallidus
973. Connective integration of hippocampal grafts in excitotoxic hippocampal lesions in adult rats: an anterograde axonal tracing study
974. Effects of RU 52583, an α2-antagonist, on memory in rats with excitotoxic damage to the septal area
975. Differential alterations of second messenger systems and cerebral glucose use following excitotoxic lesion of rat cerebral cortex
976. Transplantation of developing hippocampal neurons to ischemic and excitotoxic lesions of the adult rat hippocampus
977. excitotoxic lbnino Acids
978. Induction of transcription factor A-myb expression in reactive astrocytes following an excitotoxic lesion in the mouse hippocampus
979. Assessment of role of methyl cobalamine in excitotoxic effects of glutamicaid
980. excitotoxic ablation.
981. … desensitisation-preventing properties of a novel, subtype-selective AMPA receptor agonist,(S)-CPW 399, as a possible explanation for its excitotoxic action in cultured …
982. Effects of excitotoxic lesions of the medial prefrontal cortex on density of high affinity [125I-Tyr3] neurotensin binding sites within the ventral midbrain and striatum
983. excitotoxic lesions of the lateral parabrachial nucleus do not prevent cholecystokinin-induced suppression of milk intake in rats
984. Chronic excitotoxic neurodegeneration induced by low dose of kainic acid administration intranasally in C57BL/6 mice
985. Effects of excitotoxic lesions of the nucleus basalis magnocellularis on the acquisition of cocaine self-administration in the rat
986. excitotoxic median raphe lesions aggravate working memory storage performance deficits caused by scopolamine infusion into the dentate gyrus of the …
987. Cerebrospinal fluid flow in the excitotoxic model of posttraumatic syringomyelia
988. An improved model for examining delayed excitotoxic neurodegeneration in isolated chick retina
989. Neuroprotection of excitotoxic Brain Lesions in the Newborn Mouse by Glycine Antagonist and Inhibitor of No°. 159
990. Spinal and supraspinal expression of PKC isoforms following excitotoxic spinal cord injury and implications for chronic pain management
991. Methylation of the NMDA Receptor Agonistl-trans-2, 3-Pyrrolidine-Dicarboxylate: Enhanced excitotoxic Potency and Selectivity
992. α‐Amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid‐mediated excitotoxic axonal damage is attenuated in the absence of myelin proteolipid protein
993. Anti-excitotoxic Therapies in Neurologic Diseases: Current Evidences and New Perspectives
994. 25. Brain excitotoxic NetWorks in Heatstroke
995. Anti-excitotoxic and Antioxidant TGF-BETA Family Neurotrophic Factors: In Vitro Screening Models of Motor Neuron Degeneration
996. Drug discrimination learning in rats with excitotoxic lesions of nucleus basalis and ventral globus pallidus
997. Barrier distruption following excitotoxic lesions in the brain of the anaesthetized rat
998. excitotoxic and anti-excitotoxic effects of pyridine carboxylic acids and related compounds on various cholinergic brain nucleii.
999. Studies on immediate early gene activation and excitotoxic neuronal death.
1000. The effect of pedunculopontine tegmental nucleus and lateral hypothalamic excitotoxic lesions on motivational strength as measured by the progressive ratio …
1001. Cerebellar neurones: Differentiation and modulation of sensitivity to excitotoxic treatment
1002. Progression of ischaemic stroke and excitotoxic aminoacids
1003. Effects of a New excitotoxic Amino Acid, Dysiherbaine, on Cultured Müller Cells
1004. Effects of a new excitotoxic amino acid, dysiherbaine, on cultured Müller cells
1005. On the role of mGluR1 in acute excitotoxic neuronal degeneration
1006. excitotoxic neuronal cell death in the adult rodent brain.
1007. excitotoxic mechanisms in Huntington’s disease
1008. Anti-excitotoxic Activity of Trimetazidine in the Retina
1009. Early evolution and recovery from excitotoxic injury in the neonatal rat brain
1010. excitotoxic Mechanisms in Adult Dissociated Mouse Retinal Cell Cultures
1011. Inhibition of Oxidative Stress-induced and excitotoxic Neuronal Cell Damage by Xuesaitong Ruanjiaonang
1012. Role of Nitric Oxide in excitotoxic and Ischemic Neuronal Damage
1013. excitotoxic neurodegeneration in mouse brain: Roles of immune cells and cytokines
1014. excitotoxic neurotoxicity in an in vitro brain slice model
1015. APOPTOSIS IN AN excitotoxic MODEL OF POST-TRAUMATIC SYRINGOMYELIA
1016. Interaction of excitotoxic and oxidative mechanisms in selective motor neuron injury: A hypothesis of ALS pathogenesis.
1017. 2-iminothiazolidine-4-carboxylic acid (2-ICA): An excitotoxic-independent hippocampal neurotoxin
1018. Modulation of the brain histaminergic system by excitotoxic lesions
1019. Early events following an excitotoxic insult in rat striatum
1020. Chemokines and Neonatal excitotoxic Brain Injury
1021. excitotoxic Cell Death in Cultured Retinal Neurons
1022. Factors Regulating excitotoxic Neurodegeneration: The Role of Calcium and the Mitochondria
1023. Neural regeneration and recovery in the cochlea after excitotoxic injury
1024. CHANGES IN NEURONS AND GLIA IN RESPONSE TO GLUTAMATERGIC excitotoxic EVENTS
1025. The role of calpain in excitotoxic neuronal cell death.
1026. Developmental Changes in excitotoxic Properties of Glutamate in Cultured Central Neurons† 257
1027. excitotoxic effects of glutamate on the in vitro spiral ganglion cells [J]
1028. excitotoxic Neurodegeneration by Vital Stains in Isolated Rat Retinas
1029. The time-course changes of astrocytes following an excitotoxic lesion in the CNS
1030. excitotoxic effects of glutamate on the in vitro spiral ganglion cells
1031. Activation of volume-sensitive Cl− channel in association with excitotoxic varicosity formation in cortical neurons
1032. Xenon Prevents a Long-Term excitotoxic Injury in Adult Rats
1033. Effect of excitotoxic lesions of rat medial prefrontal cortex on spatial memory
1034. Polyamines Exacerbate excitotoxic Death of Adult Retinal Ganglion Cells in vivo
1035. Effects of excitotoxic and immunotoxic lesions of the posterior parietal cortex on attention
1036. Pharmacological inhibition of NADPH oxidase does not reduce excitotoxic brain lesion in newborn mice
1037. Modulation of glutamate receptors in search of protection from excitotoxic-induced neuron death
1038. Mechanisms of dantrolene‐induced neuroprotection against excitotoxic injury
1039. excitotoxic change of Hippocampal Neuron by Kainic Acid in Rat Brain
1040. Functional changes in pyramidal neurons surviving an excitotoxic challenge in mouse organotypic slice cultures
1041. Glutamate Transporters: Molecular Mechanisms of Functional Alteration and Role in the Development of excitotoxic Neuronal Injury
1042. the excitotoxic cell death that is brought about by excess glutamate3. What have we learned from these findings and what remains enigmatic? We finally have a …
1043. Inhibitory Effects of Xiaoshuan Zaizao Wan on excitotoxic and Oxidative Neuronal Damage Induced in Primary Cultured Rat Cortical Cells
1044. Further evidence for the role of inositol trisphosphate as an excitotoxic death signal in hippocampal neurons
1045. Unusual Molecular Form of Cathepsin E Expressed at Early Stage of excitotoxic Damage in Hippocampal Neurons of Rats
1046. Effect of excitotoxic striatal lesions on the discharge pattern in globus pallidus and entopeduncular nucleus of the cat.
1047. The role of the AMPA receptor GluR2 subunit in anesthetic neurodepression and excitotoxic cell death
1048. Acute production of hydroxyl radicals does not participate in the excitotoxic effect of an intrastriatal perfusion of glutamate in rats
1049. excitotoxic damage of the hippocampus in the rat: involvement of N-methyl-D-aspartate receptors
1050. Neuroprotection against excitotoxic cell damage in rat striatum and hippocampus.
1051. Inhibition of a downstream effector of COX2 can attenuate excitotoxic brain injury
1052. Unsettled Role of Glutamate/Glutamate Receptors in Ischemic excitotoxic Neuronal Damage
1053. NMDA-evoked inhibition of phosphatidylcholine synthesis precedes excitotoxic neuronal death
1054. Glutamate receptor transmission and ischemic nerve cell damage: evidence for involvement of excitotoxic
1055. excitotoxic lesions of the rat nucleus basalis magnocellularis: implication of basoamygdaloid cholinergic projections in memory.
1056. INCREASED CSF-LEVELS OF excitotoxic AMINO-ACIDS AFTER FULL-TERM PERINATAL ASPHYXIA
1057. Stress-induced changes in sensitivity to thermal nociceptive stimulation in normal rats and following excitotoxic spinal cord injury
1058. Regulation of brain adenosine and adenine-nucleotide levels under excitotoxic conditions and in sleep regulation
1059. Ganglioside and Growth Factor Interactions Promote Mesencephalic Cell Survival from the excitotoxic Actions of 2, 4, 5-Trihydroxyphenylalanine
1060. … and dysfunctions of the nucleus basalis as Alzheimer’s disease models: general and critical overview and analysis of the long-term changes in several excitotoxic …
1061. Carbon monoxide (CO) protects against apoptosis caused by seizure‐related excitotoxic and inflammatory factors in the cerebral vasculature
1062. Inhibition of Tissue Plasminogen Activator Attenuates Non–NMDA Receptor–Mediated excitotoxic Retinal Degeneration
1063. IMPAIRED COGNITIVE PERFORMANCE AFTER NEONATAL excitotoxic HIPPOCAMPAL DAMAGE IN RATS: FURTHER EVALUATION OF AN ANIMAL MODEL …
1064. excitotoxic lesions of the hippocampus leave sensory preconditioning intact: Implications for models of hippocampal functioning
1065. Comparison between aspirative versus excitotoxic lesions of the lateral entorhinal cortex on conditioned odor aversionin the rat
1066. Fentanyl, but Not Sufentanil, Exacerbates Neonatal excitotoxic White Matter Lesions Via the ORL-1 Receptor
1067. EFFECTS OF excitotoxic LESIONS OF THE NUCLEUS BASALIS MAGNOCELLULARIS ON LOCOMOTOR RESPONSES TO CONDITIONED AND …
1068. Detection of Single and Double Strand DNA Breaks during excitotoxic or Apoptotic Neuronal Cell Death
1069. Region-specific expression of the interleukin-1 system in rat brain following endotoxin challenge and excitotoxic neurodegeneration
1070. Potential neuroprotective characteristics of cannabinoids on excitotoxic neurodegeneration in the spastic Han-Wistar rat
1071. Anti-excitotoxic and Antioxidant TGF-BETA Family Neurotropic Factors: In Vitro Screening Models of Motor Neuron Degeneration
1072. S. Marty, I. Dusart and M. Peschanski.“Glial Changes Following an excitotoxic Lesion in the CNS–I. Microglia/Macrophages.” Neuroscience. vol. 45, No. 3,(1991 …
1073. EFFECTS OF excitotoxic LESIONS OF THE CA1 FIELD IN MARMOSET HIPPOCAMPUS AS A MODEL OF HUMAN AMNESIA
1074. Imaging of spreading depression under low oxygen/glucose and excitotoxic conditions in the mouse hemi-brain slice.
1075. Wogonin protects neuronal cells from excitotoxic and oxidative injuries in primary cultured rat cortical cells
1076. Neuroprotective effects of overexpression of the inhibitor of apoptosis proteins in the quinolinic acid model of excitotoxic injury.
1077. The effects of GDNF against kainic acid excitotoxic injury on neonatal rat doral root ganglion neurons in vitro
1078. Chronic in utero ischemia protects newborn mice against excitotoxic periventricular white matter cysts• 1122
1079. Wogonin protects neuronal cells from excitotoxic and oxidative injuries in primary cultured rat cortical cells
1080. Changes in Basal Forebrain Cholinergic Systems Following excitotoxic Cell Death in the Hippocampus and Cerebral Neocortex
1081. The role of group I metabotropic glutamate receptors in excitotoxic cell death induced by exposure to ionotropic agonist kainic acid
1082. Regulation of CNTF and CNTF receptor phosphorylation after excitotoxic lesion in neuron/astrocyte co-culture
1083. excitotoxic damage to brain tissue subsequent to a graft-induced excess of neurotransmitter substance in some brain areas remains an important subject that …
1084. Cytological alterations in nrm neurons in male rats following formalin induced pain and excitotoxic lesion of vl pag-nrm pathway by ibotenic acid
1085. The human NT-2 cell line as in vitro model system for the excitotoxic cascade during stroke
1086. Effects of excitotoxic thalamic lesion upon 14C-2-deoxyglucose (DG) uptake in the somatosensory cortex of the adult mouse
1087. Effect of Mediodorsal Thalamus and Ventral Hippocampus excitotoxic Lesion in the Adult Rat: Implicate the Neuropathology of Schizophrenia
1088. SELF-ORDERED SPATIAL SEARCHING IN PRIMATES: CONTRASTING EFFECTS OF excitotoxic LESIONS AND DOPAMINE DEPLETION OF THE …
1089. Sites and mechanisms of IL-1 action in ischemic and excitotoxic brain damage
1090. POSTERS: Localised changes in expression of calcium binding proteins induced by chronic application of an excitotoxic agent, β-N-oxalyl-L-α, β diaminopropionic …
1091. (647): Effects of acute stress on nociceptive responses following excitotoxic spinal injury: A model of stress induced hyperalgesia
1092. … COMMUNICATIONFetal striatal transplants reinstate the electrophysiological response of pallidal neurons to systemic apomorphine challenge in rats with excitotoxic …
1093. 347 Cannabinoids Protect Against excitotoxic Brain Lesions in Newborn Mice
1094. 318 Maternal LPS Enhances excitotoxic Brain Lesions in Newborn Rats
1095. … , nitric oxide; nNOS, neuronal NOS; NOS, NO synthase; ONOO−, peroxynitrite; PBD, PSD95-binding domain. a target for inhibition of excitotoxic p38 stress-activated …
1096. 325 Effect of Triiodothyronine (T3) on excitotoxic Brain Damage of Newborn Mice
1097. Distribution of betaine/gaba transporter BGT-1 in excitotoxic brain injury and its role in osmoregulation in the brain
1098. Protective Effects of Neurotrophin-3 on The excitotoxic Damage of Cochlear Afferent Neurons in Guinea Pigs
1099. Current Problems in Epilepsy, vol. 8: Epileptogenic and excitotoxic Mechanisms
1100. THE ADENOSINE A2A RECEPTOR ANTAGONIST ZM 241385 DIFFERENTIALLY INFLUENCES excitotoxic MECHANISMS AT PRE AND POST-SYNAPTIC SITE …
1101. 17 excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis
1102. A study of neuronal calcium (2+) homeostasis: Application to the pathophysiology and treatment of early excitotoxic and hypoxic/ischemic neuronal injury in vitro and …
1103. excitotoxic mechanisms in stroke: an update of concepts and treatment strategies
1104. excitotoxic damage to white matter
1105. Molecular and cellular mechanisms of excitotoxic neuronal death
1106. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo
1107. excitotoxic neuronal death and the pathogenesis of Huntington’s disease
1108. The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults
1109. Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain
1110. excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism
1111. An overview of brain-derived neurotrophic factor and implications for excitotoxic vulnerability in the hippocampus
1112. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma
1113. Tau exacerbates excitotoxic brain damage in an animal model of stroke
1114. Involvement of autophagy in hypoxic-excitotoxic neuronal death
1115. The role of excitotoxic programmed necrosis in acute brain injury
1116. Synaptic NMDA receptors mediate hypoxic excitotoxic death
1117. Calpains are downstream effectors of bax-dependent excitotoxic apoptosis
1118. excitotoxic mechanisms of ischemic injury in myelinated white matter
1119. excitotoxic neuroprotection and vulnerability with CaMKII inhibition
1120. NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders
1121. Context-but not familiarity-dependent forms of object recognition are impaired following excitotoxic hippocampal lesions in rats.
1122. Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration
1123. Neuronal Sirt3 protects against excitotoxic injury in mouse cortical neuron culture
1124. Intracellular zinc is a critical intermediate in the excitotoxic cascade
1125. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis
1126. Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death
1127. Role of NMDA receptor–dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries
1128. Pilocarpine-induced status epilepticus in rats involves ischemic and excitotoxic mechanisms
1129. Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease
1130. Roles of prostaglandin synthesis in excitotoxic brain diseases
1131. Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult
1132. Fingolimod protects cultured cortical neurons against excitotoxic death
1133. excitotoxic potential of the cyanotoxin β-methyl-amino-L-alanine (BMAA) in primary human neurons
1134. Roles of volume-sensitive chloride channel in excitotoxic neuronal injury
1135. Critical role of increased PTEN nuclear translocation in excitotoxic and ischemic neuronal injuries
1136. Striatal astrocytes produce neuroblasts in an excitotoxic model of Huntington’s disease
1137. Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage
1138. Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury‐induced cytokine response after excitotoxic damage
1139. Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro
1140. Rho mediates calcium-dependent activation of p38α and subsequent excitotoxic cell death
1141. Glucocorticoids increase excitotoxic injury and inflammation in the hippocampus of adult male rats
1142. Dexamethasone-induced acute excitotoxic cell death in the developing brain
1143. excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of l‐carnitine
1144. A β-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis
1145. excitotoxic glutamate insults block autophagic flux in hippocampal neurons
1146. A fluorescence vital assay for the recognition and quantification of excitotoxic cell death by necrosis and apoptosis using confocal microscopy on neurons in culture
1147. TNF receptor I sensitizes neurons to erythropoietin-and VEGF-mediated neuroprotection after ischemic and excitotoxic injury
1148. NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury
1149. CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia
1150. Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury
1151. excitotoxic lesions in the central nucleus of the amygdala attenuate stress-induced anxiety behavior
1152. Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration
1153. Monosodium glutamate neonatal treatment as a seizure and excitotoxic model
1154. Nanomolar concentrations of anabolic–androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures
1155. Faster perceptual learning through excitotoxic neurodegeneration
1156. The mouse brain metabolome: region-specific signatures and response to excitotoxic neuronal injury
1157. Intracellular pH reduction prevents excitotoxic and ischemic neuronal death by inhibiting NADPH oxidase
1158. excitotoxic lesions restricted to the dorsal CA1 field of the hippocampus impair spatial memory and extinction learning in C57BL/6 mice
1159. excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration
1160. Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions
1161. Novel positive allosteric modulators of glutamate transport have neuroprotective properties in an in vitro excitotoxic model
1162. Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53
1163. Quercetin, kaempferol and biapigenin from Hypericum perforatum are neuroprotective against excitotoxic insults
1164. Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice
1165. excitotoxic brain injury in adult zebrafish stimulates neurogenesis and long‐distance neuronal integration
1166. Protective effect of Calendula officinalis L. flowers against monosodium glutamate induced oxidative stress and excitotoxic brain damage in rats
1167. BACE1 mediates HIV-associated and excitotoxic neuronal damage through an APP-dependent mechanism
1168. Two-step activation of FOXO3 by AMPK generates a coherent feed-forward loop determining excitotoxic cell fate
1169. excitotoxic loss of post‐synaptic sites is distinct temporally and mechanistically from neuronal death
1170. Norrin protects retinal ganglion cells from excitotoxic damage via the induction of leukemia inhibitory factor
1171. Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor‐mediated IL‐1β release
1172. The excitotoxic effect of NMDA on human lymphocyte immune function
1173. Ca2+-permeable AMPARs mediate glutamatergic transmission and excitotoxic damage at the hair cell ribbon synapse
1174. Na+, K+-ATPase functionally interacts with the plasma membrane Na+, Ca2+ exchanger to prevent Ca2+ overload and neuronal apoptosis in excitotoxic stress
1175. Enhanced autophagy contributes to excitotoxic lesions in a rat model of preterm brain injury
1176. Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice
1177. Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord
1178. Quantitative proteomic analyses of dynamic signalling events in cortical neurons undergoing excitotoxic cell death
1179. p53 induction contributes to excitotoxic neuronal death in rat striatum through apoptotic and autophagic mechanisms
1180. Protection of cochlear synapses from noise-induced excitotoxic trauma by blockade of Ca2+-permeable AMPA receptors
1181. The redox biology of excitotoxic processes: the NMDA receptor, TOPA quinone, and the oxidative liberation of intracellular zinc
1182. The effects of glycemic control on seizures and seizure-induced excitotoxic cell death
1183. Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage
1184. Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury
1185. Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration
1186. Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries
1187. ACTH protects mature oligodendroglia from excitotoxic and inflammation‐related damage in vitro
1188. Assessment of intrinsic and extrinsic signaling pathway in excitotoxic retinal ganglion cell death
1189. A beacon of hope in stroke therapy—Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies
1190. α-MSH rescues neurons from excitotoxic cell death
1191. Cofilin activation mediates Bax translocation to mitochondria during excitotoxic neuronal death
1192. Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo
1193. Bax and calpain mediate excitotoxic oligodendrocyte death induced by activation of both AMPA and kainate receptors
1194. Kidins220/ARMS downregulation by excitotoxic activation of NMDARs reveals its involvement in neuronal survival and death pathways
1195. Longitudinal characterization of cognitive and motor deficits in an excitotoxic lesion model of striatal dysfunction in non-human primates
1196. Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study
1197. CCAAT/enhancer binding protein β deficiency provides cerebral protection following excitotoxic injury
1198. Tat-NR2B9c prevents excitotoxic neuronal superoxide production
1199. Protective effect of spermidine against excitotoxic neuronal death induced by quinolinic acid in rats: possible neurotransmitters and neuroinflammatory mechanism
1200. Selective dendritic susceptibility to bioenergetic, excitotoxic and redox perturbations in cortical neurons
1201. Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
1202. excitotoxic superoxide production and neuronal death require both ionotropic and non-ionotropic NMDA receptor signaling
1203. Diazepam neuroprotection in excitotoxic and oxidative stress involves a mitochondrial mechanism additional to the GABAAR and hypothermic effects
1204. VEGFD protects retinal ganglion cells and, consequently, capillaries against excitotoxic injury
1205. Identification of novel pharmacological targets to minimize excitotoxic retinal damage
1206. Melatonin reduces excitotoxic blood–brain barrier breakdown in neonatal rats
1207. An organotellurium compound with antioxidant activity against excitotoxic agents without neurotoxic effects in brain of rats
1208. Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology
1209. A new transgenic mouse model for studying the neurotoxicity of spermine oxidase dosage in the response to excitotoxic injury
1210. The specific PKR inhibitor C16 prevents apoptosis and IL-1β production in an acute excitotoxic rat model with a neuroinflammatory component
1211. c‐Jun N‐terminal kinase signaling pathway in excitotoxic cell death following kainic acid‐induced status epilepticus
1212. A cannabinoid receptor-mediated mechanism participates in the neuroprotective effects of oleamide against excitotoxic damage in rat brain synaptosomes and cortical …
1213. Different pathways lead to mitochondrial fragmentation during apoptotic and excitotoxic cell death in primary neurons
1214. Sustained NMDA receptor activation by spreading depolarizations can initiate excitotoxic injury in metabolically compromised neurons
1215. Anti-excitotoxic effects of cannabidiol are partly mediated by enhancement of NCX2 and NCX3 expression in animal model of cerebral ischemia
1216. Neuroprotective effects of hydroxysafflor yellow A against excitotoxic neuronal death partially through down-regulation of NR2B-containing NMDA receptors
1217. Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress-and Aβ-evoked hippocampal pathology
1218. Copaiba oil-resin treatment is neuroprotective and reduces neutrophil recruitment and microglia activation after motor cortex excitotoxic injury
1219. NR2A and NR2B subunits differentially mediate MAP kinase signaling and mitochondrial morphology following excitotoxic insult
1220. The fate of “dark” neurons produced by transient focal cerebral ischemia in a non-necrotic and non-excitotoxic environment: neurobiological aspects
1221. Cleavage of the vesicular GABA transporter under excitotoxic conditions is followed by accumulation of the truncated transporter in nonsynaptic sites
1222. Hydroxysafflor yellow A protects neurons from excitotoxic death through inhibition of NMDARs
1223. Trasmembrane chemokines CX3CL1 and CXCL16 drive interplay between neurons, microglia and astrocytes to counteract pMCAO and excitotoxic neuronal …
1224. excitotoxic glutamate causes neuronal insulin resistance by inhibiting insulin receptor/Akt/mTOR pathway
1225. Neuroprotective effect of inhaled nitric oxide on excitotoxic-induced brain damage in neonatal rat
1226. Procyanidin B2 protects neurons from oxidative, nitrosative, and excitotoxic stress
1227. Hippocampus glutamate and N-acetyl aspartate markers of excitotoxic neuronal compromise in posttraumatic stress disorder
1228. A role for polyamines in retinal ganglion cell excitotoxic death
1229. excitotoxic stimulation downregulates the ubiquitin–proteasome system through activation of NMDA receptors in cultured hippocampal neurons
1230. Vulnerability of hippocampal GABA‐ergic interneurons to kainate‐induced excitotoxic injury during old age
1231. … nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological …
1232. Beneficial effects of remifentanil against excitotoxic brain damage in newborn mice
1233. Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain
1234. Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: possible involvement of the endocannabinoid and endovanilloid systems
1235. Reduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau
1236. TNF-α triggers rapid membrane insertion of Ca2+ permeable AMPA receptors into adult motor neurons and enhances their susceptibility to slow excitotoxic injury
1237. The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing
1238. Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be …
1239. Phosphoinositide 3-kinase couples NMDA receptors to superoxide release in excitotoxic neuronal death
1240. Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration
1241. G protein–coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation‐induced sensitization to excitotoxic neurodegeneration
1242. Childhood status epilepticus and excitotoxic neuronal injury
1243. S-Allylcysteine protects against excitotoxic damage in rat cortical slices via reduction of oxidative damage, activation of Nrf2/ARE binding, and BDNF preservation
1244. Functional role of neurotrophin-3 in synapse regeneration by spiral ganglion neurons on inner hair cells after excitotoxic trauma in vitro
1245. Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis
1246. NMDA receptor‐mediated excitotoxic neuronal apoptosis in vitro and in vivo occurs in an ER stress and PUMA independent manner
1247. Antenatal bacterial endotoxin sensitizes the immature rat brain to postnatal excitotoxic injury
1248. Xenon-mediated neuroprotection in response to sustained, low-level excitotoxic stress
1249. The GluK4 kainate receptor subunit regulates memory, mood, and excitotoxic neurodegeneration
1250. Reactivity of microglia and astrocytes after an excitotoxic injury induced by kainic acid in the rat spinal cord
1251. Bok is not pro-apoptotic but suppresses poly ADP-ribose polymerase-dependent cell death pathways and protects against excitotoxic and seizure-induced neuronal …
1252. Response of transcription factor NFATc3 to excitotoxic and traumatic brain insults: identification of a subpopulation of reactive astrocytes
1253. Zeta inhibitory peptide, a candidate inhibitor of protein kinase Mζ, is excitotoxic to cultured hippocampal neurons
1254. Otx2 promotes the survival of damaged adult retinal ganglion cells and protects against excitotoxic loss of visual acuity in vivo
1255. Modulation of extrasynaptic GABAergic receptor activity influences glutamate release and neuronal survival following excitotoxic damage to mouse spinal cord …
1256. Cytosolic zinc accumulation contributes to excitotoxic oligodendroglial death
1257. Identification of synaptotagmin 10 as effector of NPAS4-mediated protection from excitotoxic neurodegeneration
1258. Genetic inhibition of caspase‐2 reduces hypoxic‐ischemic and excitotoxic neonatal brain injury
1259. A Neurotoxic Ménage-à-trois: Glutamate, Calcium, and Zinc in the excitotoxic Cascade
1260. Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
1261. Role of cyclophilin D-dependent mitochondrial permeability transition in glutamate-induced calcium deregulation and excitotoxic neuronal death
1262. Role of HSP70 in motoneuron survival after excitotoxic stress in a rat spinal cord injury model in vitro
1263. Stereotaxic surgery for excitotoxic lesion of specific brain areas in the adult rat
1264. Expression of CD200 in alternative activation of microglia following an excitotoxic lesion in the mouse hippocampus
1265. Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia
1266. Correlation between afferent rearrangements and behavioral deficits after local excitotoxic insult in the mammalian vestibule: a rat model of vertigo symptoms
1267. Endogenous Wnt/β-catenin signaling in Müller cells protects retinal ganglion cells from excitotoxic damage
1268. Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death
1269. PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study
1270. A functional dissociation of the anterior and posterior pedunculopontine tegmental nucleus: excitotoxic lesions have differential effects on locomotion and the …
1271. Ondansetron reduces lasting vestibular deficits in a model of severe peripheral excitotoxic injury
1272. Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3–phosphatidylinositol 3-kinase–akt pathway through its sex hormone-binding …
1273. excitotoxic targeting of Kidins220 to the Golgi apparatus precedes calpain cleavage of Rap1-activation complexes
1274. JNK1 inhibition by Licochalcone A leads to neuronal protection against excitotoxic insults derived of kainic acid
1275. Presynaptic silencing is an endogenous neuroprotectant during excitotoxic insults
1276. Flavor and object recognition memory impairment induced by excitotoxic lesions of the perirhinal cortex
1277. Quercetin prevents spinal motor neuron degeneration induced by chronic excitotoxic stimulus by a sirtuin 1-dependent mechanism
1278. iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite
1279. Ceftriaxone preserves glutamate transporters and prevents intermittent hypoxia-induced vulnerability to brain excitotoxic injury
1280. The inflammatory cytokine, interleukin‐1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute …
1281. Calpain activation and Na+/Ca2+ exchanger degradation occur downstream of calcium deregulation in hippocampal neurons exposed to excitotoxic glutamate
1282. Possible prophylactic anti-excitotoxic and anti-oxidant effects of virgin coconut oil on aluminium chloride-induced Alzheimer’s in rat models
1283. Exposure of neurons to excitotoxic levels of glutamate induces cleavage of the RNA editing enzyme, adenosine deaminase acting on RNA 2, and loss of GLUR2 …
1284. excitotoxic and radiation stress increase TERT levels in the mitochondria and cytosol of cerebellar Purkinje neurons
1285. The pharmacological inhibition of fatty acid amide hydrolase prevents excitotoxic damage in the rat striatum: possible involvement of CB1 receptors regulation
1286. Olfactory training prevents olfactory dysfunction induced by bulbar excitotoxic lesions: role of neurogenesis and dopaminergic interneurons
1287. Protective effects of 7, 8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress
1288. HIP/PAP prevents excitotoxic neuronal death and promotes plasticity
1289. In vivo evaluation of white matter integrity and anterograde transport in visual system after excitotoxic retinal injury with multimodal MRI and OCT
1290. TRPing into excitotoxic neuronal death
1291. Excitatory neurosteroids attenuate apoptotic and excitotoxic cell death in primary cortical neurons
1292. Absence of aryl hydrocarbon receptors increases endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress
1293. Neuroprotection by GH against excitotoxic-induced cell death in retinal ganglion cells
1294. Contribution of endogenous glycine and d-serine to excitotoxic and ischemic cell death in rat cerebrocortical slice cultures
1295. Glial response to 17β-estradiol in neonatal rats with excitotoxic brain injury
1296. Differential effects of serotonin-specific and excitotoxic lesions of OFC on conditioned reinforcer devaluation and extinction in rats
1297. Delayed neuroprotection by riluzole against excitotoxic damage evoked by kainate on rat organotypic spinal cord cultures
1298. excitotoxic lesions of the infralimbic, but not prelimbic cortex facilitate reversal of appetitive discriminative context conditioning: the role of the infralimbic cortex …
1299. Combined excitotoxic–oxidative stress and the concept of non-cell autonomous pathology of ALS: Insights into motoneuron axonopathy and astrogliosis
1300. ASIC channel inhibition enhances excitotoxic neuronal death in an in vitro model of spinal cord injury
1301. Minocycline treatment reduces white matter damage after excitotoxic striatal injury
1302. Treatment with the ketone body D-β-hydroxybutyrate attenuates autophagy activated by NMDA and reduces excitotoxic neuronal damage in the rat striatum in vivo
1303. Mild in vitro trauma induces rapid Glur2 endocytosis, robustly augments calcium permeability and enhances susceptibility to secondary excitotoxic insult in cultured …
1304. VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3‐K pathway and inhibition of p38MAPK
1305. Mutant LRRK2 enhances glutamatergic synapse activity and evokes excitotoxic dendrite degeneration
1306. Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality
1307. excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study
1308. Interactive effect of excitotoxic injury and dietary restriction on neurogenesis and neurotrophic factors in adult male rat brain
1309. Interleukin-10 and Interleukin refeceptor-I Are Upregulated in Glial Cells After an excitotoxic Injury to the Postnatal Rat Brain
1310. Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in …
1311. Sequential expression of cell‐cycle regulators and Alzheimer’s disease–related proteins in entorhinal cortex after hippocampal excitotoxic damage
1312. Recovery of olfactory function after excitotoxic lesion of the olfactory bulbs is associated with increases in bulbar SIRT1 and SIRT4 expressions
1313. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress
1314. Adenine nucleotide translocator 1 deficiency increases resistance of mouse brain and neurons to excitotoxic insults
1315. The C‐terminal domain of tetanus toxin protects motoneurons against acute excitotoxic damage on spinal cord organotypic cultures
1316. Neural crest stem cells protect spinal cord neurons from excitotoxic damage and inhibit glial activation by secretion of brain-derived neurotrophic factor
1317. Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice
1318. Delayed Administration of VEGF Rescues Spinal Motor Neurons from Death with a Short Effective Time Frame in excitotoxic Experimental Models in Vivo
1319. Intracellular Zn2+ increases contribute to the progression of excitotoxic Ca2+ increases in apical dendrites of CA1 pyramidal neurons
1320. S100β as an early biomarker of excitotoxic damage in spinal cord organotypic cultures
1321. N‐Methyl‐d‐aspartate receptor subunit‐ and neuronal‐type dependence of excitotoxic signaling through post‐synaptic density 95
1322. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy
1323. Neuroprotective effects of a protein tyrosine phosphatase inhibitor against hippocampal excitotoxic injury
1324. Inhibition of the adenosine A2A receptor mitigates excitotoxic injury in organotypic tissue cultures of the rat cochlea
1325. Cleavage of the vesicular glutamate transporters under excitotoxic conditions
1326. Cyclooxygenase-2 mediates the sensitizing effects of systemic IL-1-beta on excitotoxic brain lesions in newborn mice
1327. Olfactory function in an excitotoxic model for secondary neuronal degeneration: role of dopaminergic interneurons
1328. Implanted neurosphere-derived precursors promote recovery after neonatal excitotoxic brain injury
1329. Dapsone prolong delayed excitotoxic neuronal cell death by interacting with proapoptotic/survival signaling proteins
1330. Subarachnoid transplant of a human neuronal cell line attenuates chronic allodynia and hyperalgesia after excitotoxic spinal cord injury in the rat
1331. Generating excitotoxic lesion models of Huntington’s disease
1332. excitotoxic lesions of the superior colliculus preferentially impact multisensory neurons and multisensory integration
1333. Neuroprotection of Ilex latifolia and caffeoylquinic acid derivatives against excitotoxic and hypoxic damage of cultured rat cortical neurons
1334. Sphingosine 1‐phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes
1335. Drug screening of neuroprotective agents on an organotypic-based model of spinal cord excitotoxic damage
1336. Caspase‐3 activation in astrocytes following postnatal excitotoxic damage correlates with cytoskeletal remodeling but not with cell death or proliferation
1337. Hydrogen-rich saline protects retina against glutamate-induced excitotoxic injury in guinea pig
1338. NAD (P) H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington’s disease in rats: protective role of apocynin
1339. The G Protein‐Coupled Receptor 55 Ligand l‐α‐Lysophosphatidylinositol Exerts Microglia‐Dependent Neuroprotection After excitotoxic Lesion
1340. Magnesium sulfate prevents neurochemical and long-term behavioral consequences of neonatal excitotoxic lesions: comparison between male and female mice
1341. Selective vulnerability of hippocampal cornu ammonis 1 pyramidal cells to excitotoxic insult is associated with the expression of polyamine-sensitive N-methyl-D …
1342. Growth hormone reverses excitotoxic damage induced by kainic acid in the green iguana neuroretina
1343. The mechanism of axonal degeneration after perikaryal excitotoxic injury to the retina
1344. Successful inhibition of excitotoxic neuronal damage and microglial activation after delayed application of interleukin‐1 receptor antagonist
1345. Neuroinflammation in glaucoma: soluble tumor necrosis factor alpha and the connection with excitotoxic damage
1346. Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion
1347. Heme oxygenase-1 (HO-1) upregulation delays morphological and oxidative damage induced in an excitotoxic/pro-oxidant model in the rat striatum
1348. Neuroprotective potential of biphalin, multireceptor opioid peptide, against excitotoxic injury in hippocampal organotypic culture
1349. Apnea produces excitotoxic hippocampal synapses and neuronal apoptosis
1350. Necrotic death of neurons following an excitotoxic insult is prevented by a peptide inhibitor of c‐jun N‐terminal kinase
1351. Persistently altered metabolic phenotype following perinatal excitotoxic brain injury
1352. N -Methyl-d-Aspartate (NMDA)-Mediated excitotoxic Damage: A Mouse Model of Acute Retinal Ganglion Cell Damage
1353. Proteolytic fragments of laminin promote excitotoxic neurodegeneration by up-regulation of the KA1 subunit of the kainate receptor
1354. Mitochondrial dysfunction during the early stages of excitotoxic spinal motor neuron degeneration in vivo
1355. Reduced connexin43 expression correlates with c‐Src activation, proliferation, and glucose uptake in reactive astrocytes after an excitotoxic insult
1356. Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
1357. Exploration of the glutamate-mediated retinal excitotoxic damage: a rat model of retinal neurodegeneration
1358. HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS
1359. Role of Energy Metabolic Deficits and Oxidative Stress in excitotoxic Spinal Motor Neuron Degeneration in Vivo
1360. Leonurine ameliorates cognitive dysfunction via antagonizing excitotoxic glutamate insults and inhibiting autophagy
1361. NMDA receptor-mediated neuroprotective effect of the Scutellaria baicalensis Georgi extract on the excitotoxic neuronal cell death in primary rat cortical cell …
1362. Astrocytic expressions of phosphorylated Akt, GSK3β and CREB following an excitotoxic lesion in the mouse hippocampus
1363. Neuroprotective effect of propofol against excitotoxic injury to locomotor networks of the rat spinal cord in vitro
1364. Antiepileptic and neuroprotective effects of oleamide in rat striatum on kainate-induced behavioral seizure and excitotoxic damage via calpain inhibition
1365. Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration
1366. Accurate timing but increased impulsivity following excitotoxic lesions of the subthalamic nucleus
1367. The PtdIns (3, 4) P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
1368. Fatherhood diminishes the hippocampal damaging action of excitotoxic lesioning in mice
1369. Novel application of stem cell-derived neurons to evaluate the time-and dose-dependent progression of excitotoxic injury
1370. Calpastatin overexpression protects against excitotoxic hippocampal injury and traumatic spinal cord injury
1371. Neuroprotective effect of the alpha 7 nicotinic receptor agonist PHA 543613 in an in vivo excitotoxic adult rat model
1372. Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures
1373. Cytoplasmic calcium mediates oxidative damage in an excitotoxic/energetic deficit synergic model in rats
1374. Neuroprotective effects of pyruvate following NMDA-mediated excitotoxic insults in hippocampal slices
1375. Neuroprotective effects of R, R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor …
1376. Enhanced neurogenesis in organotypic cultures of rat hippocampus after transient subfield-selective excitotoxic insult induced by domoic acid
1377. Tenascin‐R promotes neuronal differentiation of embryonic stem cells and recruitment of host‐derived neural precursor cells after excitotoxic lesion of the mouse …
1378. Using MRI to predict the fate of excitotoxic lesions in rats
1379. Glial expression of interleukin-18 and its receptor after excitotoxic damage in the mouse hippocampus
1380. excitotoxic lesion of the medial prefrontal cortex in Wistar rats: effects on trait and state anxiety
1381. Brain‐derived neurotrophic factor inhibits cell cycle reentry but not endoplasmic reticulum stress in cultured neurons following oxidative or excitotoxic stress
1382. Post‐training excitotoxic lesions of the dorsal hippocampus attenuate generalization in auditory delay fear conditioning
1383. Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins
1384. Hydroxyurea attenuates oxidative, metabolic, and excitotoxic stress in rat hippocampal neurons and improves spatial memory in a mouse model of Alzheimer’s …
1385. Differential effect of oxidative or excitotoxic stress on the transcriptional profile of amyotrophic lateral sclerosis‐linked mutant SOD1 cultured neurons
1386. Live imaging of Kv7. 2/7.3 cell surface dynamics at the axon initial segment: high steady-state stability and calpain-dependent excitotoxic downregulation revealed
1387. Insulin-like growth factor 1 promotes cochlear synapse regeneration after excitotoxic trauma in vitro
1388. PIKfyve regulates CaV1. 2 degradation and prevents excitotoxic cell death
1389. CXCL16 orchestrates adenosine A3 receptor and MCP-1/CCL2 activity to protect neurons from excitotoxic cell death in the CNS
1390. Contribution of a mitochondrial pathway to excitotoxic neuronal necrosis
1391. Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults
1392. Glia-mediated regenerative response following acute excitotoxic damage in the postnatal squamate retina
1393. Neuroprotection of dopamine neurons by xenon against low-level excitotoxic insults is not reproduced by other noble gases
1394. Acute neuronal injury: the role of excitotoxic programmed cell death mechanisms
1395. Delayed application of the haematopoietic growth factors G-CSF/SCF and FL reduces neonatal excitotoxic brain injury
1396. Prolactin neuroprotective action against excitotoxic insult in the hippocampus of male mice
1397. … open probability of α7 nAChR can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological …
1398. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis
1399. Decreased myeloperoxidase expressing cells in the aged rat brain after excitotoxic damage
1400. excitotoxic cell death induces delayed proliferation of endogenous neuroprogenitor cells in organotypic slice cultures of the rat spinal cord
1401. Effects of parafascicular excitotoxic lesions on two-way active avoidance and odor-discrimination
1402. The recombinant human erythropoietin administered in neonatal rats after excitotoxic damage induces molecular changes in the hippocampus
1403. DGKζ is degraded through the cytoplasmic ubiquitin–proteasome system under excitotoxic conditions, which causes neuronal apoptosis because of aberrant cell …
1404. VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult
1405. … of a novel injury-induced calcium-permeable channel that plays a key role in causing extended neuronal depolarization and initiating neuronal death in excitotoxic …
1406. Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures
1407. Aging and excitotoxic stress exacerbate neural circuit reorganization in amyloid precursor protein intracellular domain transgenic mice
1408. Force spectroscopy measurements show that cortical neurons exposed to excitotoxic agonists stiffen before showing evidence of bleb damage
1409. Lipid markers and related transcripts during excitotoxic neurodegeneration in kainate‐treated mice
1410. Predifferentiated GABAergic neural precursor transplants for alleviation of dysesthetic central pain following excitotoxic spinal cord injury
1411. Non‐canonical activation of CREB mediates neuroprotection in a Caenorhabditis elegans model of excitotoxic necrosis
1412. Dextromethorphan is protective against sensitized N‐methyl‐d‐aspartate receptor‐mediated excitotoxic brain damage in the developing mouse brain
1413. The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB1)
1414. A Multi-Scale Computational Model of excitotoxic Loss of Dopaminergic Cells in Parkinson’s Disease
1415. Long-term evaluation of sensorimotor and mnesic behaviour following striatal NMDA-induced unilateral excitotoxic lesion in the mouse
1416. Defining external factors that determine neuronal survival, apoptosis and necrosis during excitotoxic injury using a high content screening imaging platform
1417. Neuroprotection from excitotoxic injury by local administration of lipid emulsion into the brain of rats
1418. Spinal cord transcriptomic and metabolomic analysis after excitotoxic injection injury model of syringomyelia
1419. Altered sensitivity to excitotoxic cell death and glutamate receptor expression between two commonly studied mouse strains
1420. Mitochondrial ATP-Mg/Pi carrier SCaMC-3/Slc25a23 counteracts PARP-1-dependent fall in mitochondrial ATP caused by excitotoxic insults in neurons
1421. Role of p75NTR in NMDAR-mediated excitotoxic brain injury in neonatal mice
1422. excitotoxic lesions of the nucleus paragigantocellularis facilitate male sexual behavior but attenuate female sexual behavior in rats
1423. … modulate mitochondrial membrane potential and neurofilament light mRNA expression in cultured dorsal root ganglion and spinal cord neurons during excitotoxic …
1424. URB597 Prevents the Short-Term excitotoxic Cell Damage in Rat Cortical Slices: Role of Cannabinoid 1 Receptors
1425. Effects of excitotoxic lesion with inhaled anesthetics on nervous system cells of rodents
1426. excitotoxic neuronal cell death during an oligodendrocyte-directed CD8+ T cell attack in the CNS gray matter
1427. Cytisine confers neuronal protection against excitotoxic injury by down-regulating GluN2B-containing NMDA receptors
1428. MRI overestimates excitotoxic amygdala lesion damage in rhesus monkeys
1429. Melanopsin-Containing ipRGCs Are Resistant to excitotoxic Injury and Maintain Functional Non-Image Forming Behaviors After Insult in a Diurnal Rodent Model
1430. Dorsal, ventral, and complete excitotoxic lesions of the hippocampus in rats failed to impair appetitive trace conditioning
1431. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington’s disease
1432. … signaling target, activating transcription factor 3 (ATF3), protects against dendrotoxicity and facilitates the recovery of synaptic transmission after an excitotoxic …
1433. excitotoxic insult results in a long-lasting activation of CaMKIIα and mitochondrial damage in living hippocampal neurons
1434. … hormone 1‐39 promotes proliferation and differentiation of oligodendroglial progenitor cells and protects from excitotoxic and inflammation‐related damage
1435. Neuroprotection against excitotoxic and ischemic insults by bis (12)-hupyridone, a novel anti-acetylcholinesterase dimer, possibly via acting on multiple targets
1436. excitotoxic motoneuron degeneration induced by glutamate receptor agonists and mitochondrial toxins in organotypic cultures of chick embryo spinal cord
1437. Glycogen synthase kinase-3/Shaggy mediates ethanol-induced excitotoxic cell death of Drosophila olfactory neurons
1438. excitotoxic neonatal damage induced by monosodium glutamate reduces several GABAergic markers in the cerebral cortex and hippocampus in adulthood
1439. Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury
1440. IL-1RAcPb signaling regulates adaptive mechanisms in neurons that promote their long-term survival following excitotoxic insults
1441. Defects in cytokine-mediated neuroprotective glial responses to excitotoxic hippocampal injury in senescence-accelerated mouse
1442. Respiratory motoneurons and pathological conditions: lessons from hypoglossal motoneurons challenged by excitotoxic or oxidative stress
1443. Subfield-specific neurovascular remodeling in the entorhino-hippocampal-organotypic slice culture as a response to oxygen–glucose deprivation and excitotoxic cell …
1444. Silymarin Inhibits Glutamate Release and Prevents against Kainic Acid-Induced excitotoxic Injury in Rats
1445. excitotoxic lesions of the bed nucleus of the stria terminalis (BNST) attenuate the effects of repeated stress on weight gain: evidence for the recruitment of BNST …
1446. Lack of kainic acid‐induced gamma oscillations predicts subsequent CA1 excitotoxic cell death
1447. Temporal progression of excitotoxic calcium following distal middle cerebral artery occlusion in freely moving mice
1448. Regenerative effect of growth hormone (GH) in the retina after kainic acid excitotoxic damage
1449. Distinct spatial and temporal activation of caspase pathways in neurons and glial cells after excitotoxic damage to the immature rat brain
1450. Computational analysis of AMPK-mediated neuroprotection suggests acute excitotoxic bioenergetics and glucose dynamics are regulated by a minimal set of …
1451. Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions
1452. The sigma-1 receptor agonist 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) protects against newborn excitotoxic brain injury by stabilizing the mitochondrial …
1453. A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death
1454. Effect of Rufinamide on the kainic acid-induced excitotoxic neuronal death in the mouse hippocampus
1455. T3 replacement does not prevent excitotoxic cell death but reduces developmental neuronal apoptosis in newborn mice
1456. … of persistent organic pollutants (POPs) and perfluorooctane sulfonic acid (PFOS) differentially affect glutamate induced excitotoxic responses in chicken …
1457. Modulation of the magnitude of conditioned taste aversion in rats with excitotoxic lesions of the basolateral amygdala
1458. Absence of striatal newborn neurons with mature phenotype following defined striatal and cortical excitotoxic brain injuries
1459. Effect of the PARP-1 inhibitor PJ 34 on excitotoxic damage evoked by kainate on rat spinal cord organotypic slices
1460. Nicotine protects rat hypoglossal motoneurons from excitotoxic death via downregulation of connexin 36
1461. Temporal dependence of cysteine protease activation following excitotoxic hippocampal injury
1462. Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata
1463. The effect of pro-neurogenic gene expression on adult subventricular zone precursor cell recruitment and fate determination after excitotoxic brain injury
1464. The DNA-PK catalytic subunit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation
1465. Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance or ATP depletion?
1466. Multicompartment Microreactors Prevent excitotoxic Dysfunctions In Rat Primary Cortical Neurons
1467. Morphometric analysis of NADPH diaphorase reactive neurons in a rat model of focal excitotoxic striatal injury
1468. excitotoxic-mediated transcriptional decreases in HCN2 channel function increase network excitability in CA1
1469. Increased expression of acyl-coenzyme A: cholesterol acyltransferase-1 and elevated cholesteryl esters in the hippocampus after excitotoxic injury
1470. Stress exacerbates neuron loss and microglia proliferation in a rat model of excitotoxic lower motor neuron injury
1471. Melanocortin receptor agonist ACTH 1–39 protects rat forebrain neurons from apoptotic, excitotoxic and inflammation-related damage
1472. Purinergic signaling induces cyclooxygenase-1-dependent prostanoid synthesis in microglia: roles in the outcome of excitotoxic brain injury
1473. An organotypic hippocampal slice culture model of excitotoxic injury induced spontaneous recurrent epileptiform discharges
1474. Serial EEG and MRI changes in status epilepticus-induced excitotoxic neuronal necrosis
1475. … D modulates F2-isoprostane and 7-ketocholesterol formation and has a neuroprotective effect on organotypic hippocampal cultures after kainate-induced excitotoxic …
1476. Involvement of VIP and PACAP in neonatal brain lesions generated by a combined excitotoxic/inflammatory challenge
1477. Minimal impairment in a rat model of duration discrimination following excitotoxic lesions of primary auditory and prefrontal cortices
1478. Spinal and supraspinal changes in tumor necrosis factor-α expression following excitotoxic spinal cord injury
1479. Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration
1480. excitotoxic SLC7A11 expression is a marker of poor glioblastoma survival and a potential therapeutic target
1481. Selenium-induced antioxidant protection recruits modulation of thioredoxin reductase during excitotoxic/pro-oxidant events in the rat striatum
1482. excitotoxic insults lead to peroxiredoxin hyperoxidation
1483. … , a subpopulation spared in Huntington’s Disease, possess functional NMDA receptors but fail to generate mitochondrial ROS in response to an excitotoxic …
1484. Investigation of elemental changes in brain tissues following excitotoxic injury
1485. Protective effect of valproic acid on cultured motor neurons under glutamate excitotoxic conditions. Ultrastructural study
1486. Neuropathological characterization of spinal motor neuron degeneration processes induced by acute and chronic excitotoxic stimulus in vivo
1487. Loss of high‐affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environment
1488. Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ
1489. excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1
1490. Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo
1491. Distinct pattern of microglial response, cyclooxygenase‐2, and inducible nitric oxide synthase expression in the aged rat brain after excitotoxic damage
1492. Aprotinin confers neuroprotection by reducing excitotoxic cell death
1493. Donepezil attenuates excitotoxic damage induced by membrane depolarization of cortical neurons exposed to veratridine
1494. Ketone bodies attenuate excitotoxic cell injury in the rat hippocampal slice under conditions of reduced glucose availability
1495. Growth differentiation factor 15 expression in astrocytes after excitotoxic lesion in the mouse hippocampus
1496. excitotoxic motoneuron disease in chick embryo evolves with autophagic neurodegeneration and deregulation of neuromuscular innervation
1497. The use of propidium iodide to assess excitotoxic neuronal death in primary mixed cortical cultures
1498. PI3K mediated activation of GSK-3β reduces at-level primary afferent growth responses associated with excitotoxic spinal cord injury dysesthesias
1499. Differential patterns of inflammatory response, axonal damage and myelin impairment following excitotoxic or ischemic damage to the trigeminal spinal nucleus of …
1500. Prognostic value of MR spectroscopy in patients with acute excitotoxic encephalopathy
1501. Regenerative effect of a ROCK inhibitor, Y-27632, on excitotoxic trauma in an organotypic culture of the cochlea
1502. excitotoxic protection by polyanionic polysaccharide: Evidence of a cell survival pathway involving AMPA receptor–MAPK Interactions
1503. excitotoxic lesion of the hippocampus of Wistar rats disrupts the circadian control of the latent inhibition of taste aversion learning
1504. Pattern of injury with a graded excitotoxic insult and ensuing chronic medial septal damage in the rat brain
1505. Peroxisome proliferator‐activated receptor‐γ coactivator‐1α mediates neuroprotection against excitotoxic brain injury in transgenic mice: role of mitochondria and X …
1506. Reduction of Prepulse Inhibition (PPI) after neonatal excitotoxic lesion of the ventral thalamus in pubertal and adult rats
1507. Tetanus toxin C-fragment protects against excitotoxic spinal motoneuron degeneration in vivo
1508. Calpain inhibition protects spinal motoneurons from the excitotoxic effects of AMPA in vivo
1509. An explanation of why schizophrenia begins with excitotoxic damage to the hippocampus
1510. ID4 mediates proliferation of astrocytes after excitotoxic damage in the mouse hippocampus
1511. Suppression to visual, auditory and gustatory stimuli habituates normally in rats with excitotoxic lesions of the perirhinal cortex
1512. Dibutyryl cyclic adenosine monophosphate rescues the neurons from degeneration in stab wound and excitotoxic injury models
1513. Neuroprotection by α2-adrenergic receptor stimulation after excitotoxic retinal injury: a study of the total population of retinal ganglion cells and their …
1514. Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress
1515. Transglutaminase 2 interaction with small heat shock proteins mediate cell survival upon excitotoxic stress
1516. Essential role of PIKE GTPases in neuronal protection against excitotoxic insults
1517. Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex
1518. Effect of pioglitazone on excitotoxic neuronal damage in the mouse hippocampus
1519. Latent inhibition of conditioned taste aversion in rats with excitotoxic dorsal hippocampal lesions
1520. AC105 increases extracellular magnesium delivery and reduces excitotoxic glutamate exposure within injured spinal cords in rats
1521. The proapoptotic BCL-2 homology domain 3-only protein Bim is not critical for acute excitotoxic cell death
1522. Memantine prevents sensitivity to excitotoxic cell death of rat cortical neurons expressing human truncated tau protein
1523. Effects of TRH and its analogues on primary cortical neuronal cell damage induced by various excitotoxic, necrotic and apoptotic agents
1524. CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors
1525. Cyclin D1 induction preceding neuronal death via the excitotoxic NMDA pathway involves selective stimulation of extrasynaptic NMDA receptors and JNK pathway
1526. Astrocytic phosphorylation of PDK1 on Tyr9 following an excitotoxic lesion in the mouse hippocampus
1527. The spatiotemporal pattern of somal and axonal pathology after perikaryal excitotoxic injury to retinal ganglion cells: a histological and morphometric study
1528. The new iminothiadiazole derivative VP1. 14 ameliorates hippocampal damage after an excitotoxic injury
1529. The kinetics of non-synaptically triggered acute excitotoxic responses in the central nervous system observed using intrinsic optical signals
1530. Hepatocyte growth factor improves synaptic localization of the NMDA receptor and intracellular signaling after excitotoxic injury in cultured hippocampal neurons
1531. Neuroprotective effects of C3 exoenzyme in excitotoxic retinopathy
1532. Sex and regional differences in effects of chronic intermittent ethanol exposure on subsequent excitotoxic challenges in hippocampal slice cultures
1533. Intracisternal IGF‐1 gene therapy abrogates kainic acid‐induced excitotoxic damage of the rat spinal cord
1534. IQGAP1 expression in spared CA1 neurons after an excitotoxic lesion in the mouse hippocampus
1535. excitotoxic spinal cord injury induced dysesthesias are associated with enhanced intrinsic growth of sensory neurons
1536. Sex differences in effects of excitotoxic spinal injury on below-level pain sensitivity
1537. The developmental expression of fluorescent proteins in organotypic hippocampal slice cultures from transgenic mice and its use in the determination of excitotoxic …
1538. Bax deficiency promotes an up-regulation of BimEL and Bak during striatal and cortical postnatal development, and after excitotoxic injury
1539. Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions
1540. Tex261 modulates the excitotoxic cell death induced by N-methyl-D-aspartate (NMDA) receptor activation
1541. excitotoxic effects of glutamate on cochlear organotypic cultures
1542. Response disengagement on a spatial self-ordered sequencing task: effects of regionally selective excitotoxic lesions and serotonin depletion within the prefrontal …
1543. Modifications in the Seizures Susceptibility by excitotoxic Neuronal Damage and Its Possible Relationship with the Pharmacoresistance
1544. excitotoxic lesions of the medial amygdala attenuate olfactory fear-potentiated startle and conditioned freezing behavior
1545. Studies of locomotor network neuroprotection by the selective poly(ADP‐ribose) polymerase‐1 inhibitor PJ‐34 against excitotoxic injury to the rat spinal cord in vitro
1546. Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes
1547. RhoGDI2 expression in astrocytes after an excitotoxic lesion in the mouse hippocampus
1548. Effects of dimeric PSD-95 inhibition on excitotoxic cell death and outcome after controlled cortical impact in rats
1549. Central pain from excitotoxic spinal cord injury induced by intraspinal NMDA injection: a pilot study
1550. Effects of neonatal excitotoxic lesions in ventral thalamus on social interaction in the rat
1551. An approach for neuroprotective therapies of secondary brain damage after excitotoxic retinal injury in mice
1552. Inflammation and neuronal susceptibility to excitotoxic cell death
1553. excitotoxicity Alters Endogenous Secretoneurin Plasma Levels, but Supplementation with Secretoneurin Does Not Protect Against excitotoxic Neonatal Brain Injury
1554. excitotoxic programmed cell death involves caspase-independent mechanisms
1555. … and altered glutamic acid decarboxylase (GAD) 65-and 67-kDa isoform protein expression from mouse cortical GABAergic neurons following excitotoxic injury in vitro
1556. Astrocytic insulin‐like growth factor‐1 prevents excitotoxic downregulation of adenosine deaminase acting on RNA in calcium dynamics
1557. excitotoxic lesions of the rodent striatum
1558. Repair of glutamate-induced excitotoxic neuronal damage mediated by intracerebroventricular transplantation of neural stem cells in adult mice
1559. excitotoxic potential of exogenous ferritin and apoferritin: Changes in ambient level of glutamate and synaptic vesicle acidification in brain nerve terminals
1560. Congenic strains provide evidence that a mapped locus on chromosome 15 influences excitotoxic cell death
1561. A quantitative trait locus on chromosome 18 is a critical determinant of excitotoxic cell death susceptibility
1562. Change of Nurr1 expression in mouse hippocampal CA3 region following excitotoxic neuronal damage
1563. excitotoxic lesion of the posterior part of the dorsal striatum does not affect the typically dopaminergic phenomenon of latent inhibition in conditioned taste aversion
1564. Overexpression of the nuclear factor kappaB inhibitor A20 is neurotoxic after an excitotoxic injury to the immature rat brain
1565. Exogenous GDNF increase the migration of the neural stem cells with no protection against kainic acid-induced excitotoxic cell death in rats
1566. excitotoxic injury to thoracolumbar gray matter alters sympathetic activation and thermal pain sensitivity
1567. Paraoxon: an anticholinesterase that triggers an excitotoxic cascade of oxidative stress, adhesion responses, and synaptic compromise
1568. … brain expression of both nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus …
1569. Microglia express functional NMDA receptors: a novel finding and a promise for innovative treatment of excitotoxic and inflammatory brain disease
1570. Dynamics of Trace Element Concentration During Development and excitotoxic Cell Death in the Cerebellum of Lurcher Mutant Mice
1571. Exosomes secretion and autophagy in long-term protection of neurons from excitotoxic damage
1572. Pyruvate blocks blood-brain barrier disruption, lymphocyte infiltration and immune response in excitotoxic brain injury
1573. Simultaneous two-voxel localized 1H-observed 13C-edited spectroscopy for in vivo MRS on rat brain at 9.4 T: Application to the investigation of excitotoxic lesions
1574. Urocortin 2 treatment is protective in excitotoxic retinal degeneration
1575. Aprotinin, but not ε-aminocaproic acid and tranexamic acid, exerts neuroprotection against excitotoxic injury in an in vitro neuronal cell culture model
1576. Glutamate decarboxylase protects neurons against excitotoxic injury
1577. Impaired sensitivity to Pavlovian stimulus–outcome learning after excitotoxic lesion of the ventrolateral neostriatum
1578. A model of excitotoxic brain injury in larval zebrafish: potential application for high-throughput drug evaluation to treat traumatic brain injury
1579. Localization of the transcription factor, sterol regulatory element binding protein-2 (SREBP-2) in the normal rat brain and changes after kainate-induced excitotoxic …
1580. Ecdysterones from Rhaponticum carthamoides (Willd.) Iljin reduce hippocampal excitotoxic cell loss and upregulate mTOR signaling in rats
1581. … survival of adult neural stem cells generated physiologically in the hippocampus, but does not protect stem cells generated in surplus after an excitotoxic …
1582. Prostacyclin mediates endothelial COX-2-dependent neuroprotective effects during excitotoxic brain injury
1583. Susceptibility to seizure-induced excitotoxic cell death is regulated by an epistatic interaction between Chr 18 (Sicd1) and Chr 15 (Sicd2) loci in mice
1584. excitotoxic lesion of the perirhinal cortex impairs spatial working memory in a delayed-alternation task
1585. Cytotoxic and Anti-excitotoxic Effects of Selected Plant and Algal Extracts Using Comet and Cell Viability Assays
1586. Exosomes Secretion and Autophagy in Long-Term Protection of Neurons from excitotoxic Damage
1587. Intrastriatal excitotoxic lesion or dopamine depletion of the neostriatum differentially impairs response execution in extrapersonal space
1588. GRK2 and group I mGluR mediate inflammation-induced sensitization to excitotoxic neurodegeneration
1589. An Atlas of Phosphorylation and Proteolytic Processing Events During excitotoxic Neuronal Death Reveals New Therapeutic Opportunities
1590. Effects of behavioral and neurochemical changes on adult excitotoxic lesion of the ventral hippocampus
1591. excitotoxic lesions to the prefrontal cortex of Sprague–Dawley rats do not impair response matching
1592. Trophic factors deprivation induces long-term protection of neurons against excitotoxic damage
1593. Effect of pharmacological modulation of activity of metabotropic glutamate receptors on their gene expression after excitotoxic damage in hippocampal neurons
1594. Acute neuronal injury: the role of excitotoxic programmed cell death mechanisms
1595. excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa-Induced Dyskinesia in Parkinson’s Disease: The Role of the Interaction Between the Dopaminergic …
1596. Regeneration of Cochlear Synapses after excitotoxic Trauma
1597. … of L-serine biosynthetic enzyme 3-phosphoglycerate dehydrogenase (Phgdh) and neutral amino acid transporter ASCT1 following an excitotoxic lesion in the mouse …
1598. Differential Neuroprotective Effects of Interleukin-1 Receptor Antagonist on Spinal Cord Neurons after excitotoxic Injury
1599. excitotoxic perirhinal cortex lesions leave stimulus-specific habituation of suppression to lights intact
1600. Development of an acute excitotoxic model of Huntington’s disease in sheep
1601. Early postnatal ethanol exposure: glutamatergic excitotoxic cell death during acute withdrawal
1602. In vitro evidence for post-insult neuroprotective activity of an evolutionarily conserved motif against excitotoxic neuronal cell death
1603. Role of NADPH oxidase-2 in the progression of the inflammatory response secondary to striatum excitotoxic damage
1604. Multi-ancestry genetic study in 5,876 patients identifies an association between excitotoxic genes and early outcomes after acute ischemic stroke
1605. The effect of ginsenoside Rd on the intracellular free calcium after excitotoxic injury in cultured cortical neurons [J]
1606. l‐dopa‐induced dyskinesias in unilateral 6‐hydroxydopamine‐lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra …
1607. Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage
1608. Ethyl pyruvate does not require microglia for mediating neuroprotection after excitotoxic injury
1609. Neurobehavioral function of neonatal mice following excitotoxic brain damage
1610. Astrocytic expression of CTMP following an excitotoxic lesion in the mouse hippocampus
1611. Cyclosporine a protects RGC-5 cells from excitotoxic cell death
1612. A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro
1613. Kainic acid-induced seizures: inflammation and excitotoxic neuronal damage in the developing rat hippocampus
1614. Procedural performance benefits after excitotoxic hippocampal lesions in the rat sequential reaction time task
1615. Reduced size of the dendritic tree does not protect Purkinje cells from excitotoxic death
1616. excitotoxic Stimulation of Brain Microslices as an In vitro Model of Stroke
1617. Comparison of the effects of perinatal and neonatal administration of sodium ferulate on repair following excitotoxic neuronal damages induced by maternal …
1618. Author Correction: excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1
1619. Neuroprotective effect of estradiol-loaded poly (lactic-co-glycolic acid) nanoparticles on glutamate-induced excitotoxic neuronal death
1620. Microreactors: Multicompartment Microreactors Prevent excitotoxic Dysfunctions In Rat Primary Cortical Neurons (Adv. Biosys. 10/2020)
1621. Genes on distal chromosome 18 determine vulnerability to excitotoxic neurodegeneration following status epilepticus, but not striatal neurodegeneration induced by …
1622. Investigating the effects of excitotoxic stimuli on the suprachiasmatic nucleus
1623. Cysteine-Mediated excitotoxic Neuronal Death is an Apoptosis—Necrosis Continuum
1624. excitotoxic programmed cell death involves caspase-independent mechanisms
1625. In vivo assessment of experimental neonatal excitotoxic brain lesion with USPIO-enhanced MR imaging
1626. The neonatal excitotoxic process modifies the protein expression levels of EAAT1 (GLAST) and EAAT2 (GLT-1) in various brain regions of the adult rat brain.
1627. Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-PI3K-Akt pathway through its SHBG-like region
1628. EFFECTS OF excitotoxic LESION WITH INHALED ANESTHETICS ON NERVOUS SYSTEM CELLS OF RODENTS
1629. excitotoxic Injury Mechanisms in Central White Matter
1630. The GluK4 Kainate Receptor Subunit Regulates Mood, Memory and excitotoxic Neurodegeneration
1631. Key proteins of activating cell death can be predicted through a kainic acid-induced excitotoxic stress
1632. Neuroprotective strategies in excitotoxic brain injury: potential applications to the preterm brain
1633. Neuroprotection from excitotoxic RGC death: is there a role for MMPs?
1634. Ambivalent action of cyclic AMP on degeneration and regeneration of cochlear afferent synapses during and after excitotoxic trauma
1635. Kinetic Model of AMPK-mediated Autophagy as excitotoxic Stress Response
1636. Enhancement of endogenous cannabinoid responses through FAAH inhibition provides cellular and functional protection against excitotoxic brain damage.
1637. The excitotoxic impairment of brain in patients with discirculatory encephalopathyand therapeutic correction
1638. Transient sublethal excitotoxic stress and its connections to long term neurodegeneration in primary neurons.
1639. Neural crest stem cells protect spinal cord slice cultures from excitotoxic neuronal damage and inhibit glial activation
1640. excitotoxic PATHOLOGY: DESCRIPTION OF A MODEL IN THE VISUAL SYSTEM OF MICE
1641. Modeling excitotoxic ischemic brain injury of cerebellar Purkinje neurons by intravital and in vitro multi-photon laser scanning microscopy
1642. Effects of age on chick light adapted ERGs with and without inner retinal excitotoxic damage
1643. Intracellular zinc mobilization is required for nNOS (+) neuron loss. Role of zinc in the excitotoxic cascade
1644. Persistently altered metabolic phenotype following perinatal excitotoxic brain injury
1645. Longitudinal assessments of retinal degeneration after excitotoxic injury using an end-to-end pipeline with deep learning-based automatic layer segmentation
1646. excitotoxic Injury to Retinal Ganglion Cells
1647. Effects of furin inhibitors on excitotoxic neuronal damage
1648. FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for Gria2 mRNA processing
1649. VGLUT1 and VGLUT2 cleavage under excitotoxic conditions and in cerebral ischemia
1650. Exploring the signalling mechanism of excitotoxic neuronal injury by molecular and quantitative proteomic approaches
1651. Effect of Triiodothyronine on Brain Pathological Lesion and Expressions of Caspase-3 and Myelin Basic Protein after excitotoxic Brain Injury in Neonatal Mice
1652. Lipid alterations in excitotoxic brain injury
1653. excitotoxic MECHANISMS, NEUROINFLAMMATORY RESPONSE AND SERUM FACTORS IN EXPERIMENTAL AND HUMAN AMYOTROPHIC LATERAL …
1654. Synthesis and Anti-oxidant/Anti-excitotoxic Activity of (1S)-(-) Verbenone Derivatives
1655. The Mechanism of Axonal Degeneration after Perikaryal excitotoxic Injury to the Retina
1656. VGLUT1 and VGLUT2 cleavage under excitotoxic conditions and in cerebral ischemia
1657. Distinct Roles of Cyclooxygenase-1 and Cyclooxygenase-2 in Inflammatory and excitotoxic Brain Injury
1658. Investigating the role of c-Src in excitotoxic neuronal death
1659. Role of excitotoxic Programmed Necrosis in Acute Brain Injury
1660. MIF Inhibitor Ibudilast Prevents Retinal Cell Death in Chick excitotoxic Retinal Damage Model
1661. Assessment of the Involvement of Intrinsic and Extrinsic Cell Death Pathways in Retinal Ganglion Cell Death after excitotoxic Injury
1662. Retinal MMP expression is upregulated in an excitotoxic mouse model of glaucoma
1663. Developing novel therapeutics for excitotoxic neuronal death following stroke
1664. Studying the excitotoxic Amino Acids Impact on the Degree of Impairment of Consciousness in Purulent Meningitises in Children
1665. Therapeutic Proposals for Childhood Status Epilepticus-Induced excitotoxic Neuronal Injury
1666. Characterisation of calpain activation in response to excitotoxic events in primary neurons
1667. Animal Models of Cerebral Dysgenesis: excitotoxic Brain Injury
1668. Abstract TP264: Actin Reorganization is a Rapid and Reversible Adaptive Response by Neurons Exposed to Ischemic and excitotoxic Injury in vitro and in vivo
1669. Effects of visual inputs on recovery after excitotoxic lesion of visual cortex
1670. Regulatory Role of HIF-1α in the SH-SY5Y Cells excitotoxic Injury
1671. The role of adenosine A2A receptors in regeneration of afferent synapses in the cochlea after excitotoxic injury
1672. Detecting Acute Inner Retinal excitotoxic Injury in Mice Using Diffusion MRI
1673. Bioluminescent Imaging of excitotoxic and Endotoxic Brain Injury in Living Mice
1674. Aspects of retinal and optic nerve pathology after excitotoxic retinal injury.
1675. excitotoxic Cell Death Mediated by Ca2+-Permeable Ampa Receptors is Coupled to the JNK Signalling Pathway
1676. Regulation of GABA receptors under excitotoxic conditions: contribution to neuronal death and potential implications to novel therapeutic approaches
1677. The interplay of JNK and SCG10 during cortical development and in excitotoxic responses in brain
1678. IL-1β conveys neuroprotection via astrocytic IL1R1 signaling following excitotoxic retinal injury
1679. Effects of triiodothyronine on the learning and memory behaviors in neonatal mice following excitotoxic brain damage
1680. Glial response to 17β-estradiol in neonatal rats with excitotoxic brain injury
1681. ROLE OF REACTIVE OXIGEN SPECIES IN THE REGULATION OF NEUROINFLAMMATION INDUCED BY excitotoxic DAMAGE IN CEREBELLAR …
1682. Abstract TP281: Increased Susceptibility to excitotoxic Injury in Rat Hippocampal Slices Exposed to Intermittent Hypoxia
1683. The role of glutamate in immune cell infiltration and excitotoxic mechanisms in autoimmune demyelination
1684. A new transgenic mouse model for studying the neurotoxicity of spermine oxidase dosage in the response to excitotoxic injury
1685. Inflammation in excitotoxic neuronal death and survival: involvement of tumor necrosis factor-α and interleukin-1β
1686. The Neuroprotective Qualities of Creatine on Rat Retinal Cultures Exposed to Glutamate-Induced excitotoxic Injury
1687. Role of PTEN nuclear translocation in excitotoxic and ischemic neuronal injuries following stroke
1688. A New Transgenic Mouse Model for Studying the Neurotoxicity of Spermine Oxidase Dosage in the Response to excitotoxic Injury
1689. Neuroprotective roles for apelin, a novel neuropeptide, in HIV-associated excitotoxic injury
1690. The Role of Transcription Factors in Regulating Adult Neurogenesis after excitotoxic Brain Injury
1691. Somatic Injury Precedes Distal Atrophy Following excitotoxic Hippocampal Insult
1692. Calcineurin mediated CREB phosphorylation regulate hippocampal neuron death in excitotoxic rats
1693. Real-time imaging analysis and functional characterisation of transcription factor NF-kappaB activation in a model of excitotoxic injury in rat neurons.
1694. Endogenous WNT/β-catenin signaling in Müller cells protects retinal ganglion cells against excitotoxic damage
1695. The role of calpains on TrkB and Gephyrin cleavage under excitotoxic conditions: Characterization and functional implications
1696. Protecting Inner Hair Cell-Spiral Ganglion Neuron Synapses from excitotoxic Trauma
1697. Spatial memory impairments following excitotoxic lesions of the basal forebrain noncholinergic neuronal ensembles
1698. Tau Hyperphosphorylation In Retinal Ganglion Cells Is Associated With Reduced Axonal Transport And Enhanced Sensitivity To excitotoxic Injury
1699. Asymmetric dimethylarginine protects PC12 cells against glutamate-induced excitotoxic damage
1700. A new function for an old enzyme: Src protein tyrosine kinase directs excitotoxic neuronal death in stroke (596.3)
1701. Inhibition of excitotoxic and Aβ (25-35)-induced Neuronal Damage by Fractions Prepared from Mangosteen Pericarp in Primary Cultured Rat Cortical Cells
1702. Effects of clozapine (CLZ) on reduced prepulse inhibition (PPI) after neonatal excitotoxic lesion of the ventral thalamus in pubertal and adult rats
1703. Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-PI3K-Akt pathway through its SHBG-like region
1704. … enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus …
1705. PO-0472 Evaluation Of Secretoneurin As Therapeutic Strategy In Neonatal excitotoxic Brain Injury
1706. O-216 Melatonine Reduces Bbb Breakdown In A Rat Model Of Neonatal excitotoxic Damage
1707. 671. Gene Delivery to the Bone Marrow Targeting CCR5 Can Protect the CNS from In. ammation and In. ammation-Related excitotoxic Neuron Loss
1708. 299 PRE-084, A Sigma-1 Receptor Ligand, Protects Against excitotoxic Perinatal Brain Injury in Newborn Mice
1709. 197 P75 Ntr is Upregulated After Nmdar-Mediated excitotoxic Brain Injury in Newborn Mice
1710. Effects of Novel Benzofuran-2-carboxamide Derivatives on the excitotoxic Neuronal Damage in Primary Cultured Rat Cortical Cells
1711. L-trans-pyrrolidine-2, 4-dicarboxylate (PDC) induces excitotoxic and Oxidative Neuronal Death in Cultured Cortical Neurons
1712. Neuroprotection with Melatonin and the Caspase-2 Inhibitor TRP601: Novel Aspects by Analysis of the Metabolome in excitotoxic Brain Injury
1713. Effects of erythropoietin on neuron apoptosis and expression of caspase-3 after excitotoxic brain injury in mice during different developmental stages
1714. 311 The Sigma-Receptor-Agonist 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Decreases Neonatal excitotoxic Brain Injury and Diminishes Microglial Cell Activation
1715. Insulin-Like Growth Factor 1 (IGF1) Stimulates a Novel Type of Glia-Like Cell in the Retina and Renders Neurons Susceptible to excitotoxic Damage
1716. … is not mandatory for neuroprotection with 1alpha, 25-dihydroxyvitamin D3 in perinatal hypoxic-ischemic rat brain damage in vivo and in excitotoxic injury of primary …
1717. 195 The Selective Sigma-1 Receptor Agonist Pre-084 Reduces Ndmar-Mediated excitotoxic Brain Injury in Newborn Mice
1718. 9 The Sigma-1 Receptor Agonist PRE-084 Attenuates Inflammation-Sensitized Nmdar-Mediated excitotoxic Brain Injury in Newborn Mice
1719. Chapter’1 1 excitotoxic Lesions of the Developing Brain
1720. Mechanisms of Interleukin-1 (IL-1) Induced excitotoxic Neurodegeneration
1721. Mechanisms of excitotoxicity in neurologic diseases
1722. excitotoxicity hypothesis
1723. The role of excitotoxicity in neurodegenerative disease: implications for therapy
1724. excitotoxicity: an overview.
1725. Glutamate excitotoxicity in a model of multiple sclerosis
1726. Molecular mechanisms of calcium-dependent excitotoxicity
1727. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis
1728. Apoptosis, excitotoxicity, and neuropathology
1729. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity
1730. The role of excitotoxicity in neurodegeneration.
1731. excitotoxicity in perinatal brain injury
1732. excitotoxicity, free radicals, and cell membrane changes
1733. Involvement of free radicals in excitotoxicity in vivo
1734. Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging
1735. excitotoxicity and nitric oxide in Parkinson’s disease pathogenesis
1736. The relationship between excitotoxicity and oxidative stress in the central nervous system
1737. excitotoxicity
1738. excitotoxicity and amyotrophic lateral sclerosis
1739. Possible role of excitotoxicity in the pathogenesis of glaucoma
1740. excitotoxicity in glial cells
1741. Bioenergetics and glutamate excitotoxicity
1742. Biochemical abnormalities and excitotoxicity in Huntington’s disease brain
1743. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer’s disease
1744. Traumatic brain injury‐induced excitotoxicity assessed in a controlled cortical impact model
1745. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts
1746. excitotoxicity in neonatal hypoxia
1747. A proposed role for excitotoxicity in glaucoma
1748. Kainic acid-mediated excitotoxicity as a model for neurodegeneration
1749. Glutamate, excitotoxicity and amyotrophic lateral sclerosis
1750. excitotoxicity, apoptosis and neuropsychiatric disorders
1751. The role of excitotoxicity in ALS–what is the evidence?
1752. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration
1753. Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity
1754. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
1755. Role of excitotoxicity in human neurological disease
1756. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
1757. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging
1758. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
1759. Oxidative glutamate toxicity can be a component of the excitotoxicity cascade
1760. CB1 cannabinoid receptors and on-demand defense against excitotoxicity
1761. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis
1762. NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release
1763. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease
1764. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases
1765. excitotoxicity and selective neuronal loss in epilepsy
1766. excitotoxicity and alcohol‐related brain damage
1767. excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.
1768. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
1769. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy
1770. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis
1771. excitotoxicity: a possible central mechanism in fluoride neurotoxicity
1772. The role of excitotoxicity in organophosphorous nerve agents central poisoning
1773. Inflammation and excitotoxicity: role in migraine pathogenesis
1774. excitotoxicity, synaptic repair, and functional recovery in the mammalian cochlea: a review of recent findings
1775. excitotoxicity and new antiglutamatergic strategies in Parkinson’s disease and Alzheimer’s disease
1776. Calpain-mediated mGluR1α truncation: a key step in excitotoxicity
1777. excitotoxicity: perspectives based onN-methyl-D-aspartate receptor subtypes
1778. Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity
1779. Mitochondria and neuronal glutamate excitotoxicity
1780. Pathophysiology of oligodendroglial excitotoxicity
1781. Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia
1782. Role of astrocytes in glutamate homeostasis: implications for excitotoxicity
1783. excitotoxicity in neurological disorders—the glutamate paradox
1784. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity
1785. excitotoxicity in ALS
1786. Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures
1787. excitotoxicity in vitro by NR2A-and NR2B-containing NMDA receptors
1788. Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury?
1789. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity
1790. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity
1791. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
1792. Wild‐type huntingtin protects neurons from excitotoxicity
1793. Interleukin‐1β promotes oligodendrocyte death through glutamate excitotoxicity
1794. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia
1795. Subthalamic nucleus‐mediated excitotoxicity in Parkinson’s disease: a target for neuroprotection
1796. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington’s disease
1797. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington’s disease
1798. excitotoxicity and neurodegenerative diseases.
1799. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis
1800. Neurochemical aspects of excitotoxicity
1801. Dendritic and mitochondrial changes during glutamate excitotoxicity
1802. Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity
1803. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2
1804. Neuronal excitotoxicity: the role of mitochondria
1805. Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells
1806. Involvement of brain‐derived neurotrophic factor in cannabinoid receptor‐dependent protection against excitotoxicity
1807. excitotoxicity and repair of cochlear synapses after noise-trauma induced hearing loss
1808. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity
1809. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress
1810. Invulnerability of retinal ganglion cells to NMDA excitotoxicity
1811. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage
1812. Intracellular calcium levels during the period of delayed excitotoxicity
1813. Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity
1814. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism
1815. Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells
1816. Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity
1817. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity
1818. The stress protein response in cultured neurons: characterization and evidence for a protective role in excitotoxicity
1819. Neuroprotective effects of atorvastatin against glutamate‐induced excitotoxicity in primary cortical neurones
1820. Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide
1821. Acute neuronal injury, excitotoxicity, and the endocannabinoid system
1822. Selenium deficiency increases susceptibility to glutamate‐induced excitotoxicity
1823. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity
1824. excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin
1825. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo
1826. 17β-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors
1827. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter
1828. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity
1829. Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neurons
1830. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice
1831. Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus
1832. Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis
1833. NMDA but not non-NMDA excitotoxicity is mediated by Poly (ADP-ribose) polymerase
1834. Excitatory amino acid antagonists protect cochlear auditory neurons from excitotoxicity
1835. Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons
1836. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β‐peptide toxicity in hippocampal neurons
1837. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation
1838. Blocking excitotoxicity
1839. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium …
1840. Prolonged glutamate excitotoxicity: effects on mitochondrial antioxidants and antioxidant enzymes
1841. excitotoxicity and motor neurone disease: a review of the evidence
1842. P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis
1843. excitotoxicity and mitochondria
1844. ALS-linked Cu/Zn–SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium …
1845. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity
1846. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells
1847. Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity
1848. Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors
1849. The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of …
1850. Immunocytochemical characterization of quisqualic acid‐and N‐methyl‐D‐aspartate‐induced excitotoxicity in the retina of chicks
1851. Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity
1852. Changes in intracellular pH associated with glutamate excitotoxicity
1853. Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition.
1854. Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS
1855. excitotoxicity in the enteric nervous system
1856. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity
1857. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions
1858. Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor–mediated excitotoxicity in humans
1859. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine …
1860. Memantine: targeting glutamate excitotoxicity in Alzheimer’s disease and other dementias
1861. Reduced Progesterone Metabolites Protect Rat Hippocampal Neurones From Kainic Acid excitotoxicity In Vivo
1862. Cysteine-induced hypoglycemic brain damage: an alternative mechanism to excitotoxicity
1863. Mitochondrial control of acute glutamate excitotoxicity in cultured cerebellar granule cells
1864. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures
1865. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors
1866. Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity
1867. Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone
1868. Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain
1869. Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia
1870. Glutamate transporters and retinal excitotoxicity
1871. Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53.
1872. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis
1873. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice
1874. Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity
1875. Asiatic acid derivatives protect cultured cortical neurons from glutamate-induced excitotoxicity.
1876. Tumor necrosis factor α but not interleukin 1β mediates neuroprotection in response to acute nitric oxide excitotoxicity
1877. Experimental excitotoxicity provokes oxidative damage in mice brain and attenuation by extract of Asparagus racemosus
1878. Modulator effects of interleukin-1β and tumor necrosis factor-α on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures
1879. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures
1880. Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity
1881. Neuroprotection by Δ9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity
1882. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors
1883. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons
1884. Transgenic mice expressing a Huntington’s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
1885. Oxidative stress, mitochondrial function, and acute glutamate excitotoxicity in cultured cerebellar granule cells
1886. Mechanisms of excitotoxicity and Excitoprotection
1887. Direct Evidence That excitotoxicity in Cultured Neurons Is Mediated via N‐Methyl‐D‐Aspartate (NMDA) as well as Non‐NMDA Receptors
1888. Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity
1889. Neuroprotection by melatonin from kainate‐induced excitotoxicity in rats
1890. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage
1891. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington’s disease
1892. Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity
1893. α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage
1894. excitotoxicity induced by enhanced excitatory neurotransmission in cultured hippocampal pyramidal neurons
1895. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures
1896. Δ9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity
1897. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease
1898. … α-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity
1899. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation …
1900. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington’s disease
1901. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term …
1902. Ebselen prevents noise-induced excitotoxicity and temporary threshold shift
1903. Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1–specific ligand
1904. Neurotrophic effects of Cerebrolysin® in animal models of excitotoxicity
1905. Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro
1906. excitotoxicity and neurological disorders: involvement of membrane phospholipids
1907. Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity
1908. Reply to: Glutamate excitotoxicity in glaucoma: throwing the baby out with the bathwater?
1909. The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity.
1910. Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity
1911. Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus
1912. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases
1913. NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro
1914. The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity
1915. Regulation of proteins affecting NMDA receptor‐induced excitotoxicity in a Huntington’s mouse model
1916. Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus
1917. excitotoxicity and oxidative stress during inhibition of energy metabolism
1918. Ca2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells
1919. Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity
1920. Neurolathyrism: mitochondrial dysfunction in excitotoxicity mediated by L-β-oxalyl aminoalanine
1921. Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate/γ‐aminobutyric acid release and biosynthesis
1922. Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity
1923. The α7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca2+ dependent …
1924. Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity
1925. Blockade of glutamate excitotoxicity and its clinical applications
1926. Peroxisome-proliferator-activated receptor-gamma (PPARγ) activation protects neurons from NMDA excitotoxicity
1927. Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol
1928. Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity
1929. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity
1930. Glutamate‐mediated excitotoxicity in neonatal hippocampal neurons is mediated by mGluR‐induced release of Ca++ from intracellular stores and is prevented by …
1931. Nitric oxide synthase isoforms undertake unique roles during excitotoxicity
1932. Zinc induces a Src family kinase-mediated up-regulation of NMDA receptor activity and excitotoxicity
1933. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons
1934. excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson’s and Huntington’s diseases
1935. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective …
1936. Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia.
1937. TNFα-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity?
1938. Mitochondrial membrane potential and the permeability transition in excitotoxicity
1939. Gangliosides prevent excitotoxicity through activation of TrkB receptor
1940. The contributions of excitotoxicity, glutathione depletion and DNA repair in chemically induced injury to neurones: exemplified with toxic effects on cerebellar granule …
1941. Acidotoxicity trumps excitotoxicity in ischemic brain
1942. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity
1943. Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model
1944. Glutamate excitotoxicity in transient global cerebral ischemia
1945. Ethanol inhibits NMDA receptor‐mediated excitotoxicity in rat primary neuronal cultures
1946. Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases
1947. Ca2+ influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes
1948. Glutamate excitotoxicity—a mechanism for axonal damage and oligodendrocyte death in multiple sclerosis?
1949. Peripheral markers of oxidative stress and excitotoxicity in neurodegenerative disorders: tools for diagnosis and therapy?
1950. excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid
1951. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid
1952. Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons
1953. Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats
1954. The biochemical mechanisms of the excitotoxicity of kainic acid
1955. Glutamate excitotoxicity: a mechanism of neurologic injury associated with hypothermic circulatory arrest
1956. Modulation of glutamate release and excitotoxicity by adenosine A2A receptors
1957. Effects of Volatile Anesthetics on N -methyl-d-aspartate excitotoxicity in Primary Rat Neuronal–Glial Cultures
1958. Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists
1959. The effect of thiopental and propofol on NMDA-and AMPA-mediated glutamate excitotoxicity
1960. Allopregnanolone attenuates N-methyl-D-aspartate-induced excitotoxicity and apoptosis in the human NT2 cell line in culture
1961. excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of …
1962. Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress: glutamate and lead
1963. In Vivo excitotoxicity Induced by Ouabain, a Na+/K+-ATPase Inhibitor
1964. Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures
1965. Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity
1966. excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation
1967. The exacerbation of hippocampal excitotoxicity by glucocorticoids is not mediated by apoptosis
1968. Acteoside and its aglycones protect primary cultures of rat cortical cells from glutamate-induced excitotoxicity
1969. Inhibition of nuclear factor κB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons
1970. Glycogen synthase kinase 3β inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia
1971. An activity‐dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors
1972. Delayed antagonism of calpain reduces excitotoxicity in cultured neurons
1973. Pathophysiology of neonatal brain lesions: lessons from animal models of excitotoxicity
1974. Oligodendrocyte excitotoxicity determined by local glutamate accumulation and mitochondrial function
1975. Calcium green-5N, a novel fluorescent probe for monitoring high intracellular free Ca2+ concentrations associated with glutamate excitotoxicity in cultured rat brain …
1976. Lactate induced excitotoxicity in hippocampal slice cultures
1977. Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity
1978. Hyperthermia and hypoxia increase tolerance of retinal ganglion cells to anoxia and excitotoxicity.
1979. Apnea promotes glutamate-induced excitotoxicity in hippocampal neurons
1980. Potential signalling pathways underlying corticotrophin‐releasing hormone‐mediated neuroprotection from excitotoxicity in rat hippocampus
1981. Calpain and N-methyl-d-aspartate (NMDA)-induced excitotoxicity in rat retinas
1982. Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist
1983. Development of N-methyl-D-aspartate excitotoxicity in cultured hippocampal neurons
1984. Rapid and reversible changes in dendrite morphology and synaptic efficacy following NMDA receptor activation: implication for a cellular defense against excitotoxicity
1985. A role for Na+‐dependent Ca2+ extrusion in protection against neuronal excitotoxicity
1986. excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?
1987. Curcumin treatment protects rat retinal neurons against excitotoxicity: effect on N-methyl-D-aspartate-induced intracellular Ca2+ increase
1988. Carboxyl‐terminal fragment of Alzheimer’s APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity
1989. Plasminogen activators promote excitotoxicity‐induced retinal damage
1990. Sympathetic excitotoxicity in sepsis: pro-inflammatory priming of macrophages by norepinephrine
1991. Localization of glutamate receptors in developing cortical neurons in culture and relationship to susceptibility to excitotoxicity
1992. Brevetoxins cause acute excitotoxicity in primary cultures of rat cerebellar granule neurons
1993. Glutamate excitotoxicity and neuronal energy metabolism
1994. Neuroprotective potential of dietary restriction against kainate-induced excitotoxicity in adult male Wistar rats
1995. Apolipoprotein E protects against NMDA excitotoxicity
1996. Different receptors mediate motor neuron death induced by short and long exposures to excitotoxicity
1997. Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats
1998. Medroxyprogesterone acetate exacerbates glutamate excitotoxicity
1999. Protective effects of tetramethylpyrazine on kainate-induced excitotoxicity in hippocampal culture
2000. Microglial response to N‐methyl‐D‐aspartate‐mediated excitotoxicity in the immature rat brain
2001. Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity
2002. Hippocampal Seizure Resistance and Reduced Neuronal excitotoxicity in Mice Lacking the Cav2.3 E/R-Type Voltage-Gated Calcium Channel
2003. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors
2004. … of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity
2005. Role of glutamate and excitotoxicity in neurologic diseases
2006. 17β-Estradiol reduces cortical lesion size in the glutamate excitotoxicity model by enhancing extracellular lactate: a new neuroprotective pathway
2007. excitotoxicity and bioenergetics in glutaryl‐CoA dehydrogenase deficiency
2008. Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity
2009. Ethanol, stroke, brain damage, and excitotoxicity
2010. Glutamate excitotoxicity is involved in cell death caused by tributyltin in cultured rat cortical neurons
2011. DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures
2012. Protective effect of apolipoprotein E-mimetic peptides on N-methyl-D-aspartate excitotoxicity in primary rat neuronal–glial cell cultures
2013. Protection by eliprodil against excitotoxicity in cultured rat retinal ganglion cells.
2014. Excitatory amino acids in the developing brain: ontogeny, plasticity, and excitotoxicity
2015. Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice
2016. excitotoxicity of quinolinic acid: modulation by endogenous antagonists
2017. Enzymatic degradation protects neurons from glutamate excitotoxicity
2018. The NMDA receptor/ion channel complex: a drug target for modulating synaptic plasticity and excitotoxicity
2019. … of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen–glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal …
2020. Chicken cerebellar granule neurons rapidly develop excitotoxicity in culture
2021. Long-term activation of adenosine A2a receptors blocks glutamate excitotoxicity in cultures of avian retinal neurons
2022. Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease
2023. Differential c-Fos and caspase expression following kainic acid excitotoxicity
2024. Acute excitotoxicity in chick retina caused by the unusual amino acids BOAA and BMAA: effects of MK-801 and kynurenate
2025. excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex: therapeutic implications
2026. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity
2027. Lipopolysaccharide induces early tolerance to excitotoxicity via nitric oxide and cGMP
2028. Potassium channel activators abolish excitotoxicity in cultured hippocampal pyramidal neurons
2029. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development
2030. The role of excitotoxicity and metabolic failure in the pathogenesis of neurological disorders.
2031. Neuroprotective potency of kynurenic acid against excitotoxicity
2032. Evaluation of the role of NMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke encephalopathy
2033. Blockade of cannabinoid CB1 receptor function protects against in vivo disseminating brain damage following NMDA‐induced excitotoxicity
2034. Delayed neurodegeneration and early astrogliosis after excitotoxicity to the aged brain
2035. Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18–RE 105 neuroblastoma–retina hybrid …
2036. Hypoxia, excitotoxicity, and neuroprotection in the hippocampal slice preparation
2037. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types
2038. Differential effects of BDNF, ADNF9, and TNFα on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity
2039. In vivo neuroprotective role of NMDA receptors against kainate‐induced excitotoxicity in murine hippocampal pyramidal neurons
2040. Neuroprotective Effects of Thymosin β4 in Experimental Models of excitotoxicity
2041. Excitatory amino acid receptors, excitotoxicity, and the human nervous system.
2042. Brevetoxin‐Induced Autocrine excitotoxicity Is Associated with Manifold Routes of Ca2+ Influx
2043. Ability of GDNF to diminish free radical production leads to protection against kainate‐induced excitotoxicity in hippocampus
2044. Calcium mediated excitotoxicity in neurofilament aggregate-bearing neurons in vitro is NMDA receptor dependant
2045. Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia
2046. Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices
2047. Cyclosporin A targets involved in protection against glutamate excitotoxicity
2048. AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3‐kinase‐dependent activation in extracellular signal‐regulated …
2049. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members
2050. Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca2+] i increases and NMDA receptor mRNA levels
2051. Interferon‐γ is up‐regulated in the hippocampus in response to intermittent fasting and protects hippocampal neurons against excitotoxicity
2052. The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo
2053. Prevention of in vivo excitotoxicity by a family of trialkylglycines, a novel class of neuroprotectants
2054. Acetylcholine protection of adult pig retinal ganglion cells from glutamate-induced excitotoxicity
2055. Protein-protein coupling/uncoupling enables dopamine D2 receptor regulation of AMPA receptor-mediated excitotoxicity
2056. Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity
2057. Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia
2058. excitotoxicity‐related endocytosis in cortical neurons
2059. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression: a prominent role in neuroprotection against excitotoxicity
2060. TGFβ trophic factors differentially modulate motor axon outgrowth and protection from excitotoxicity
2061. … membrane potential and increased mitochondrial reactive oxygen species production correlate with age‐related glutamate excitotoxicity in rat hippocampal neurons
2062. Ergothioneine treatment protects neurons against N-methyl-D-aspartate excitotoxicity in an in vivo rat retinal model
2063. Genetic basis of kainate-induced excitotoxicity in mice: phenotypic modulation of seizure-induced cell death
2064. An ex vivo rat retinal preparation for excitotoxicity studies
2065. excitotoxicity and N‐methyl‐D‐Aspartate receptors
2066. N‐methyl‐D‐aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal‐regulated kinase pathway
2067. Potentiation of excitotoxicity in HIV-1-associated dementia and the significance of glutaminase
2068. A novel organotypic culture model of the postnatal mouse retina allows the study of glutamate-mediated excitotoxicity
2069. Hippocampal neurons of mice deficient in DNA-dependent protein kinase exhibit increased vulnerability to DNA damage, oxidative stress and excitotoxicity
2070. Adeno-associated viruses containing bFGF or BDNF are neuroprotective against excitotoxicity
2071. Oxidative stress in anticholinesterase-induced excitotoxicity
2072. Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: a possible role for mast cells
2073. excitotoxicity, energy metabolism and neurodegeneration
2074. Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: implications in excitotoxicity
2075. mGluR7‐like metabotropic glutamate receptors inhibit NMDA‐mediated excitotoxicity in cultured mouse cerebellar granule neurons
2076. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats
2077. Glutamate excitotoxicity attenuates insulin-like growth factor-I prosurvival signaling
2078. Neuronal death and tumor necrosis factor-α response to glutamate-induced excitotoxicity in the cerebral cortex of neonatal rats
2079. The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes
2080. Nitric oxide in cerebral ischemic neurodegeneration and excitotoxicity
2081. Acute neuroinflammation exacerbates excitotoxicity in rat hippocampus in vivo
2082. Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity
2083. Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity1
2084. Taxol stabilizes [Ca2+] i and protects hippocampal neurons against excitotoxicity
2085. Recovery of structure and function of inner ear afferent synapses following kainic acid excitotoxicity
2086. excitotoxicity mediated by non‐NMDA receptors causes distal axonopathy in long‐term cultured spinal motor neurons
2087. GABAA Receptor Activation Attenuates excitotoxicity but Exacerbates Oxygen—Glucose Deprivation-Induced Neuronal Injury In Vitro
2088. Cyclic AMP‐elevating agents prevent oligodendroglial excitotoxicity
2089. Is zinc the link between compromises of brain perfusion (excitotoxicity) and Alzheimer’s disease?
2090. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A …
2091. … inhibition of Src tyrosine kinase in rat cerebral cortical neurons: a role in neuroprotection against N-methyl-D-aspartate receptor-mediated excitotoxicity
2092. N-methyl-D-aspartate excitotoxicity: relationships among plasma membrane potential, Na+/Ca2+ exchange, mitochondrial Ca2+ overload, and cytoplasmic …
2093. Dietary restriction differentially protects from neurodegeneration in animal models of excitotoxicity
2094. Effects of puerarin against glutamate excitotoxicity on cultured mouse cerebral cortical neurons.
2095. Glutamate excitotoxicity in glaucoma: truth or fiction?
2096. In vitro and in vivo protection against kainate‐induced excitotoxicity by melatonin
2097. Melatonin protects primary cultures of rat cortical neurones from NMDA excitotoxicity and hypoxia/reoxygenation
2098. Platelet activating factor receptor expression is associated with neuronal apoptosis in an in vivo model of excitotoxicity
2099. Neuronal bioenergetic defects, excitotoxicity and Alzheimer’s disease:“Use it and lose it”
2100. Rabies virus infection of primary neuronal cultures and adult mice: failure to demonstrate evidence of excitotoxicity
2101. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity
2102. Synergistic versus antagonistic actions of glutamate and glutathione: the role of excitotoxicity and oxidative stress in neuronal disease.
2103. Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons
2104. … nucleoside triphosphatase, suppresses the accumulation of oxidative damage of nucleic acids in the hippocampal microglia during kainate-induced excitotoxicity
2105. Differential vulnerability of hippocampus, basal ganglia, and prefrontal cortex to long-term NMDA excitotoxicity
2106. Strain-dependent differences in calcium signaling predict excitotoxicity in murine hippocampal neurons
2107. A behavioral model of excitotoxicity: retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA administration in adult rats
2108. Acamprosate is neuroprotective against glutamate‐induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain
2109. HIV‐1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity
2110. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor‐mediated excitotoxicity in ALS
2111. Developmental expression, compartmentalization, and possible role in excitotoxicity of a putative NMDA receptor protein in cultured hippocampal neurons
2112. The intact isolated (ex vivo) retina as a model system for the study of excitotoxicity
2113. Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents
2114. Reversible and irreversible damage to cochlear afferent neurons by kainic acid excitotoxicity
2115. Glutamate receptors and excitotoxicity.
2116. NMDA and AMPA receptor expression and cortical neuronal death are associated with p38 in glutamate‐induced excitotoxicity in vivo
2117. The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer’s disease
2118. The role of apoptosis and excitotoxicity in the death of spinal motoneurons and interneurons after neonatal nerve injury
2119. Evidence that actin depolymerization protects hippocampal neurons against excitotoxicity by stabilizing [Ca2+] i
2120. N-methyl-D-aspartate-induced excitotoxicity in adult rat retina is antagonized by single systemic injection of MK-801
2121. l‐(−)‐Desmethylselegiline, a Metabolite of Selegiline [l‐(−)‐Deprenyl], Protects Mesencephalic Dopamine Neurons from excitotoxicity In Vitro
2122. Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons
2123. Differential contribution of plasmalemmal Na+/Ca2+ exchange isoforms to sodium‐dependent calcium influx and NMDA excitotoxicity in depolarized neurons
2124. Neuroprotection of adenoviral-vector-mediated GDNF expression against kainic-acid-induced excitotoxicity in the rat hippocampus
2125. excitotoxicity in Huntington disease
2126. AMPA‐mediated excitotoxicity in oligodendrocytes: role for Na+–K+–Cl− co‐transport and reversal of Na+/Ca2+ exchanger
2127. excitotoxicity in the embryonic chick spinal cord
2128. Differential effects of NMDA–receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices
2129. The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity
2130. Kainate excitotoxicity in organotypic hippocampal slice cultures: evidence for multiple apoptotic pathways
2131. Homocysteic and homocysteine sulphinic acid exhibit excitotoxicity in organotypic cultures from rat brain
2132. Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse
2133. 1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis
2134. Ability of retinal Müller glial cells to protect neurons against excitotoxicity in vitro depends upon maturation and neuron‐glial interactions
2135. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity
2136. Poly (ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage
2137. Pharmacological properties of acquired excitotoxicity in Chinese hamster ovary cells transfected with N-methyl-D-aspartate receptor subunits.
2138. Involvement of superoxide in excitotoxicity and DNA fragmentation in striatal vulnerability in mice after treatment with the mitochondrial toxin, 3-nitropropionic acid
2139. alpha-Phenyl-N-tert-butylnitrone attenuates excitotoxicity in rat striatum by preventing hydroxyl radical accumulation
2140. Acetylcholine neuroprotection against glutamate-induced excitotoxicity in adult pig retinal ganglion cells is partially mediated through α4 nAChRs
2141. excitotoxicity in the brain
2142. Basal ganglia calcification induced by excitotoxicity: an experimental model characterised by electron microscopy and X-ray microanalysis
2143. Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures
2144. Antiparkinsonian drugs and in vitro excitotoxicity
2145. Susceptibility of cerebellar granule neurons from GM2/GD2 synthase-null mice to apoptosis induced by glutamate excitotoxicity and elevated KCl: rescue by GM1 and …
2146. Ethanol inhibits excitotoxicity in cerebral cortical cultures
2147. Chronic excitotoxicity in the guinea pig cochlea induces temporary functional deficits without disrupting otoacoustic emissions
2148. Modulation of NMDA‐mediated excitotoxicity by protein kinase C
2149. Maturation of vulnerability to excitotoxicity: intracellular mechanisms in cultured postnatal hippocampal neurons
2150. … 2+‐dependent generation of mitochondrial reactive oxygen species serves as a signal for poly(ADP‐ribose) polymerase‐1 activation during glutamate excitotoxicity
2151. Protection of cortical cells by equine estrogens against glutamate-induced excitotoxicity is mediated through a calcium independent mechanism
2152. Genetic evidence for adenylyl cyclase 1 as a target for preventing neuronal excitotoxicity mediated by N-methyl-D-aspartate receptors
2153. Regulation of c‐Jun N‐terminal kinase, p38 kinase and AP‐1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection
2154. … enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity
2155. Protective effect of methanol extract of Uncaria rhynchophylla against excitotoxicity induced by N-methyl-D-aspartate in rat hippocampus
2156. 9. excitotoxicity and epileptic brain damage
2157. Effects of IL6 and IL1β on aFGF expression and excitotoxicity in NT2N cells
2158. Mechanisms of neuronal apoptosis and excitotoxicity
2159. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral …
2160. Decreased epileptic susceptibility correlates with neuropeptide Y overexpression in a model of tolerance to excitotoxicity
2161. Intracellular calcium and magnesium: critical determinants of excitotoxicity?
2162. NMDA receptor overstimulation triggers a prolonged wave of immediate early gene expression: relationship to excitotoxicity
2163. N-methyl-D-aspartate-induced excitotoxicity causes myopia in hatched chicks.
2164. excitotoxicity and neuroprotection
2165. Dopaminergic modulation of excitotoxicity in rat striatum: evidence from nigrostriatal lesions
2166. Lysosomal enzyme cathepsin B is involved in kainic acid-induced excitotoxicity in rat striatum
2167. … , phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat
2168. Exacerbation of NMDA, AMPA, and l‐Glutamate excitotoxicity by the Succinate Dehydrogenase Inhibitor Malonate
2169. Why do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury?
2170. Free radicals and mitochondria dysfunction in excitotoxicity and neurodegenerative disease
2171. Neuroprotectins A and B, bicyclohexapeptides protecting chick telencephalic neuronal cells from excitotoxicity I. Fermentation, isolation, physico-chemical properties …
2172. Susceptibility of retinal ganglion cells to excitotoxicity depends on soma size and retinal eccentricity
2173. Haloperidol induces neurotoxicity by the NMDA receptor downstream signaling pathway, alternative from glutamate excitotoxicity
2174. c-fos mRNA Expression in Rat Cortical Neurons During Glutamate-Mediated excitotoxicity
2175. Heterogeneity between hippocampal and septal astroglia as a contributing factor to differential in vivo AMPA excitotoxicity
2176. Dearth of glutamate transporters contributes to striatal excitotoxicity
2177. Phenformin suppresses calcium responses to glutamate and protects hippocampal neurons against excitotoxicity
2178. Intrastriatal grafting of a GDNF‐producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo
2179. Sequential expression of surface antigens and transcription factor NFκB by hippocampal cells in excitotoxicity and experimental epilepsy
2180. Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity
2181. … transport alteration triggers differentiation‐state selective oxidative death of cultured astrocytes: a mechanism different from excitotoxicity depending on intracellular …
2182. Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers
2183. Vulnerability of the hippocampus to kainate excitotoxicity in the aged, mature and young adult rat
2184. Neuroprotection by melatonin from glutamate‐induced excitotoxicity during development of the cerebellum in the chick embryo
2185. Evidence disputing the importance of excitotoxicity in hippocampal neuron death after experimental traumatic brain injury
2186. Reduction of excitotoxicity and associated leukocyte recruitment by a broad‐spectrum matrix metalloproteinase inhibitor
2187. The dual role of prostaglandin E2 in excitotoxicity and preconditioning-induced neuroprotection
2188. Erratum to “Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity”[J. Lip. Med. Cell Signal. 14 (1996) 15]
2189. GDNF and neublastin protect against NMDA-induced excitotoxicity in hippocampal slice cultures
2190. Electrophysiological mechanisms of delayed excitotoxicity: positive feedback loop between NMDA receptor current and depolarization-mediated glutamate release
2191. The excitotoxicity theory of glaucoma
2192. Excitatory amino acid neurotransmission, excitotoxicity and excitotoxins.
2193. Depolarization of mitochondria in isolated CA1 neurons during hypoxia, glucose deprivation and glutamate excitotoxicity
2194. Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity
2195. Parvalbumin-containing interneurons in rat hippocampus have an AMPA receptor profile suggestive of vulnerability to excitotoxicity
2196. Hypothermia, metabolic stress, and NMDA‐mediated excitotoxicity
2197. Ro5‐4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity
2198. Diltiazem-induced neuroprotection in glutamate excitotoxicity and ischemic insult of retinal neurons
2199. Failure of neuronal ion exchange, not potentiated excitation, causes excitotoxicity after inhibition of oxidative phosphorylation
2200. … glucose‐deprived neurons, Na+ influx reverses plasmalemmal K+‐dependent and K+‐independent Na+/Ca2+ exchangers and contributes to NMDA excitotoxicity
2201. Metabotropic glutamate receptor modulation of excitotoxicity in the neostriatum: role of calcium channels
2202. Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity
2203. The effects of excitotoxicity on the expression of the amyloid precursor protein gene in the brain and its modulation by neuroprotective agents
2204. Recovery of kainic acid excitotoxicity in chinchilla cochlea
2205. Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity
2206. excitotoxicity mediated by Ca 2+-permeable GluR4-containing AMPA receptors involves the AP-1 transcription factor
2207. Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA‐induced excitotoxicity in rat hippocampal slices
2208. Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity.
2209. Manipulation of membrane potential modulates malonate‐induced striatal excitotoxicity in vivo
2210. Schwann cells exhibit excitotoxicity consistent with release of NMDA receptor agonists
2211. In vitro hypoxia and excitotoxicity in human brain induce calcineurin–Bcl-2 interactions
2212. Characterization of neuroprotection from excitotoxicity by moderate and profound hypothermia in cultured cortical neurons unmasks a temperature-insensitive …
2213. excitotoxicity and plasticity of IHC-auditory nerve contributes to both temporary and permanent threshold shift
2214. Induction of neurosteroid synthesis by NMDA receptors in isolated rat retina: a potential early event in excitotoxicity
2215. Astroglial alterations in amyotrophic lateral sclerosis (ALS) model of slow glutamate excitotoxicity in vitro.
2216. Involvement of the Snk-SPAR pathway in glutamate-induced excitotoxicity in cultured hippocampal neurons
2217. Dopamine–glutamate interactions in the striatum: behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms
2218. Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by α-or γ-tocopherol
2219. Glutamate excitotoxicity in glaucoma: truth or fiction? By AJ Lotery
2220. Excitatory receptors and their role in excitotoxicity
2221. The effect of gp130 stimulation on glutamate-induced excitotoxicity in primary hippocampal neurons
2222. Heme oxygenase-1 protects brain from acute excitotoxicity
2223. Instrumental role of Na+ in NMDA excitotoxicity in glucose‐deprived and depolarized cerebellar granule cells
2224. Interleukin-1β exacerbates hypoxia-induced neuronal damage, but attenuates toxicity produced by simulated ischaemia and excitotoxicity in rat organotypic …
2225. Tachykinins protect cholinergic neurons from quinolinic acid excitotoxicity in striatal cultures
2226. Phosphoinositide second messengers in cholinergic excitotoxicity.
2227. NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization
2228. Nuclear disintegration as a leading step of glutamate excitotoxicity in brain neurons
2229. Roscovitine triggers excitotoxicity in cultured granule neurons by enhancing glutamate release
2230. β‐Amyloid excitotoxicity in Rat Magnocellular Nucleus Basalis: Effect of Cortical Deafferentation on Cerebral Blood Flow Regulation and Implications for Alzheimer’s …
2231. Blockade of desensitization augments quisqualate excitotoxicity in hippocampal neurons
2232. Fimbria–fornix transection and excitotoxicity produce similar neurodegeneration in the septum
2233. The Competitive Transport Inhibitor L‐trans‐pyrrolidine‐2,4‐dicarboxylate Triggers excitotoxicity in Rat Cortical Neuron‐Astrocyte Co‐cultures via Glutamate Release …
2234. Ethanol pretreatment enhances NMDA excitotoxicity in biogenic amine neurons: protection by brain derived neurotrophic factor
2235. Nuclear magnetic resonance imaging measurements of water diffusion in the perfused hippocampal slice during N-methyl-D-aspartate-induced excitotoxicity
2236. Neurotrophic factor mediated protection from excitotoxicity and disturbances in calcium and free radical metabolism
2237. Astrocytes regulate N-methyl-D-aspartate receptor subunit composition increasing neuronal sensitivity to excitotoxicity
2238. AMPA receptor mediated excitotoxicity in neocortical neurons is developmentally regulated and dependent upon receptor desensitization.
2239. excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres
2240. Role of endonuclease G in neuronal excitotoxicity in mice
2241. NMDA-evoked excitotoxicity increases tissue transglutaminase in cerebellar granule cells
2242. Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity.
2243. Lubeluzole protects hippocampal neurons from excitotoxicity in vitro and reduces brain damage caused by ischemia
2244. GM1 and NGF modulate Ca2+ homeostasis and GAP43 mRNA expression in cultured dorsal root ganglion neurons with excitotoxicity induced by glutamate
2245. Targeting PDZ domain proteins for treating NMDA receptor-mediated excitotoxicity
2246. Neuroprotectins A and B, Bicyclohexapeptides Protecting Chick Telencephalic Neurons from excitotoxicity
2247. NMDA excitotoxicity and free radical generation in rat brain homogenates: application of a chemiluminescence assay
2248. Contributing mechanisms for cysteine excitotoxicity in cultured cerebellar granule cells
2249. The effects of artificial calcium buffers on calcium responses and glutamate-mediated excitotoxicity in cultured hippocampal neurons
2250. NMDA receptor-mediated excitotoxicity contributes to the cerebral hypoxic injury of a rat model of posthypoxic myoclonus
2251. DNA damage and nonhomologous end joining in excitotoxicity: Neuroprotective role of DNA‐PKcs in kainic acid‐induced seizures
2252. … ‐specific repression of calpain expression and calpain enzymatic activity in neuronal cells – implications for neuroprotection against Ca2+‐mediated excitotoxicity
2253. An experimental model combining microdialysis with electrophysiology, histology, and neurochemistry for studying excitotoxicity in spinal cord injury
2254. The selective AMPA receptor antagonist GYKI 53784 blocks action potential generation and excitotoxicity in the guinea pig cochlea
2255. Amyotrophic lateral sclerosis, excitotoxicity and riluzole
2256. Evaluation of drugs acting at glutamate transporters in organotypic hippocampal cultures: new evidence on substrates and blockers in excitotoxicity
2257. Nitric oxide in retina: relation to excitatory amino acids and excitotoxicity
2258. Brain‐derived neurotrophic factor prevents changes in Bcl‐2 family members and caspase‐3 activation induced by excitotoxicity in the striatum
2259. Release and uptake of glutamate as related to excitotoxicity.
2260. Prevention of glutamate excitotoxicity in motor neurons by 5, 6-dihydrocyclopenta-1, 2-dithiole-3-thione: implication to the development of neuroprotective drugs
2261. excitotoxicity, apoptosis, and ischemic stroke
2262. Effect of ebselen and organochalcogenides on excitotoxicity induced by glutamate in isolated chick retina
2263. Peroxiredoxin 2 overexpression protects cortical neuronal cultures from ischemic and oxidative injury but not glutamate excitotoxicity, whereas Cu/Zn superoxide …
2264. Glial‐derived arginine, the nitric oxide precursor, protects neurons from NMDA‐induced excitotoxicity
2265. Cyclic GMP/cyclic GMP‐dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line
2266. Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture
2267. Subchronic intraventricular infusion of quinolinic acid produces working memory impairment—a model of progressive excitotoxicity
2268. Kainic acid—induced excitotoxicity is associated with a complex c‐Fos and c‐Jun response which does not preclude either cell death or survival
2269. Quinolinic Acid Accumulation During Neuroinflammation: Does it Imply excitotoxicity?
2270. Cholesterol deficiency increases the vulnerability of hippocampal glia in primary culture to glutamate-induced excitotoxicity
2271. In vivo assessment of kynurenate neuroprotective potency and quinolinate excitotoxicity
2272. Short‐term effects of kainic acid on CA1 hippocampal interneurons differentially vulnerable to excitotoxicity
2273. Rat cerebellar granule cells are protected from glutamate-induced excitotoxicity by S-nitrosoglutathione but not glutathione
2274. Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retina
2275. Intrinsic redox properties of N-methyl-D-aspartate receptor can determine the developmental expression of excitotoxicity in rat cortical neurons in vitro
2276. Cortical and striatal neuronal cultures of the same embryonic origin show intrinsic differences in glutamate receptor expression and vulnerability to excitotoxicity
2277. Effects of calcium chelators on intracellular calcium and excitotoxicity
2278. Pregnenolone sulfate modulates NMDA receptors, inducing and potentiating acute excitotoxicity in isolated retina
2279. Mechanisms of VIP‐induced neuroprotection against neonatal excitotoxicity
2280. The mode of spinal motor neurons degeneration in a model of slow glutamate excitotoxicity in vitro.
2281. The influence of glutamate receptor 2 expression on excitotoxicity in Glur2 null mutant mice
2282. … of 1, 2, 3, 4‐tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate‐induced excitotoxicity
2283. Transcriptional pharmacology of neurodegenerative disorders: novel venue towards neuroprotection against excitotoxicity?
2284. Substance P containing polymer implants protect against striatal excitotoxicity
2285. Aldolase C‐positive cerebellar Purkinje cells are resistant to delayed death after cerebral trauma and AMPA‐mediated excitotoxicity
2286. excitotoxicity
2287. Kainic acid-induced excitotoxicity in neurons and glial cells
2288. Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer’s disease and vascular …
2289. Hypoxia in presence of blockers of excitotoxicity induces a caspase-dependent neuronal necrosis
2290. Insulin-specific sensitization of cultured cerebrocortical neurons to glutamate excitotoxicity
2291. excitotoxicity and neuropsychiatric disorders
2292. HSV-mediated delivery of virally derived anti-apoptotic genes protects the rat hippocampus from damage following excitotoxicity, but not metabolic disruption
2293. Use of a multiwell fluorescence scanner with propidium iodide to assess NMDA mediated excitotoxicity in rat cortical neuronal cultures
2294. [3H]L-NG-Nitroarginine Binding after Transient Focal Ischemia and NMDA-Induced excitotoxicity in Type I and Type III Nitric Oxide Synthase Null Mice
2295. Association of c‐fos mRNA expression and excitotoxicity in primary cultures of mouse neocortical and cerebellar neurons
2296. A sublethal dose of TNFα potentiates kainate-induced excitotoxicity in optic nerve oligodendrocytes
2297. Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus
2298. Ca 2+ and Na+ dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons
2299. excitotoxicity plays a role in the death of tyrosine hydroxylase-immunopositive nigral neurons cultured in serum-free medium
2300. excitotoxicity affects membrane potential and calmodulin kinase II activity in cultured rat cortical neurons.
2301. Improvements in an in-vitro assay for excitotoxicity by measurement of early gene (c-fos mRNA) levels
2302. excitotoxicity in neurological diseases: New therapeutic challenge
2303. Aurintricarboxylic acid protects hippocampal neurons from glutamate excitotoxicity in vitro
2304. T-cells and excitotoxicity
2305. Kainate excitotoxicity is mediated by AMPA-but not kainate-preferring receptors in embryonic rat hippocampal cultures
2306. AMPA receptor‐mediated excitotoxicity in human NT2‐N neurons results from loss of intracellular Ca2+ homeostasis following marked elevation of intracellular Na+
2307. Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: an implication to Alzheimer’s disease
2308. Peptide growth factors but not ganglioside protect against excitotoxicity in rat retinal neurons in vitro
2309. Parathyroid hormone-related protein protects against kainic acid excitotoxicity in rat cerebellar granule cells by regulating L-type channel calcium flux
2310. Lithium protection from glutamate excitotoxicity: therapeutic implications
2311. excitotoxicity and neuroprotection
2312. Vascular changes in the spinal cord in N-methyl-D-aspartate-induced excitotoxicity: morphological and permeability studies
2313. Caspase-3 activation and DNA fragmentation in primary hippocampal neurons following glutamate excitotoxicity
2314. Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof
2315. Polyamine metabolism and glutamate receptor agonists‐mediated excitotoxicity in the rat brain
2316. In vivo studies on the protective role of minocycline against excitotoxicity caused by malonate or N-methyl-D-aspartate
2317. excitotoxicity at Both NMDA and Non‐NMDA Glutamate Receptors Is Antagonized by Aurintricarboxylic Acid: Evidence for Differing Mechanisms of Action
2318. Real-time imaging of intrinsic optical signals during early excitotoxicity evoked by domoic acid in the rat hippocampal slice
2319. Glycine-induced CA1 excitotoxicity in the rat hippocampal slice
2320. Nerve growth factor and basic fibroblast growth factor protect cholinergic neurons against quinolinic acid excitotoxicity in rat neostriatum
2321. Na+/H+ Exchanger Inhibitor, SM-20220, Is Protective Against excitotoxicity in Cultured Cortical Neurons
2322. Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically
2323. Postnatal treatment with ACTH-(4-9) analog ORG 2766 attenuates N-methyl-D-aspartate-induced excitotoxicity in rat nucleus basalis in adulthood
2324. ■ REVIEW: excitotoxicity, Free Radicals, Necrosis, and Apoptosis
2325. Intracellular Survival Pathways against Glutamate Receptor Agonist excitotoxicity in Cultured Neurons: Intracellular Calcium Responsesa
2326. Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures
2327. Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule …
2328. 17β-Estradiol effect on the extracellular concentration of amino acids in the glutamate excitotoxicity model in the rat
2329. Action of the anti-ischemic agent ifenprodil onn-methyl-D-aspartate and kainate-mediated excitotoxicity
2330. Ethanol and excitotoxicity in Cultured Cortical Neurons: Differential Sensitivity of N‐Methyl‐D‐Aspartate and Sodium Nitroprusside Toxicity
2331. Aurintricarboxylic acid prevents NMDA‐mediated excitotoxicity: evidence for its action as an NMDA receptor antagonist
2332. Infection with adeno-associated virus may protect against excitotoxicity
2333. Normal sensitivity to excitotoxicity in a transgenic Huntington’s disease rat
2334. Transforming growth factor α‐induced expression of type‐1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity
2335. Selectively increasing inducible heat shock protein 70 via TAT‐protein transduction protects neurons from nitrosative stress and excitotoxicity
2336. Heat shock protein HSP70 increases the resistance of cortical cells to glutamate excitotoxicity
2337. Oxidative stress during energy impairment in mesencephalic cultures is not a downstream consequence of a secondary excitotoxicity
2338. Tyrosine phosphatase SHP‐2 is a mediator of activity‐dependent neuronal excitotoxicity
2339. Group I metabotropic glutamate receptor inhibition selectively blocks a prolonged Ca2+ elevation associated with age-dependent excitotoxicity
2340. Nuclear translocation of extracellular signal-regulated kinases in neuronal excitotoxicity
2341. Neuronal TGF-β1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice
2342. Short-term consequences of N-methyl-D-aspartate excitotoxicity in rat magnocellular nucleus basalis: effects on in vivo labelling of cholinergic neurons
2343. Diminished calcium homeostasis and increased susceptibility to excitotoxicity of JS 3/16 progenitor cells after differentiation to oligodendroglia
2344. The antioxidant cocktail, effective microorganism X (EM-X), protects retinal neurons in rats against N-methyl-D-aspartate excitotoxicity in vivo
2345. … factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in …
2346. Accumulation of quinolinic acid with neuroinflammation: does it mean excitotoxicity?
2347. GM1 ganglioside administration protects spinal neurons after glutamate excitotoxicity
2348. Role of polyamine metabolism in kainic acid excitotoxicity in organotypic hippocampal slice cultures
2349. Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity
2350. ω-Agatoxin IVA and excitotoxicity in cortical neuronal cultures
2351. Neuroprotection against excitotoxicity by N-alkylglycines in rat hippocampal neurons
2352. Apoptosis is not enhanced in primary mixed neuronal/glial cultures protected by isoflurane against N-methyl-D-aspartate excitotoxicity
2353. Radiation-induced apoptosis in developing rats and kainic acid-induced excitotoxicity in adult rats are associated with distinctive morphological and biochemical c-Jun …
2354. Differential vulnerability of autonomic and somatic motor neurons to N-methyl-D-aspartate-induced excitotoxicity
2355. Propionyl-IIGL tetrapeptide antagonizes β-amyloid excitotoxicity in rat nucleus basalis
2356. … 3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit composition and cAMP-response element-binding protein regulate oligodendrocyte excitotoxicity
2357. TrkB and TrkC are differentially regulated by excitotoxicity during development of the basal ganglia
2358. Postlesional transcriptional regulation of metabotropic glutamate receptors: implications for plasticity and excitotoxicity
2359. Reversal of glutamate excitotoxicity by activation of PKC‐associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression
2360. excitotoxicity-induced expression of amyloid precursor protein (beta-APP) in the hippocampus and cortex of rat brain. an electron-microscopy and biochemical study.
2361. The metabotropic glutamate receptor agonist 1S, 3R-ACPD stimulates and modulates NMDA receptor mediated excitotoxicity in organotypic hippocampal slice …
2362. excitotoxicity of lathyrus sativus neurotoxin in leech retzius neurons
2363. Preliminary evaluation of an in vitro test for assessment of excitotoxicity by measurement of early gene (c-fos mRNA) levels
2364. Inhibition of excitotoxicity in cultured rat cortical neurons by a mixture of conjugated linoleic acid isomers
2365. Effects of kainate-mediated excitotoxicity on the expression of rat counterparts of A170 and MSP23 stress proteins in the brain
2366. The calretinin‐containing mossy cells survive excitotoxic insult in the gerbil dentate gyrus. Comparison of excitotoxicity‐induced neuropathological changes in the …
2367. Adenylyl cyclase isoforms as novel therapeutic targets: an exciting example of excitotoxicity neuroprotection
2368. Melatonin exhibits antioxidant properties in a mouse brain slice model of excitotoxicity
2369. Human, bovine, and rabbit retinal glutamate-induced [3H] D-aspartate release: role in excitotoxicity
2370. Melatonin Reducesthe Expression of excitotoxicity-Triggered Markers of Apoptosis1
2371. Altered vulnerability to kainate excitotoxicity of transgenic-Cu/Zn SOD1 neurones
2372. Excitatory and inhibitory pathways modulate kainate excitotoxicity in hippocampal slice cultures
2373. The correlation between excitatory amino acid-induced current responses and excitotoxicity in striatal cultures
2374. Electroclinical and pathological studies after parenteral administration of domoic acid in freely moving nonanesthetized rats: an animal model of excitotoxicity
2375. Effects of a traditional Chinese medicine, Qing Nao Yi Zhi Fang, on glutamate excitotoxicity in rat fetal cerebral neuronal cells in primary culture
2376. excitotoxins, glutamate receptors, and excitotoxicity
2377. excitotoxicity can be mediated through an interaction within the optic nerve; activation of cell body NMDA receptors is not required
2378. Effects of ciliary neurotrophic factor on excitotoxicity and calcium-ionophore A23187-induced cell death in cultured embryonic striatal neurons
2379. excitotoxicity and stroke
2380. Neurotrophins and excitotoxicity
2381. Effect of the noncompetitive NMDA antagonists MK-801 and ketamine on the spastic Han-Wistar mutant: a rat model of excitotoxicity
2382. Gangliosides in the protection against glutamate excitotoxicity
2383. … proteomic analysis and characterization of the intracellular mechanisms of bis (7)-tacrine in protecting against glutamate-induced excitotoxicity in primary cultured …
2384. Distinct subsets of nucleus basalis neurons exhibit similar sensitivity to excitotoxicity
2385. Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures
2386. The difference between mechanisms of kainate and glutamate excitotoxicity in vitro: osmotic lesion versus mitochondrial depolarization
2387. … between acute exposures to ethanol and acetaldehyde on neurotoxicity, nitric oxide production and NMDA-induced excitotoxicity in primary cultures of cortical …
2388. Spin trapping agent phenyl-N-tert-butylnitrone prevents diisopropylphosphorofluoridate-induced excitotoxicity in skeletal muscle of the rat
2389. Glutamate-mediated excitotoxicity
2390. Wernicke’s encephalopathy: an excitotoxicity hypothesis
2391. Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina
2392. Bioenergetics and excitotoxicity: the weak excitotoxic hypothesis
2393. Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington’s …
2394. The vulnerability of striatal projection neurons and interneurons to excitotoxicity is differentially regulated by dopamine during development
2395. Nitric oxide synthase inhibitors L-NAME and 7-nitroindazole protect rat hippocampus against kainate-induced excitotoxicity
2396. Evidence against a permissive role of the metabotropic glutamate receptor 1 in acute excitotoxicity.
2397. Superoxide dismutase activity in organotypic midbrain–striatum co‐cultures is associated with resistance of dopaminergic neurons to excitotoxicity
2398. excitotoxicity in aging and dementia
2399. Elevated Extracellular K+ Concentrations InhibitN-Methyl-d-Aspartate-Induced Ca2+ Influx and excitotoxicity
2400. Involvement of three glutamate receptor ϵ subunits in the formation of N-methyl-d-aspartate receptors mediating excitotoxicity in primary cultures of mouse cerebellar …
2401. Effects of glutamate-induced excitotoxicity on calretinin-expressing neuron populations in the area postrema of the rat
2402. excitotoxicity of glutamate and four analogs in primary spinal cord cell cultures
2403. Neuroprotective role of neurokinin B (NKB) on β-amyloid (25–35) induced toxicity in aging rat brain synaptosomes: involvement in oxidative stress and excitotoxicity
2404. Biochemical and morphological analysis of non-NMDA receptor mediated excitotoxicity in chick embryo retina
2405. Secobarbital Attenuates excitotoxicity but Potentiates Oxygen—Glucose Deprivation Neuronal Injury in Cortical Cell Culture
2406. Soluble KDI domain of γ1 laminin protects adult hippocampus from excitotoxicity of kainic acid
2407. Transforming growth factor-β2 increases NMDA receptor-mediated excitotoxicity in rat cerebral cortical neurons independently of glia
2408. Neurotrophin‐3 (NT‐3) diminishes susceptibility of the oligodendroglial lineage to AMPA glutamate receptor‐mediated excitotoxicity
2409. Stroke: Mechanisms of excitotoxicity and Approaches for Therapy
2410. Reduction of excitotoxicity-induced brain damage by the competitive NMDA antagonist CGP 40116: a longitudinal study using diffusion-weighted imaging
2411. GYKI 52466 protects against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures
2412. Growth hormone releasing peptide‐6 acts as a survival factor in glutamate‐induced excitotoxicity
2413. Reduced NMDA receptor sensitivity may underlie the resistance of subpopulations of PVN neurons to excitotoxicity
2414. Differential regulation of ciliary neurotrophic factor and its receptor in the rat hippocampus in response to kainic acid-induced excitotoxicity.
2415. Effects of antisense oligodeoxynucleotides to NR1 on suppression of seizures and protection of cortical neurons from excitotoxicity in vivo and in vitro.
2416. Mitochondrial dysfunction and increased sensitivity to excitotoxicity in mice deficient in DNA mismatch repair
2417. excitotoxicity and Traumatic Brain Injury
2418. Calcium indicators and excitotoxicity in cultured cortical neurons
2419. excitotoxicity on cultured cortical neurons
2420. Enhanced excitotoxicity in primary feline neural cultures exposed to feline immunodeficiency virus (FIV)
2421. Mitochondria as targets for neuronal protection against excitotoxicity: a role for phenolic compounds?
2422. Lack of involvement of glutamate‐induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate
2423. Chromatin condensation during glutamate-induced excitotoxicity of celebellar granule neurons precedes disintegration of nuclear DNA into high molecular weight …
2424. Oxidative stress-related proteins A170 and heme oxygenase-1 are differently induced in the rat cerebellum under kainate-mediated excitotoxicity
2425. excitotoxicity in amyotrophic lateral sclerosis: selective vulnerability of motor neurons
2426. Kainate‐induced excitotoxicity is dependent upon extracellular potassium concentrations that regulate the activity of AMPA/KA type glutamate receptors
2427. 17β‐estradiol does not protect cerebellar granule cells from excitotoxicity or apoptosis
2428. Apoptosis is induced by excitotoxicity in goldfish retina
2429. Tolerance of horizontal cells to excitotoxicity in the developing FVB/N mouse retina
2430. Prevention of kainate-induced excitotoxicity by a purine analogue.
2431. Ca2+-dependent kainate excitotoxicity in the chick embryonic neural retina ex vivo
2432. excitotoxicity induces changes in rat brain gangliosides
2433. Differential actions and excitotoxicity of glutamate agonists on motoneurons in adult mouse cervical spinal cord slices
2434. Selective glutamate antagonists block the excitotoxicity caused either by glutamate agonists or by ischemia
2435. Neurodegeneration induced by reversed microdialysis of NMDA; a quantitative model for excitotoxicity in vivo
2436. 2,7-Bis-(4-Amidinobenzylidene)-Cycloheptan-1-One Dihydrochloride, tPA Stop, Prevents tPA-Enhanced excitotoxicity Both In Vitro and In Vivo
2437. A derivative of a rigid glutamate analog protects the retina from excitotoxicity.
2438. The excitotoxicity of heterocyclic dicar☐ yclic acids in rat hippocampal slices: structure-activity relationships
2439. Signaling pathways to neuronal damage and apoptosis in human immunodeficiency virus type 1-associated dementia: chemokine receptors, excitotoxicity, and …
2440. Induction of Ornithine Decarboxylase by N‐Methyl‐D‐Aspartate Receptor Activation Is Unrelated to Potentiation of Glutamate excitotoxicity by Polyamines in …
2441. An unconventional hypothesis of oxidation in Alzheimer’s disease: intersections with excitotoxicity
2442. The study of protective effects of ginsenoside against excitotoxicity in neurons [J]
2443. Malonic acid and the chronic administration model of excitotoxicity
2444. In vivo brain microdialysis as a tool in studies of neuroprotective effects of cyclosporin A in acute excitotoxicity.
2445. AMPA-induced excitotoxicity increases nuclear levels of CAD, endonuclease G, and acinus and induces chromatin condensation in rat hippocampal pyramidal …
2446. β-Amyloid prevents excitotoxicity via recruitment of glial glutamate transporters
2447. Calcium homeostasis deregulation in glutamate-induced excitotoxicity and its role in neurodegenerative diseases
2448. Stereoselective neuroprotection by novel 2, 3-benzodiazepine non-competitive AMPA antagonists against non-NMDA receptor-mediated excitotoxicity in primary rat …
2449. Regulation of protein kinase C activity by taurine and β-alanine during excitotoxicity in cat and mouse cerebellar cultures
2450. Neonatal hypothalamic c-fos expression in an excitotoxicity-induced model of precocious puberty
2451. Increased sensitivity to N-methyl-D-aspartate receptor-induced excitotoxicity in cerebellar granule cells from interleukin-1 receptor type I-deficient mice
2452. Post-lesion administration of 5-HT1A receptor agonist 8-OH-DPAT protects cholinergic nucleus basalis neurons against NMDA excitotoxicity
2453. Selective enhancement of tonic inhibition by increasing ambient GABA is insufficient to suppress excitotoxicity in hippocampal neurons
2454. Methanol extract of Polygalae radix protects excitotoxicity in cultured neuronal cells
2455. Possible role for the FosB/JunD AP‐1 transcription factor complex in glutamate‐mediated excitotoxicity in cultured cerebellar granule cells
2456. Protection against non-NMDA receptor-mediated excitotoxicity by GYKI 52466 in mature telencephalic cultures of the rat.
2457. Amino acid neurotransmitter levels in the cerebral cortex of mice receiving imipenem/cilastatin-lack of excitotoxicity in the central nervous system
2458. Insulin growth factor-1 protects against excitotoxicity in the rat striatum
2459. Tachykinins and excitotoxicity in cerebellar granule cells
2460. Protective effect of NT-3 gene mediated by hydroxyapatite nanoparticle on the cochlea of guinea pigs injured by excitotoxicity
2461. Alterations of chaperone protein expression in presenilin mutant neurons in response to glutamate excitotoxicity
2462. Mechanisms of selective neuronal vulnerability: bioenergetics and excitotoxicity
2463. Glutathione prevents 2, 4, 5-trihydroxyphenylalanine excitotoxicity by maintaining it in a reduced, non-active form
2464. Glutamate-Induced white matter injury: excitotoxicity without synapses
2465. Kainic acid induced excitotoxicity and cfos expression in fibroblasts transfected with glutamate receptor subunit, GluR1
2466. Ibudilast prevents oligodendroglial excitotoxicity
2467. … neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase kinase activation to protect the developing mouse brain against excitotoxicity
2468. Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia
2469. Pathological study of retinal excitotoxicity following subretinal injection of NMDA
2470. excitotoxicity: theories and diseases
2471. Contribution of astrocyte glutamate release to excitotoxicity
2472. Mice heterozygous for neurotrophin-3 display enhanced vulnerability to excitotoxicity in the striatum through increased expression of N-methyl-D-aspartate receptors
2473. Mitochondrial dysfunction in oxidative stress, excitotoxicity, and apoptosis
2474. excitotoxicity as a stochastic process.
2475. An antisense construct reduces N‐methyl‐D‐aspartate receptor 2A expression and receptor‐mediated excitotoxicity as determined by a novel flow cytometric …
2476. excitotoxicity and the future of stroke imaging
2477. excitotoxicity
2478. … of p75 receptors and nerve growth factor neurotrophic effects: lack of p75 immunoreactivity in striatum following physical trauma, excitotoxicity and NGF administration
2479. Type‐2 astrocyte‐like cells are more resistant than oligodendrocyte‐like cells against non‐N‐methyl‐D‐aspartate glutamate receptor‐mediated excitotoxicity
2480. Protease-activated receptor (PAR) 1-mediated anti-apoptotic effect of activated protein C on glutamate excitotoxicity in hippocampal neurons
2481. Batten Disease: A Typical Neuronal Storage Disease or a Genetic Neurodegenerative Disorder Characterized by excitotoxicity?
2482. Cl−-dependent excitotoxicity is associated with 3H2O influx in chick embryonic retina
2483. bcl-2 gene therapy exacerbates excitotoxicity
2484. Nitric oxide: implication in excitotoxicity and cerebral ischemia
2485. excitotoxicity in Huntington’s Disease
2486. Counteractive Mechanism of Tongmai Injection for excitotoxicity in Rats with Cerebral Ischemia/Reperfusion [J]
2487. Drug treatments to reduce excitotoxicity in vivo: a potential for α 2-adrenoceptor antagonists?
2488. Ester derivatives of tournefolic acid B attenuate N-methyl-D-aspartate-mediated excitotoxicity in rat cortical neurons
2489. Psychosine blocks quisqualate-induced glutamate excitotoxicity in hippocampal CA sector neurons
2490. Induction of heme oxygenase-1 in the rat brain by kainic acid-mediated excitotoxicity: the dissociation of mRNA and protein expression in hippocampus
2491. Intracellular signalling in glutamate excitotoxicity
2492. The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures
2493. Do the glutamate excitotoxicity theory and potential free radicals implication in schizophrenia aetiopathogenesis provide a new enlightenment to links between …
2494. excitotoxicity and neurodegenerative disorders
2495. excitotoxicity: Too Much Glutamate May Be Hazardous to Your Health
2496. excitotoxicity and Oxidative Stress in Pathogenesis of Amyotrophic Lateral Sclerosis/Motor Neuron Disease
2497. Effect of GDNF against kainic acid excitotoxicity on cultured neonatal rats doral root ganlian neurons
2498. Effects of dopamine and excitotoxicity in experimental models of Huntington’s disease
2499. Glutamate excitotoxicity in the immunopathogenesis of multiple sclerosis
2500. The role of free radicals in NMDA and glutamate excitotoxicity
2501. excitotoxicity, cerebral ischemia, and neuroprotection by competitive NMDA receptor antagonists
2502. In vitro neuronal death: contrasts between excitotoxicity and chemical hypoxia
2503. Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents
2504. Effects of glutamate excitotoxicity and taurine intervention on retinal expression of glial fibrillary acid protein in rats [J]
2505. Developmental expression of NMDA receptors in primary cortical cell culture: relationship to function and excitotoxicity
2506. Epilepsy and Seizures: excitotoxicity or Excitotrophicity?
2507. … produce a loss of neuroprotective efficacy of competitive but not non-competitive antagonists in a model of NMDA-mediated excitotoxicity in organotypic hippocampal …
2508. 2-Deoxy-D-glucose protects retinal ganglion cells against excitotoxicity
2509. Neuroinflammation and excitotoxicity in neurobiology of HIV-1 infection and AIDS: targets for neuroprotection
2510. Nitric oxide, mitochondrial function and excitotoxicity
2511. excitotoxicity and cholinergic chemical markers during programmed motor neurone death
2512. Administration Model of excitotoxicity
2513. Amyotrophic lateral sclerosis: is excitotoxicity the key?
2514. ACUTE excitotoxicity IN THE ECIPPOCAMPAL
2515. Multiple mechanisms of excitotoxicity
2516. Effect of melatonin against glutamate-induced excitotoxicity on cultured cerebral cortical neurons
2517. Brain excitatory amino acid concentrations are lower in the neonatal pig: A buffer against excitotoxicity?
2518. THE PROTECTIVE EFFECTS OF TAURINE AGAINST GLUTAMATE-INDUCED excitotoxicity IN RAT RETINA [J]
2519. excitotoxicity in motor neurone diseases
2520. Role of Nitric Oxide in excitotoxicity and Memory Impairment Induced by Kanic Acid
2521. Mitochondrial inhibition induces glutamate excitotoxicity mediated motoneuron death
2522. Role of nitric oxide in excitotoxicity and memory impairment induced by kainic acid
2523. N-Acetylaspartate monomethyl ester increases N-acetylaspartate concentration in cultured rat hippocampal slices: Effects on excitotoxicity and levels of amino acids …
2524. NITRIC OXIDE, LIPIDPEROXIDATION AND TOTAL ANTIOXIDANT STATUS IN DIFFERENT REGIONS OF RAT BRAIN IN KAINIC ACID MEDIATED excitotoxicity.
2525. Ultrastructural studies of endothelium in NMDA-induced excitotoxicity
2526. excitotoxicity, genetics and neurodegeneration in amyotrophic lateral sclerosis
2527. The NR1-4 C-terminus interferes with N-methyl-d-aspartate receptor-mediated excitotoxicity: Evidence against a typical T/SXV-PDZ interaction
2528. Neuroprotective activity of neuroserpin against NMDA receptor-mediated excitotoxicity
2529. Can secondary brain insults exacerbate diffuse brain injuries through glutamate excitotoxicity and cyclic nucleotides system: a randomly controlled study in SD rats
2530. excitotoxicity and excitatory amino acid antagonists in chronic neurodegenerative diseases
2531. Endocytosis and autophagy in cerebral ischemia and excitotoxicity
2532. Blocking the pathway to excitotoxicity
2533. N-Methyl-D-Aspartate excitotoxicity: Is It Important in Ischemic Neuronal Injury?
2534. Markers of excitotoxicity in Patients: Tool for Diagnosis or Therapy?
2535. Effect of dizocilpine and taurine on the cerebral excitotoxicity of manganese chloride in rats
2536. Metabolic alterations as major contributing factors to the excitotoxicity-induced cellular damage and/or death
2537. excitotoxicity in Cerebral Ischemia
2538. Modifications of Phosphorylated Tau Immunoreactivity Linked to excitotoxicity in Neuronal Cultures
2539. excitotoxicity IN HUNTINGTON’S
2540. Seizure-linked hippocampal plasticity and protection against excitotoxicity: possible role of neuropeptide-y
2541. excitotoxicity, reflex responses, and evoked changes in extracellular potassium in the frog spinal cord.
2542. MONITORING OF excitotoxicity IN NEUROLOGIC DISORDERS
2543. Role of excitotoxicity in the degeneration of motor neurones in ALS
2544. Neuron protection of N-acetylcysteine on hippocampal neuron against glutamate excitotoxicity
2545. Nerve growth factor protects cholinergic neurons against quinolinic acid-induced excitotoxicity in wistar rats
2546. AND ASSESSMENT OF excitotoxicity MODILATION BY NEUROSTEROIDS
2547. excitotoxicity in ALS: Investigations of underlying molecular mechanisms and evaluation of neuroprotective strategies
2548. Does Ketamine Affect excitotoxicity?
2549. Characteristics of direct and indirect excitotoxicity in the mammalian hippocampus in vitro.
2550. AMPA‐induced excitotoxicity stimulates calpain activity and is exacerbated by tumor necrosis factor‐α;(TNF‐α) in the CA1 and CA3 regions of the hippocampus in an …
2551. Noradrenergic Modulation of excitotoxicity
2552. Glutamate excitotoxicity in Multiple Sclerosis
2553. Microglia recruitment during excitotoxicity
2554. The process and purpose of establishing excitotoxicity model with hippocampal neurons
2555. Chromatin condensation during glutamate-induced excitotoxicity of cerebellar [correction of celebellar] granule neurons precedes disintegration of nuclear DNA into …
2556. Development of excitotoxicity model with primary hippocampal neurons and implications of viability essay
2557. AMPA receptor mediated excitotoxicity in ALS: pathophysiology and neuropharmacology
2558. Excito-depletion: An Upside Down View of excitotoxicity Following Brain Injury
2559. KN-62 provides neuroprotection against glutamate-induced excitotoxicity in neurons.
2560. Neuroprotectins A and B, Two New Bicyclohexapeptides Protecting Primary Cultured Neurons from excitotoxicity
2561. excitotoxicity plays an important role in the pathologic progress of amyotrophic lateral sclerosis.
2562. Neuroprotective effects of nGBE against glutamate excitotoxicity
2563. excitotoxicity, Glutamate, Calcium and Neuronal Damage
2564. Neuroprotective properties of memantine in different models of excitotoxicity
2565. Fourier transform infrared spectroscopic investigation of excitotoxicity-protective mechanism of monoclonal antibody against NMDAR
2566. Tardive dyskinesia: An excitotoxicity hypothesis investigated in a rat model.
2567. Glutamate excitotoxicity in pathogenesis of multiple sclerosis
2568. Inhibiting glutamate excitotoxicity in spinal cord injury
2569. Counteractive Mechanism of Tongmai Injection for excitotoxicity in Rats with Cerebral Ischemia/Reperfusion
2570. Mechanisms of kainate-induced neuronal excitotoxicity.
2571. Glutamate excitotoxicity In Epilepsy And Ischemia
2572. The role of the NMDA receptor in the developmental onset of excitotoxicity in rat cortical neurons in vitro.
2573. An in Vivo Study of excitotoxicity in Generalized Epilepsy with MRS at 0.5 Tesla
2574. Na and K Changes Due to excitotoxicity are Mediated by Glutamate Transporters
2575. Characterization of the Molecular Mechanisms by which Endocytosed AMP AR Mediates NMDAR-Mediated Synaptic Plasticity and excitotoxicity
2576. Modulation of kainate-induced excitotoxicity in rats
2577. Secondary Neuronal Injury After Head Trauma: Role of excitotoxicity
2578. Involvement of Antioxidant Enzymes in NMDA-Induced Retinal excitotoxicity
2579. Hyperexcitability in adrenal cells after culture in ethanol: withdrawal or excitotoxicity.
2580. Myristicae Semen Extract Protects excitotoxicity in Cultured Neuronal Cells
2581. Glutamate excitotoxicity on primary cultured hippocampal neurons
2582. INVOLVEMENT OF GLUTAMINE SYNTHETASE IN KAINIC ACID MEDIATED excitotoxicity IN RAT BRAIN.
2583. Digital imaging of free intracellular calcium: a quantitative approach to assess excitotoxicity and neuronal protection in vitro
2584. The effect of glutamate excitotoxicity on the dopaminergic cells in the rat retina
2585. Involvement of excitotoxicity or oxidative stress in the pathophysiology of white and grey matter injury
2586. Molecular mechanisms of Tay Sachs Disease: calcium, excitotoxicity, and apoptosis
2587. Neuroprotective effects of stearic acid in primarily cultured hippocampal neurons insulted by excitotoxicity
2588. Glutamate excitotoxicity: An apoptosis-necrosis continuum of neuronal cell death.
2589. The effects of excitotoxicity and microglial activation on oligodendrocyte survival
2590. Regulation of effector pathways involved in protection from NMDA receptor-induced excitotoxicity in a mouse model of Huntington’s disease
2591. Neuronal apoptosis in excitotoxicity: involvement of nitric oxide and cytoskeletal damage
2592. Interactions between excitotoxicity and lysosomal inhibition: Implications for Alzheimer’s disease pathogenesis
2593. Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress
2594. The Effects of Ginkgo Biloba Extract on Glutamate excitotoxicity in vitro and Its Correlation with Cholesterol Pathway
2595. Effect of Minocycline on the Survival of Cultered Retinal Neurons in Glutamate excitotoxicity Assays
2596. Acute DNA fragmentation detected by Comet Assay in excitotoxicity
2597. LIGA20 ganglioside prevents excitotoxicity through activation of TrkB receptor
2598. Kainate Receptors in the Striatum: Implications for excitotoxicity in Huntington’s Disease
2599. Purines, Lactate and Myo-Inositol in CSF Might Reflect excitotoxicity in Inherited Metabolic Disorders
2600. Volume-sensitive chloride channel involved in necrotic neuronal death by excitotoxicity
2601. ROLE OF CITRULLINE-NITRIC OXIDE CYCLE ENZYMES AND ARGINASE IN KAINIC ACID MEDIATED excitotoxicity.
2602. An orchestra of glutamate receptors and transporters in synaptic transmission, plasticity and excitotoxicity
2603. Neuroprotective Effects of Lithium on NMDA-induced excitotoxicity in Mouse Cerebrum
2604. Correction: Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
2605. Dantrolene protects motoneurons in culture against AMPA receptor mediated excitotoxicity
2606. Protein Kinase B (PKB) and Protein Kinase C (PKC) in N-Methyl-D-Aspartate (NMDA)-Induced excitotoxicity in Rats
2607. Glutamate-induced changes in intracellular calcium and magnesium in rat forebrain neurons in vitro: Relationship to excitotoxicity.
2608. The protective effect of CDP-choline on neuronal changes in a model of slow glutamate excitotoxicity in vitro
2609. 2-deoxy-D-glucose Protects Retinal Ganglion Cells against N-methyl-D-aspartate Mediated excitotoxicity
2610. ACh Receptor Activation Links Two Separate Signaling Proteins to Neuroprotection Against Glutamate–Induced excitotoxicity in Isolated Pig Retinal Ganglion Cells
2611. EFFECT OF CALCIUM CHANNEL ANTAGONISTS ON EAA-MEDIATED excitotoxicity IN ETHANOL WITHDRAWN NEOCORTICAL CULTURES
2612. Effects of glutamate excitotoxicity and taurine intervention on retinal expression of glial fibrillary acid protein in rats
2613. Neuroprotective effects of calpain inhibitor MDL 28170 in a model of intravitreal excitotoxicity
2614. Histological changes in brain tissue of rat induced neuronal excitotoxicity by NMDA (N-methyl-D-asparate)
2615. excitotoxicity of AMPA and kainate receptor activation and desensitization in cultured neurons
2616. AIDS DEMENTIA AS A FORM OF excitotoxicity: POTENTIAL THERAPY WITH NMDA OPEN-CHANNEL BLOCKERS AND REDOX CONGENERS OF NITRIC …
2617. Mutant huntingtin enhanced sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity
2618. A possible mechanism of excitotoxicity: Autoregulation of glutamate release from hippocampal mossy fiber terminals.
2619. Actions and Interactions of Cholinergic and Excitatory Aminoacid Receptors on Phosphoinositide Signals, excitotoxicity and Neuroplasticity
2620. AIDS dementia as a form of excitotoxicity: potential therapy with NMDA open-channel blockers and redox congeners of nitric oxide
2621. Hypothetical Mechanisms of G protein-coupled neurodegeneration in glutamate excitotoxicity in human SH-SY5Y neuroblastoma cells
2622. The role of mitochondria in N-methyl-D-aspartate receptor-mediated excitotoxicity: A mechanistic explanation for neurodegeneration.
2623. Mechanisms of domoic acid action: Glutamate receptor-mediated excitotoxicity and changes of hippocampal neurotransmission and synaptic plasticity
2624. Crude Extract of Zizyphi Jujube Semen Protects Kainic Acid-induced excitotoxicity in Cultured Rat Neuronal Cells
2625. Protective Effects of Na+/H+ Exchanger Inhibition Against Glutamate excitotoxicity Occur through Blockade of Mitochondrial Ca2+ Overload
2626. Protective Effects of Shenqi-wan and Its Fractions on N-methyl-D-aspartate-induced excitotoxicity in Rat Hippocampal CA1 Region
2627. Hypothetical Mechanisms of G protein-coupled neurodegeneration in glutamate excitotoxicity in human SH-SY5Y neuroblastoma cells
2628. Dibenzylbutyrolactone lignans from Torreya nucifera Protect CuItured Rat Cortical Neurons from Glutamate-lnduced excitotoxicity
2629. Proteomics Analysis of the Retina of EAAC1–Knock Out Mice: Neuroprotective Effect of PDGF Against Glutamate–Induced excitotoxicity in Retinal Ganglion Cells
2630. Delayed preconditioning with rosuvastatin protects cultured rat cortical neurons against oxygen‐glucose deprivation and excitotoxicity
2631. P25 IN VITRO NEUROPROTECTIVE EFFECTS OF MTEP, A SELECTIVE MGLUR5 ANTAGONIST AGAINST KAINATE–INDUCED excitotoxicity.
2632. Olfactory receptor neurons persist during extensive remodeling of the olfactory bulb following NMDA-induced excitotoxicity
2633. THE AUTOCRINE excitotoxicity OF ANTILLATOXIN, A NOVEL LIPOPEPTIDE DERIVED FROM THE PANTROPICAL MARINE CYANOBACTERIUM …
2634. Neuroprotective effect of betaine against N-methyl-D-aspartate excitotoxicity in hippocampal slice culture
2635. Intrinsic optical signals characterizing acute excitotoxicity in the hippocampal slice evoked by the marine toxin domoic acid.
2636. In vitro studies with AMPA and NMDA receptor antagonists and modulators on synaptic transmission, LTP and excitotoxicity-implications for therapeutic safety
2637. The autocrine excitotoxicity of antillatoxin, a novel lipopeptide derived from the antropical [sic] marine cyanobacterium Lyngbya majuscula
2638. Low Mg2+-induced Calcium Spiking Protects Against Subsequent Longer Exposure-induced excitotoxicity in Cultured Rat Hippocampal Neurons
2639. Nitric oxid inhibits excitotoxicity of glutamate in purified chick embryo retinal cultures: role of NMDA receptors; Oxido nitrico inibe a excitotoxicidade do glutamato em …
2640. … Huntingtin-mediated alterations of N-Methyl-D-Aspartate receptor currents and downstream events underlying enhanced excitotoxicity in Huntington’s disease
2641. A Possible Central Mechanism in Autism Spectrum Disorders: Interaction of Activated Microglia, excitotoxicity, Reactive Oxygen and Nitrogen Species, Lipid …
2642. Neuroprotective effect of Acanthopanax sessiliflorm Stems and Roots against N-methyl-D-aspartate excitotoxicity in rat organotypic hippocampal slice culture
2643. 1069. The HSV-2 Vector ΔRR Prevents excitotoxicity-Induced Neuronal Cell Loss through Activation of Survival Pathways and Glial Cell Modulation
2644. Protective Effects of Li’s No. 5 on Glutamate excitotoxicity on Primary Cultured Cortical Neurons by Serum Pharmacological Test [J]
2645. Molecular pathogenesis of Huntington’s disease: the role of excitotoxicity
2646. Change of the Ca~(2+) density in the cortical neurons after excitotoxicity
2647. 14 Minocycline in Cerebral Ischemia and excitotoxicity
2648. STUDIES ON THE CHANGES OF Ca-(2+)/CaM PKⅡ ACTIVITY ANDTHEIR RELATION WITH excitotoxicity OF BRAIN ISCHEMIA
2649. Insulin-like growth factor type 1 receptor activity promotes survival and inhibits glutamate-induced excitotoxicity of cortical neurons
2650. The Role of Glia in excitotoxicity and Stroke
2651. Non-NMDA Glutamate Receptors in the Regulation of Neuronal Ca2+ and excitotoxicity
2652. IL-6 Decreases Low Mg2+-induced excitotoxicity in Cultured Rat Hippocampal Neurons by Inhibition of [Ca2+] i Spikes and Activation of RAS/MAPK and JAK-STAT
2653. IL-6 Decreases Low [Mg2+] o-induced excitotoxicity in Cultured Rat Hippocampal Neurons
2654. Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca 2+ concentration and excitotoxicity
2655. The HSV-2 protein ICP10PK protects CNS neurons from NMDA-induced excitotoxicity in vitro and in vivo
2656. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases
2657. Calcium, ischemia and excitotoxicity
2658. excitotoxicity: bridge to various triggers in neurodegenerative disorders
2659. excitotoxicity and stroke: identifying novel targets for neuroprotection
2660. A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
2661. Methylxanthines, seizures, and excitotoxicity
2662. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity
2663. excitotoxicity in ALS: overstimulation, or overreaction?
2664. excitotoxicity in the pathogenesis of autism
2665. Slow excitotoxicity in Alzheimer’s disease
2666. excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications
2667. Spare respiratory capacity, oxidative stress and excitotoxicity
2668. Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity
2669. Kainate receptors in epilepsy and excitotoxicity
2670. Interleukin‐1β: a bridge between inflammation and excitotoxicity?
2671. Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity
2672. Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?
2673. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients
2674. Glutamate-mediated excitotoxicity in schizophrenia: a review
2675. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation
2676. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics
2677. Multiple sclerosis and glutamate excitotoxicity
2678. Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity
2679. Chemical pathology of homocysteine. IV. excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation
2680. Neuroprotective function for ramified microglia in hippocampal excitotoxicity
2681. Beyond the critical point: An overview of excitotoxicity, calcium overload and the downstream consequences
2682. excitotoxicity triggered by Neurobasal culture medium
2683. Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target
2684. Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity
2685. Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection
2686. White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity
2687. Amyloid β, glutamate, excitotoxicity in Alzheimer’s disease: are we on the right track?
2688. Mechanisms of neuronal protection against excitotoxicity, endoplasmic reticulum stress, and mitochondrial dysfunction in stroke and neurodegenerative …
2689. Mechanisms of synaptic dysfunction and excitotoxicity in Huntington’s disease
2690. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity
2691. Cortical cultures coupled to micro-electrode arrays: a novel approach to perform in vitro excitotoxicity testing
2692. ATP signaling in brain: release, excitotoxicity and potential therapeutic targets
2693. Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms
2694. Cholesterol loss during glutamate‐mediated excitotoxicity
2695. Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?
2696. Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation
2697. Abnormalities in glutamate metabolism and excitotoxicity in the retinal diseases
2698. Inhibition of reactive gliosis attenuates excitotoxicity-mediated death of retinal ganglion cells
2699. Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity
2700. Dopamine protects neurons against glutamate-induced excitotoxicity
2701. FTY720 attenuates excitotoxicity and neuroinflammation
2702. Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death
2703. Spreading depolarizations mediate excitotoxicity in the development of acute cortical lesions
2704. Polysaccharides from wolfberry antagonizes glutamate excitotoxicity in rat cortical neurons
2705. MFN2 couples glutamate excitotoxicity and mitochondrial dysfunction in motor neurons
2706. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington’s disease excitotoxicity
2707. Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders
2708. Postsynaptic mechanisms of excitotoxicity: Involvement of postsynaptic density proteins, radicals, and oxidant molecules
2709. Serine racemase deletion protects against cerebral ischemia and excitotoxicity
2710. Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP
2711. Hyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders
2712. Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly (ADP-ribose) polymer-induced cell death
2713. P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia
2714. Neuroprotective effects of naturally occurring polyphenols on quinolinic acid‐induced excitotoxicity in human neurons
2715. Protection of apigenin against kainate-induced excitotoxicity by anti-oxidative effects
2716. α2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity
2717. Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons
2718. An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis
2719. Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by neuroprotective nuclear calcium signals
2720. excitotoxicity and oxidative stress in acute ischemic stroke
2721. Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity
2722. NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors
2723. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2
2724. In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease
2725. Adiponectin protects rat hippocampal neurons against excitotoxicity
2726. L-Lactate protects neurons against excitotoxicity: implication of an ATP-mediated signaling cascade
2727. Necroptosis contributes to the NMDA-induced excitotoxicity in rat’s cultured cortical neurons
2728. Taming glutamate excitotoxicity: strategic pathway modulation for neuroprotection
2729. Down-regulation of Homer1b/c attenuates glutamate-mediated excitotoxicity through endoplasmic reticulum and mitochondria pathways in rat cortical neurons
2730. An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
2731. NR1 and GluR2 expression mediates excitotoxicity in chronic hypobaric hypoxia
2732. Calpains and delayed calcium deregulation in excitotoxicity
2733. Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration
2734. Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington’s disease
2735. Glutamate excitotoxicity and oxidative stress in epilepsy: modulatory role of melatonin
2736. Mechanisms underlying the neurotoxicity induced by glyphosate-based herbicide in immature rat hippocampus: involvement of glutamate excitotoxicity
2737. Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity
2738. Nicotinamide riboside, a form of vitamin B3, protects against excitotoxicity‐induced axonal degeneration
2739. … : motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity
2740. Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress–mediated mitochondrial alteration in a mouse model of glaucoma
2741. excitotoxicity as a common mechanism for fetal neuronal injury with hypoxia and intrauterine inflammation
2742. Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity
2743. Normobaric hyperoxia is associated with increased cerebral excitotoxicity after severe traumatic brain injury
2744. Mitochondria, bioenergetics and excitotoxicity: new therapeutic targets in perinatal brain injury
2745. The metabolic response to excitotoxicity–lessons from single-cell imaging
2746. excitotoxicity and metabolic crisis are associated with spreading depolarizations in severe traumatic brain injury patients
2747. GABAergic excitotoxicity injury of the immature hippocampal pyramidal neurons’ exposure to isoflurane
2748. excitotoxicity in acute encephalopathy with biphasic seizures and late reduced diffusion
2749. In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity
2750. Neuroprotective effect of magnesium acetyltaurate against NMDA-induced excitotoxicity in rat retina
2751. Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction
2752. Perspectives on neuroinflammation and excitotoxicity: a neurotoxic conspiracy?
2753. Endoplasmic reticulum Ca2+ release through ryanodine and IP3 receptors contributes to neuronal excitotoxicity
2754. excitotoxicity effects of glutamate on human neuroblastoma SH-SY5Y cells via oxidative damage
2755. Axonal degeneration induced by glutamate excitotoxicity is mediated by necroptosis
2756. excitotoxicity and oxidative stress in acute stroke
2757. Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity
2758. Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells
2759. Mitogen‐activated protein kinase‐signaling regulates the ability of Müller glia to proliferate and protect retinal neurons against excitotoxicity
2760. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective …
2761. Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger …
2762. Microglial contact prevents excess depolarization and rescues neurons from excitotoxicity
2763. Simvastatin is the statin that most efficiently protects against kainate-induced excitotoxicity and memory impairment
2764. Tinospora cordifolia as a potential neuroregenerative candidate against glutamate induced excitotoxicity: an in vitro perspective
2765. Differentiation renders susceptibility to excitotoxicity in HT22 neurons
2766. Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents
2767. Glutamate excitotoxicity and Ca2+-regulation of respiration: Role of the Ca2+ activated mitochondrial transporters (CaMCs)
2768. Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and neuronal excitotoxicity
2769. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease
2770. Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity
2771. Vascular endothelial growth factor protects spinal cord motoneurons against glutamate‐induced excitotoxicity via phosphatidylinositol 3‐kinase
2772. Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicity
2773. PGC-1α negatively regulates extrasynaptic NMDAR activity and excitotoxicity
2774. NMDA receptor-dependent glutamate excitotoxicity in human embryonic stem cell-derived neurons
2775. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFα pathway and protection by …
2776. NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity
2777. Mechanisms of tau and Aβ-induced excitotoxicity
2778. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB
2779. The Tau/A152T mutation, a risk factor for frontotemporal‐spectrum disorders, leads to NR 2B receptor‐mediated excitotoxicity
2780. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone
2781. Caloric restriction increases brain mitochondrial calcium retention capacity and protects against excitotoxicity
2782. Abnormal visual gain control and excitotoxicity in early-onset Parkinson’s disease Drosophila models
2783. Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients
2784. Changes in brain cholesterol metabolome after excitotoxicity
2785. Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity
2786. Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function
2787. Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress
2788. Neuronal Gap Junctions Are Required for NMDA Receptor–Mediated excitotoxicity: Implications in Ischemic Stroke
2789. … exposure to glyphosate-based herbicide and depressive-like behavior in adult offspring: Implication of glutamate excitotoxicity and oxidative stress
2790. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity
2791. β-N-methylamino-L-alanine toxicity in PC12: excitotoxicity vs. misincorporation
2792. Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington’s disease: a STEP in the resistance to excitotoxicity
2793. excitotoxicity and focal cerebral ischemia induce truncation of the NR2A and NR2B subunits of the NMDA receptor and cleavage of the scaffolding protein …
2794. Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K/Akt activation
2795. Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity
2796. TNF‐α‐mediates neuroprotection against glutamate‐induced excitotoxicity via NF‐κB‐dependent up‐regulation of KCa2.2 channels
2797. The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury
2798. Involvement of PrP C in kainate-induced excitotoxicity in several mouse strains
2799. Zinc binding to S100B affords regulation of trace metal homeostasis and excitotoxicity in the brain
2800. Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity
2801. Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes
2802. Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity
2803. Preventing NAD+ depletion protects neurons against excitotoxicity: bioenergetic effects of mild mitochondrial uncoupling and caloric restriction
2804. L-lactate-mediated neuroprotection against glutamate-induced excitotoxicity requires ARALAR/AGC1
2805. excitotoxicity of TNFα derived from KA activated microglia on hippocampal neurons in vitro and in vivo
2806. Biodegradable spheres protect traumatically injured spinal cord by alleviating the glutamate‐induced excitotoxicity
2807. Chemical analysis and effect of blueberry and lingonberry fruits and leaves against glutamate-mediated excitotoxicity
2808. Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury
2809. Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation
2810. Probucol modulates oxidative stress and excitotoxicity in Huntington’s disease models in vitro
2811. Single-cell imaging of bioenergetic responses to neuronal excitotoxicity and oxygen and glucose deprivation
2812. Protection from glutamate-induced excitotoxicity by memantine
2813. excitotoxicity: an organized crime at the cellular level
2814. Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy
2815. Extrasynaptic NMDA receptor in excitotoxicity: function revisited
2816. Neuroprotective effect of resveratrol against glutamate-induced excitotoxicity
2817. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo
2818. System xc− regulates microglia and macrophage glutamate excitotoxicity in vivo
2819. Recent findings on neuroprotection against excitotoxicity in the hippocampus of female rats
2820. Prolactin reduces the damaging effects of excitotoxicity in the dorsal hippocampus of the female rat independently of ovarian hormones
2821. Prolactin-induced neuroprotection against glutamate excitotoxicity is mediated by the reduction of [Ca2+]i overload and NF-κB activation
2822. The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine
2823. Synaptic activity protects neurons against calcium-mediated oxidation and contraction of mitochondria during excitotoxicity
2824. Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice
2825. excitotoxicity and metabolic changes in association with infarct progression
2826. Prolactin mediates neuroprotection against excitotoxicity in primary cell cultures of hippocampal neurons via its receptor
2827. excitotoxicity downregulates TrkB. FL signaling and upregulates the neuroprotective truncated TrkB receptors in cultured hippocampal and striatal neurons
2828. Glutamate excitotoxicity linked to spermine oxidase overexpression
2829. Glutamatergic metabolites, volume and cortical thickness in antipsychotic-naive patients with first-episode psychosis: implications for excitotoxicity
2830. The neuroprotective effects of SIRT1 on NMDA-induced excitotoxicity
2831. Androgens predispose males to GABAA-mediated excitotoxicity in the developing hippocampus
2832. Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of α7 nicotinic receptors and internalization of NMDA receptors
2833. Total oligomeric flavonoids of Cyperus rotundus ameliorates neurological deficits, excitotoxicity and behavioral alterations induced by cerebral ischemic–reperfusion …
2834. Ethanol and adult CNS neurodamage: oxidative stress, but possibly not excitotoxicity.
2835. … medium of human adipose-derived mesenchymal stem cells mediates protection in neurons following glutamate excitotoxicity by regulating energy …
2836. Calpain-dependent degradation of nucleoporins contributes to motor neuron death in a mouse model of chronic excitotoxicity
2837. β-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway
2838. excitotoxicity triggered by neonatal monosodium glutamate treatment and blood–brain barrier function
2839. Novel model for the mechanisms of glutamate-dependent excitotoxicity: role of neuronal gap junctions
2840. Direct interaction between GluR2 and GAPDH regulates AMPAR-mediated excitotoxicity
2841. Galantamine potentiates the neuroprotective effect of memantine against NMDA‐induced excitotoxicity
2842. Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis–vulnerability of lower motor neurons to proximal excitotoxicity
2843. Regulated expression of surface AMPA receptors reduces excitotoxicity in auditory neurons
2844. Acidotoxicity via ASIC1a mediates cell death during oxygen glucose deprivation and abolishes excitotoxicity
2845. Susceptibility to excitotoxicity in aged hippocampal cultures and neuroprotection by non‐steroidal anti‐inflammatory drugs: role of mitochondrial calcium
2846. Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein
2847. L-theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway
2848. Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and …
2849. Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by …
2850. Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine
2851. Ceftriaxone rescues hippocampal neurons from excitotoxicity and enhances memory retrieval in chronic hypobaric hypoxia
2852. Anthocyanins Protect against Kainic Acid‐induced excitotoxicity and Apoptosis via ROS‐activated AMPK Pathway in Hippocampal Neurons
2853. Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture
2854. Myelin‐associated glycoprotein protects neurons from excitotoxicity
2855. Agathisflavone, a flavonoid derived from Poincianella pyramidalis (Tul.), enhances neuronal population and protects against glutamate excitotoxicity
2856. Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity
2857. Differential molecular targets for neuroprotective effect of chlorogenic acid and its related compounds against glutamate induced excitotoxicity and oxidative stress in …
2858. Unraveling the neuroprotective mechanisms of PrPC in excitotoxicity
2859. Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke
2860. Inhibition of Bcl-xL prevents pro-death actions of ΔN-Bcl-xL at the mitochondrial inner membrane during glutamate excitotoxicity
2861. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy–implications for excitotoxicity
2862. Alzheimer’s disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and kynurenines
2863. A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity
2864. Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain
2865. NeuroEPO preserves neurons from glutamate-induced excitotoxicity
2866. C9orf72 dipeptide repeats cause selective neurodegeneration and cell-autonomous excitotoxicity in Drosophila glutamatergic neurons
2867. Pharmacological enhancement of glutamate transport reduces excitotoxicity in vitro
2868. Glutamate excitotoxicity induced by orally administered propionic acid, a short chain fatty acid can be ameliorated by bee pollen
2869. Progesterone inhibits estrogen‐mediated neuroprotection against excitotoxicity by down‐regulating estrogen receptor‐β
2870. Ginsenoside Rd Protects Neurons Against Glutamate-Induced excitotoxicity by Inhibiting Ca2+ Influx
2871. DR-region of Na+/K+ ATPase is a target to treat excitotoxicity and stroke
2872. Brain energy metabolism in glutamate-receptor activation and excitotoxicity: role for APC/C-Cdh1 in the balance glycolysis/pentose phosphate pathway
2873. Alcohol, excitotoxicity and adult brain damage: an experimentally unproven chain-of-events
2874. A ‘danse macabre’: tau and F yn in STEP with amyloid beta to facilitate induction of synaptic depression and excitotoxicity
2875. Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons
2876. Chronic stress enhances methamphetamine‐induced extracellular glutamate and excitotoxicity in the rat striatum
2877. The role of canonical transient receptor potential channels in seizure and excitotoxicity
2878. Role of adaptor protein MyD88 in TLR-mediated preconditioning and neuroprotection after acute excitotoxicity
2879. Kainic acid-induced excitotoxicity experimental model: protective merits of natural products and plant extracts
2880. Microglia activation contributes to quinolinic acid-induced neuronal excitotoxicity through TNF-α
2881. Growth hormone protects against kainate excitotoxicity and induces BDNF and NT3 expression in chicken neuroretinal cells
2882. A novel Conus snail polypeptide causes excitotoxicity by blocking desensitization of AMPA receptors
2883. Lactation is a natural model of hippocampus neuroprotection against excitotoxicity
2884. Kainate-induced delayed onset of excitotoxicity with functional loss unrelated to the extent of neuronal damage in the in vitro spinal cord
2885. Calpain-mediated degradation of drebrin by excitotoxicity in vitro and in vivo
2886. Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity
2887. Homocysteine-induced acute excitotoxicity in cerebellar granule cells in vitro is accompanied by PP2A-mediated dephosphorylation of tau
2888. Sulforaphane prevents methylmercury-induced oxidative damage and excitotoxicity through activation of the Nrf2-ARE pathway
2889. Neuroprotection of the leaf and stem of Vitis amurensis and their active compounds against ischemic brain damage in rats and excitotoxicity in cultured neurons
2890. The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity
2891. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity
2892. Mild mitochondrial uncoupling’induced protection against neuronal excitotoxicity requires AMPK activity
2893. Kainate-mediated excitotoxicity induces neuronal death in the rat spinal cord in vitro via a PARP-1 dependent cell death pathway (Parthanatos)
2894. Humanin attenuates NMDA-induced excitotoxicity by inhibiting ROS-dependent JNK/p38 MAPK pathway
2895. Intrinsically photosensitive retinal ganglion cells are resistant to N-methyl-D-aspartic acid excitotoxicity
2896. Inhibition of cPLA2 activation by Ginkgo biloba extract protects spinal cord neurons from glutamate excitotoxicity and oxidative stress‐induced cell death
2897. Protection of cortical neurons from excitotoxicity by conjugated linoleic acid
2898. Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity
2899. Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity
2900. Glutamatergic nervous system degeneration in a C. elegans TauA152T tauopathy model involves pathways of excitotoxicity and Ca2+ dysregulation
2901. Withanone, an active constituent from Withania somnifera, affords protection against NMDA-induced excitotoxicity in neuron-like cells
2902. Guanosine protects against traumatic brain injury-induced functional impairments and neuronal loss by modulating excitotoxicity, mitochondrial dysfunction, and …
2903. NMDA and AMPA receptor mediated excitotoxicity in cerebral cortex of streptozotocin induced diabetic rat: ameliorating effects of curcumin
2904. Attenuation of glutamate-induced excitotoxicity by Withanolide-A in neuron-like cells: role for PI3K/Akt/MAPK signaling pathway
2905. Hesperidin inhibits glutamate release and exerts neuroprotection against excitotoxicity induced by kainic acid in the hippocampus of rats
2906. The effects of NAD+ on apoptotic neuronal death and mitochondrial biogenesis and function after glutamate excitotoxicity
2907. Topiramate protects against glutamate excitotoxicity via activating BDNF/TrkB-dependent ERK pathway in rodent hippocampal neurons
2908. excitotoxicity induced by realgar in the rat hippocampus: the involvement of learning memory injury, dysfunction of glutamate metabolism and NMDA receptors
2909. Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: potential therapeutic application for treatment of gliomas
2910. Insight into glutamate excitotoxicity from synaptic zinc homeostasis
2911. Anesthetic protection of neurons injured by hypothermia and rewarming: roles of intracellular Ca2+ and excitotoxicity
2912. p53 mediates autophagy activation and mitochondria dysfunction in kainic acid-induced excitotoxicity in primary striatal neurons
2913. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: involvement of PI3K/Akt and MEK …
2914. Protective role of arginase II in cerebral ischemia and excitotoxicity
2915. Neuroprotective effects of daphnetin against NMDA receptor-mediated excitotoxicity
2916. ATP leakage induces P2XR activation and contributes to acute synaptic excitotoxicity induced by soluble oligomers of β-amyloid peptide in hippocampal neurons
2917. A truncated fragment of Src protein kinase generated by calpain-mediated cleavage is a mediator of neuronal death in excitotoxicity
2918. Rapid loss of glutamine synthetase from astrocytes in response to hypoxia: implications for excitotoxicity
2919. Adenosine A 2B receptor-mediated leukemia inhibitory factor release from astrocytes protects cortical neurons against excitotoxicity
2920. HIF‐1α triggers long‐lasting glutamate excitotoxicity via system xc− in cerebral ischaemia–reperfusion
2921. Green tea polyphenols attenuated glutamate excitotoxicity via antioxidative and antiapoptotic pathway in the primary cultured cortical neurons
2922. A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity
2923. Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity
2924. Bis (propyl)-cognitin protects against glutamate-induced neuro-excitotoxicity via concurrent regulation of NO, MAPK/ERK and PI3-K/Akt/GSK3β pathways
2925. NOX2 deficiency ameliorates cerebral injury through reduction of complexin II-mediated glutamate excitotoxicity in experimental stroke
2926. SIRT1-mediated deacetylation of PGC1α attributes to the protection of curcumin against glutamate excitotoxicity in cortical neurons
2927. Transient mitochondrial permeability transition mediates excitotoxicity in glutamate-sensitive NSC34D motor neuron-like cells
2928. ACh receptors link two signaling pathways to neuroprotection against glutamate‐induced excitotoxicity in isolated RGCs
2929. Pharmacologic modulation of cerebral metabolic derangement and excitotoxicity in a porcine model of traumatic brain injury and hemorrhagic shock
2930. Acetate mediates alcohol excitotoxicity in dopaminergic-like PC12 cells
2931. Canonical transient receptor channel 5 (TRPC5) and TRPC1/4 contribute to seizure and excitotoxicity by distinct cellular mechanisms
2932. Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats
2933. Schizandrin protects primary cultures of rat cortical cells from glutamate-induced excitotoxicity
2934. Acidosis-induced dysfunction of cortical GABAergic neurons through astrocyte-related excitotoxicity
2935. Glutamate excitotoxicity mediates neuronal apoptosis after hypothermic circulatory arrest
2936. Tumour associated epilepsy and glutamate excitotoxicity in patients with gliomas
2937. Notch signaling in response to excitotoxicity induces neurodegeneration via erroneous cell cycle reentry
2938. Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction
2939. PFOS-induced excitotoxicity is dependent on Ca2+ influx via NMDA receptors in rat cerebellar granule neurons
2940. Adiponectin protects against glutamate-induced excitotoxicity via activating SIRT1-dependent PGC-1 expression in HT22 hippocampal neurons
2941. Protective Effect of Gabapentin on N-Methyl-D-aspartate–Induced excitotoxicity in Rat Hippocampal CA1 Neurons
2942. … -rich protamine peptides, poly-arginine peptides (R12-cyclic, R22) and arginine–tryptophan-containing peptides following in vitro excitotoxicity and/or permanent …
2943. Role of the c‐Jun N‐terminal kinase pathway in retinal excitotoxicity, and neuroprotection by its inhibition
2944. Medicinal species as MTDLs: Turnera diffusa Willd. Ex Schult inhibits CNS enzymes and delays glutamate excitotoxicity in SH-SY5Y cells via oxidative damage
2945. Aβ induces excitotoxicity mediated by APC/C-Cdh1 depletion that can be prevented by glutaminase inhibition promoting neuronal survival
2946. Glutamate excitotoxicity activates the MAPK/ERK signaling pathway and induces the survival of rat hippocampal neurons in vivo
2947. CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes
2948. Oxidative stress and glutamate excitotoxicity contribute to apoptosis in cerebral venous sinus thrombosis
2949. Interaction between neuropeptide Y (NPY) and brain‐derived neurotrophic factor in NPY‐mediated neuroprotection against excitotoxicity: a role for microglia
2950. Icariin, a major constituent from Epimedium brevicornum, attenuates ibotenic acid-induced excitotoxicity in rat hippocampus
2951. excitotoxicity upregulates SARM1 protein expression and promotes Wallerian-like degeneration of retinal ganglion cells and their axons
2952. BMP4 is a peripherally-derived factor for motor neurons and attenuates glutamate-induced excitotoxicity in vitro
2953. Parkin overexpression protects retinal ganglion cells against glutamate excitotoxicity
2954. Cabergoline, dopamine D2 receptor agonist, prevents neuronal cell death under oxidative stress via reducing excitotoxicity
2955. … ischemia and reperfusion injury in middle cerebral artery occlusion of rat via modulation of apoptosis, inflammation, oxidative stress, and excitotoxicity
2956. Tetramethylpyrazine nitrone protects retinal ganglion cells against N‐methyl‐d‐aspartate‐induced excitotoxicity
2957. Mesenchymal stem cell protection of neurons against glutamate excitotoxicity involves reduction of NMDA-triggered calcium responses and surface GluR1, and is …
2958. RNF146 inhibits excessive autophagy by modulating the Wnt-β-Catenin pathway in glutamate excitotoxicity injury
2959. A novel tetramethylpyrazine derivative prophylactically protects against glutamate-induced excitotoxicity in primary neurons through the blockage of N-methyl …
2960. αCaMKII is differentially regulated in brain regions that exhibit differing sensitivities to ischemia and excitotoxicity
2961. Cannabinoid receptor activation reduces TNFα-induced surface localization of AMPAR-type glutamate receptors and excitotoxicity
2962. Real‐time visualization of cytoplasmic calpain activation and calcium deregulation in acute glutamate excitotoxicity
2963. Astrocyte-dependent vulnerability to excitotoxicity in spermine oxidase-overexpressing mouse
2964. excitotoxicity and mitochondrial dysfunction underlie age-dependent ischemic white matter injury
2965. Mitochondrial fragmentation in excitotoxicity requires ROCK activation
2966. Protection of neuronal cells from excitotoxicity by disrupting nNOS-PSD95 interaction with a small molecule SCR-4026
2967. Melanopsin-expressing retinal ganglion cells are relatively resistant to excitotoxicity induced by N-methyl-d-aspartate
2968. Ghrelin protects spinal cord motoneurons against chronic glutamate excitotoxicity by inhibiting microglial activation
2969. Depletion of polysialic acid from neural cell adhesion molecule (PSA-NCAM) increases CA3 dendritic arborization and increases vulnerability to excitotoxicity
2970. Neuroprotection against glutamate-induced excitotoxicity and induction of neurite outgrowth by T-006, a novel multifunctional derivative of tetramethylpyrazine in …
2971. Changes in cholesterol biosynthetic and transport pathways after excitotoxicity
2972. Both prolactin (PRL) and a molecular mimic of phosphorylated PRL, S179D-PRL, protect the hippocampus of female rats against excitotoxicity
2973. Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis
2974. Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury
2975. Knockdown of the aryl hydrocarbon receptor attenuates excitotoxicity and enhances NMDA‐induced BDNF expression in cortical neurons
2976. Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus
2977. Acute treatment with red wine polyphenols protects from ischemia-induced excitotoxicity, energy failure and oxidative stress in rats
2978. Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia–ischemia
2979. Knockdown of m‐calpain increases survival of primary hippocampal neurons following NMDA excitotoxicity
2980. Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for P arkinson’s disease
2981. Neuroprotective effects of oxymatrine against excitotoxicity partially through down-regulation of NR2B-containing NMDA receptors
2982. Self‐induced accumulation of glutamate in striatal astrocytes and basal ganglia excitotoxicity
2983. Ciliary neurotrophic factor protects striatal neurons against excitotoxicity by enhancing glial glutamate uptake
2984. Unconjugated TAT carrier peptide protects against excitotoxicity
2985. O-GlcNAc glycosylation of nNOS promotes neuronal apoptosis following glutamate excitotoxicity
2986. Neuroprotective effects of intrastriatal injection of rapamycin in a mouse model of excitotoxicity induced by quinolinic acid
2987. Activation of ERK1/2 and PI3K/Akt by IGF-1 on GAP-43 expression in DRG neurons with excitotoxicity induced by glutamate in vitro
2988. Sodium metabisulfite: effects on ionic currents and excitotoxicity
2989. Nicotine‐mediated neuroprotection of rat spinal networks against excitotoxicity
2990. excitotoxicity‐induced endocytosis confers drug targeting in cerebral ischemia
2991. Spatiotemporal resolution of BDNF neuroprotection against glutamate excitotoxicity in cultured hippocampal neurons